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ABSTRACT
Dysfunction in homeostatic mechanisms of cell death and
proliferation are considered to be important in carcinogenesis.

The

p53 gene has been implicated in the regulation of cell death and
proliferation.

The host response was measured through sequential

immunohistochemical (IHC) detection of apoptosis, PCNA, and p53 in
livers of Fundulus grandis fish exposed to MNNG or to 2-AF, two known
carcinogens.

Studies performed determined the stability of MNNG in

saltwater, the suitability of different fixatives on IHC detection of
apoptosis, PCNA-PC10, and p53 (various clones), and frequencies of
expression of apoptosis, PCNA, and p53.

A total of 996 fish specimens

were utilized.
Results indicated that 34 |iM MNNG saltwater solution degraded
into its components 70 minutes after its preparation.

Preservation of

tissue morphology and application of mammalian methodologies for
immunohistochemical detection of apoptosis, PCNA-PC10, and p53-PAb240
were best accomplished by buffered 10 % formalin solution.
Significant differences were found in the levels of p53 protein
detected at experimental day 180 between the MNNG exposed and the
control fish groups.

Experimental data suggested that apoptosis in

fish livers is significantly suppressed at experimental day 180 as a
result of exposure to MNNG and possibly to 2-AF.

Detection of PCNA in

liver cells was significantly increased by day 9 of the experiment as
a result of chemically-mediated cell injury regardless of the compound
used.

Concurrent use of a marker for cell death, such as apoptosis,

with one for proliferation greatly enhances the assessment of the
effect of these compounds on liver cell response.

Increased detection

of p53, suppression of apoptosis, increased cellular proliferation,
and increased occurrence of putative preneoplastic changes noted
histologically (basophilic foci, megalocytosis, and karyomegaly) in

vii
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the liver of fish subjected to MNNG suggest that tumors with mutated
p53 gene would develop, in time, in liver.

Because similar

histological changes were noted in the 2-AF exposed fish group in the
absence of increased p53, it is hypothesized that the neoplastic
process which may occur as a result of exposure to this compound may
not initially involve mutation of the p53 gene, but that other
mechanisms of carcinogenesis may be involved.
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INTRODUCTION
In multicellular organisms homeostasis is maintained through a
balance between cell proliferation and cell death.

Dysfunction in the

maintenance of this balance is believed to be important in the
pathogenesis of neoplasia.

This makes the study of cell death, such

as apoptosis, an active area of research in today's multidisciplinary
biological sciences.

Apoptosis is now accepted as a critical element

in the repertoire of cellular responses,

but there is still an

incomplete picture of the multiple features and complex intracellular
processes involved.

The assessment of cell proliferation has also

become a common monitor of homeostatic host response to cell injury.
Concurrent use of a marker for cell death, such as apoptosis, with one
for proliferation greatly enhances the assessment of injurious agents
on host cellular response.

The p53 gene has been implicated directly

and indirectly in the regulation of cell death and proliferation.

The

normal (wild type) p53 gene protein suppresses the division of
genetically damaged or altered cells by causing a pause in the cell
cycle and by promoting exit from it through apoptosis (Sidransky and
Hollstein 1996).

Damage to the cellular DNA can result in either

restoration of its genomic integrity, or in activation of the cell's
own suicide mechanism,

apoptosis, resulting in the elimination of the

affected cell from the rest of the population.

This function of p53

as "guardian of the genome" may extend to a role in initial monitoring
and repair of DNA damage in addition to direct control of cell growth
and death (Lane 1992) .
In this study the host response was measured through sequential
immunohistochemical detection of apoptosis, proliferating cell nuclear
antigen (PCNA), and p53 in livers and liver lesions of Fundulus
grandis fish exposed to the alkylating agent, n-methyl-n’-nitro-nnitrosoguanidine (MNNG), or to the polycyclic aromatic hydrocarbon, 2aminofluorene (2-AF).

1
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The first chapter covers an extensive review of the current
literature on apoptosis, including appropriate reviews on cell
proliferation and on p53 gene as these relate to the process of
apoptosis.

The review is centered primarily on the molecular aspects

of the control of apoptosis.
The second chapter explains the experimental design and discuss
preliminary work required to perfect the methodology for subsequent
experiments; these include studies on MNNG stability on saltwater,
development and application of an in-situ DNA labeling technique for
detection of apoptosis in fish, and evaluation of different fixatives
on immunohistochemical detection of apoptosis.

This is followed by an

experiment on the comparative immunohistochemical detection of
apoptosis and related histological changes in the liver of Fundulus
grandis exposed to MNNG and 2-AF compared to unexposed fish at
different time intervals.

The chapter finalizes with sections on

results and discussion.
The third chapter describes primarily applications of a
mammalian technique for immunolocalization of proliferating cell
nuclear antigen (PCNA) protein in fish, preceded by a brief
description of the experimental design and pertinent preliminary work
needed, as discussed in chapter 2.

Experiments on the comparative

liver tissue response to MNNG and 2-AF exposure compared to control
fish through sequential evaluation of both immunolocalization of PCNA
and histological changes will be discussed.

The chapter will end with

sections on results and discussion.
The fourth chapter describes experiments on the comparative
immunohistochemical detection of the p53 protein in the liver of
Fundulus grandis exposed to MNNG and 2-AF compared to unexposed fish.
As in the previous chapters, brief descriptions on experimental design
and pertinent preliminary work are included.

The effect of different

2
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fixatives on immunohistochemical detection of p53 protein using
various commercially available p53 antibody clones on were evaluated
initially.

This was followed by application of the results obtained

in the preliminary experiments, and the sections on results and
discussion.
The final chapter contains the overall conclusions and outcomes
about this work.

Appendixes are included at the end of the

manuscript, before the Vita, and include data and statistical tables.
Philosophy of using aquatic organisms as test species for human health
risk assessment
In the past few years fish have become popular models for the
study of carcinogenesis.

The philosophy of using aquatic organisms as

test species for human health risk assessment rests on several factors
(Huff 1995).

These include the public awareness that the water used

for drinking, recreational and commercial use, and fishing may contain
significant amounts of toxic and carcinogenic compounds, and that the
consumption of aquatic organisms living in contaminated waters could
pose serious health hazards.

Human concern centers on whether eating

fish and other sea creatures contaminated with chemicals causes or
exacerbates toxic, reproductive, and long-term adverse effects such as
cancer.

It follows also that fish are natural sentinels of aquatic

pollution and that use of fish as an alternative species for
experimental carcinogenesis studies has sound scientific basis.

The

use of fish in this manner has several advantages and disadvantages.
Advantages include: 1) the low cost per animal, which permits
statistically challenging, large-scale studies; 2) small body size at
exposure times allows studies with several different chemicals at one
time; 3) its nonmammalian status strengthens the comparative aspects
of different mechanisms of chemically-induced cell injury and
carcinogenesis for extrapolation of animal studies to humans;

4) the

availability of externalized embryos in large numbers provides for a

3

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

practical approach in carcinogenesis, teratogenesis, and gene transfer
studies; 5) totally homozygous clones may be created and propagated
relatively easily; 6) a similar overall biochemical and molecular
basis of carcinogenesis (i. e., xenobiotic metabolism pathways, proto
oncogene activation, and histological progression) exists between fish
and mammals; and 7) direct contact of fish with environmentally
sensitive marine and fresh water habitats makes them a more suitable
sentinel for assessment of potential carcinogenic and/or toxicologic
hazardous conditions.

Disadvantages include: 1) absence of certain

target organs in fish, such as colon, rectum, breasts, prostate, and
others; 2) the long generation time of some species (trout for
example) may hinder and limit genetic studies; 3) unavailability of
nutritional and husbandry requirements for local, ecologically
sensitive species (Fundulus grandis, for example) could hinder its
potential as a laboratory-raised species; 4) the lack of current
knowledge of the role of the immune or endocrine systems on regulation
and control of cancer; 5) the relative availability of only a few,
well characterized fish cell lines suitable for transformation
studies, gene sequencing, and chromosomal mapping; and 6) the
relatively low number of different test species used today for
carcinogenesis studies.
A main legal, ethical, and scientific concern in using
alternative test species, like fish or even rats and mice, is the
direct extrapolation of the data obtained from these organisms to
humans.

Could it be ultimately predicted that humans are at increased

risk from eating fish from contaminated waters?

Probably not.

We

could gain substantially more by unraveling the processes of
chemically-induced cell injury and the host's subsequent cell and
tissue response.

Public health logic and human safety priorities will

ultimately dictate the reliance on the use of aquatic species for the
study of cancer.

4
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If the field of toxicologic pathology is moving increasingly
toward the use of molecular markers, one could ask in terms of
classical pathology methods what is to be gained by the use of
molecular biomarkers and what is to be lost by abandoning such
classical techniques?

Such a question strikes straight at today's

quandary about the involvement, or the lack thereof, of pathologists'
participation in molecular pathology.
For the most part, diagnosis and classification of cell injury
is based on a combination of clinical, macroscopic, and microscopic
features.

This is true for humans and animals, including fish.

Descriptions and diagnosis of chemically-mediated cell injury as well
as of certain other types of cell injury, are frequently subjective
and semiquantitative at best.

Efforts to develop special

instrumentation along with new biotechnology products, which allow the
application of many molecular and immunohistochemical techniques, have
widened our appreciation and understanding of those events that occur
in an injured cell.

This has expanded the view and interpretation of

disease to the extent that a better, more informative, less
subjective, and more quantitative assessment can be made about
chemically-mediated cell injury.

Pathologists will make substantial

gain by combining molecular biomarkers with the more classic
histologic techniques.

Replacement of one technique by the other

would pose a great danger for the discipline, as replacement of the
pathologist by the molecular biologist could become the norm rather
than the exception.

The use of molecular biology techniques in

pathology are here to stay, whether we are ready or not.
What is Pathology anyway?
Pathology studies the derangement of molecules, cells, tissues,
and function that occur in living organisms in response to injurious
agents or deprivations.

Injurious agents may include chemical

compounds, forms of energy, injurious substances and deprivation of

5
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essential nutrients.

Genetic factors can also be considered as

potential injurious agents (Jones, Hunt et al. 1997).
The key word is response, which consists of a spectrum of reactions
ranging from reversible injury, to irreversible injury and death, to
malignant transformation.

When the response impairs the health and/or

well-being of an individual, it is then regarded as disease.
The body is also subjected to many normal stimuli to which it
responds in a similar manner as it does to abnormal or deleterious
stimuli.

For example, the atrophy and necrosis found in thymic

involution is similar to the atrophy and necrosis noted in an organ or
tissue after impairment of its blood supply.

Tissue (or cell) death

caused by anoxia may be passive or active (as in inflammation).

Most

cases represent life saving defense mechanisms, that may be efficient
(leading to no disease) or inefficient (leading to disease).
"Pathologists must be able to recognize that all such reactions are
real, consistent, and recognizable, and must be aware of both the
benefits and disadvantages of these reactions in the host" (Jones,
Hunt et al. 1997) .
About cell injury, cell death, and necrosis
Cell injury refers to any biochemical or structural alteration
that impairs the ability of a cell to function normally.

Such injury

may be mild, transient, and reversible, or it may of such severity
that it becomes irreversible.
Cell death refers to that point when cell injury becomes
irreversible, or has passed the "point of no return".

Cell death

occurs in two biochemical and morphologically distinct ways:
accidental or "unscheduled" cell death (formerly known simply as
necrosis) and apoptosis (Majno and Joris 1995; Jones, Hunt et al.
1997).
Necrosis refers to the characteristic light microscopic changes
that result from enzymatic degradation of the nucleus and cytoplasm

6
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that define cell death, whether through accidental cell death or
through apoptosis.

The typical morphologic changes of necrosis are

not usually seen for 12 to 18 hours after death of the cell.

Hence,

there is a period of time when a "dead" cell appears microscopically
identical to a "living" cell.

Hopefully, these statements help to

clarify the confusion that exists in today's literature that is still
trying to differentiate between apoptosis and necrosis as different
forms of cell death.

For an even

"bigger" confusion see the paper of

Columbano, 1995 (Columbano 1995).
The causes of cell injury and death are several.

These include:

1) forms of kinetic injury (including mechanical, thermal, and
radiation); 2) exposure to reactive forms of exogenous chemicals (such
as poisonous plants and microbiologic origin) and exogenous chemicals
(such as toxic products of metabolism, peroxidases, and free
radicals); 3) deprivation of essential nutrients (like water, oxygen,
and foodstuffs); 4) immunologic reactions; and 5) genetic diseases.
Accidental cell death is the most commonly recognized type, and,
although it has numerous causes, it is typified by biochemical and
morphologic alterations resulting from anoxia (ischemia).

The term

oncosis has been used to describe the morphological appearance of
ischemic cell death (Majno and Joris 1995).
referred to as "programmed cell death",

Apoptosis, which is often

often results from activation

and transcription of specific genes present in all cells.

In some

situations, activation of these genes occurs normally, accounting for
the normal turnover of cells in the body.

Examples of these

situations are found during normal embryologic development of limbs,
thymus, or brain, where certain cells are predetermined or programmed
to die at certain times while others continue to proliferate and
differentiate.

Under certain pathologic conditions, however, these

genes can be activated prematurely or triggered in cells where they
are normally suppressed leading to premature atrophy or senescence of

7
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the affected organs or tissues.

Examples of this phenomenon are noted

in thymic atrophy, experimentally induced by corticosteroids and
radiation; tumor necrosis factor alpha (TNF-a)-induced cachexia;

in

the lymphoid depletion that occurs in human, simian, feline, and
probably bovine immunodeficiency syndromes; and in the elimination of
foreign or virally infected cells, when such death is mediated by
cytotoxic T-lymphocytes.
Unlike accidental cell death, where large numbers of diversified
cells in a tissue or organ are often affected, apoptosis tends to
affect individual or small clusters of cells of a specific type.

This

suggests that different cells may vary in their threshold level for
apoptosis to occur.
Although often referred to as genetically mediated or programmed
cell death, the cytoplasmic changes that characterize apoptosis have
been induced in cells from which the nuclei has been removed
experimentally;

this suggests that transcription of genes and

synthesis of their protein products are not essential for induction of
apoptosis under most situations.
The proteins involved are constitutively expressed in mammalian
cells, but are normally rendered inactive by "antiapoptotic" proteins,
synthesized by the same cell, possibly in response to the so-called
survival signal received from neighboring cells, extracellular
substrates, or fluids.

The survival signals include growth factors,

extracellular matrix components, and various hormones.

Loss of these

factors spontaneously initiates apoptosis.
Apoptosis may be physiologic and represent a mechanism by which
a balance between cell growth (proliferation) and cell death is
maintained.

On the other hand, apoptosis may be regarded at times as

pathologic or deleterious to the host, especially when this delicate
balance between growth and death is disturbed.

Inhibition of

8
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apoptosis may be as important as amplified oncogene expression in the
pathogenesis of certain neoplastic diseases.
Although apoptosis may be initiated by many different intrinsic
and extrinsic signals, all of these signal pathways converge at some
point to activate a common, genetically controlled mechanism of cell
death.

The genes and gene-products responsible for this apoptotic

mechanism are thought to be present in all cells.
expression is tightly controlled by other genes.

Regulation of their
Mammalian examples

of these regulatory genes lie in the bcl-2 gene family, while related
genes have been found in the fruit fly, Drosophila melanogaster, and
in the nematode, Caenorhabditis elegans.

Of vital biological

importance is their conservation among such a wide range of phylogenic
species.
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An

CHAPTER 1.

LITERATURE REVIEW ON APOPTOSIS

Introduction
The importance of the process known as apoptosis has been widely
recognized over the past few years and its significance in the field
of biology is still being evaluated today.

Apoptosis is now accepted

as a critical element in the repertoire of cellular responses,

but

there is still an incomplete picture of the multiple features and
complex intracellular processes involved.

This makes the study of

apoptosis an active area of research in today's multidisciplinary
biological sciences, including the field of veterinary pathology.
Many articles have been published in recent years reviewing the
process of apoptosis (Columbano 1995; Liebermann, Hoffman et al. 1995;
Majno and Joris 1995; Moller 1995; Payne, Bernstein et al. 1995;
Steller 1995; Lee and Bernstein 1995a; Bosman, Visser et al. 1996;
Chiarugi and Ruggiero 1996; Denmeade, Lin et al. 1996; Hale, Smith et
al. 1996; McConkey, Zhivotovsky et al. 1996; Pritchard and Watson
1996; Wu 1996; Dixon, Soriano et al. 1997; Fleisher 1997; Rowan and
Fisher 1997).
Dysfunction of apoptotic mechanisms are probably responsible for
oncogenesis, autoimmunity,

and degenerative diseases as reviewed by

several recently published articles (Bursch, Oberhammer et al. 1992;
Carson and Ribeiro 1993; Thompsom 1995; Bosman, Visser et al. 1996;
Duke, Ojcius et al. 1996; Mallat, Tedgui et al. 1996; Shimushi, Masuda
et al. 1996)

.

In multicellular organisms homeostasis is maintained through a
balance between cell proliferation and cell death.

Much is known

about the control of cell proliferation; however, less is known about
the control of cell death.

Cell death during embryogenesis,

metamorphosis, endocrine-dependent tissue atrophy, and normal or
physiologic tissue turn over occurs primarily through an
evolutionarily conserved form of cell suicide called apoptosis.

10
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Apoptosis is a Greek word that means "leaves dropping off here and
there from a tree".

The prefix "apo" means "from" and

"ptosis" means

"a fall".
Programmed cell death was discussed as a physiological event as
soon as stains became available.

It was introduced in an 1885 paper

by the same Walter Flemming who created the terms chromatin and
mitosis (Flemming 1885); Flemming studied ovarian follicles in mammals
and noticed that the epithelial lining of regressing follicles was
littered with cells, the nuclei of which were breaking up; Flemming
described the half-moons of pyknotic chromatin typical of apoptosis as
well as apoptotic bodies loose in the cavity of the follicle, and
called it chromatolysis, referring to the fact that the nucleus
ultimately disappears.
Franz Nissen,

A few months later, a german medical student,

(Nissen 1886) published a paper describing similar

observations in the mammary gland.

In 1914, a german anatomist,

Ludwig Graper, published a paper entitled:

"A new point of view

regarding the elimination of cells” (Graper 1914), where it was
established that some mechanism must exist to counterbalance mitosis;
he concluded that Flemming's chromatolysis was the answer.

But his

paper had no significant impact; it was overlooked, perhaps because it
appeared right at the outset of WW1 in a German journal on cellular
investigation that many pathologists might have missed.
In 1971 Kerr (Kerr 1971) described shrinkage necrosis in an
induced liver atrophy experiment.

A year later, Kerr called it

apoptosis (Kerr, Wyllie et al. 1972).
Between 1976 and 1981, three groups examined chromatin from
irradiated tissues electrophoretically and found that it broke down
into fragments with ladder-like pattern (Skalka, Matyasova et al.
1976; Yamada, Ohyama et al. 1981; Zhivotovsky, Zvonareva et al. 1981).

11
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In 1984 Wyllie et al. linked this phenomenon to apoptosis(Wyllie,
Morris et al. 1984).
The morphologic and biochemical features of apoptosis have been
reviewed in textbooks of pathology and recent articles(Majno and Joris
1995; Jones, Hunt et al. 1997).

Apoptosis is a form of cell death

characterized by morphological as well as biochemical criteria, and it
can be considered as a counterpart of mitosis.

Cell shrinkage

characterizes apoptosis in contrast to the cell swelling (cytoplasm
and organelles) that occurs in hypoxic cell death.

The Na-K pump

remains unaffected initially, and the membranes remain intact.
Activation of cellular proteases lead to disruption of cytoskeletal
elements and causes the cell to shrink.

Activation of endonucleases

occurs early in apoptosis; this leads to DNA cleavage between
nucleosomes giving rise to fragments of 180-200 base pairs, agarose
gel migration of which leaves a characteristic ladder pattern; this is
in contrast with the heterogeneous agarose gel migration pattern left
by the DNA from cells which have died as a consequence of
hypoxia/anoxia.
The nuclear chromatin becomes electrodense, and often assumes a
characteristic "half-moon" configuration beneath the undisrupted
nuclear membrane.

The nuclei may break up into dense, membrane bound

masses, in contrast to the karyorrhexis seen in accidental cell death
(Jones, Hunt et al. 1997) or in oncosis (Majno and Joris 1995), in
which the nuclear membrane is disrupted.

During the shrinkage

process, the cytoplasmic plasma membrane emits small pseudopodia
(buds), rather than the cytoplasmic blebs noted in hypoxic cell death.
These pinch off from the shrunken remains of the apoptotic cell,
giving rise to apoptotic bodies, which are membrane-bound bodies that
may contain several cellular organelles including mitochondria,
lysosomes, golgi, endoplasmic reticulum, and masses of condensed
chromatin surrounded by a nuclear membrane.
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A perceptible inflammatory reaction is not elicited by these
apoptotic bodies since no leakage of the usual mediators found in an
inflammatory process occurs.

Scavenger macrophages and/ or

neighboring cells ingest and degrade these apoptotic bodies.
The process is under genetic control (Kerr, Winterford et al.
1994; Wyllie 1994) and can be initiated by an internal clock, or by
extracellular agents, such as hormones, cytokines, killer cells, and a
variety of chemical, physical, and viral agents.

Apoptosis can run

its course very fast, even in minutes (34 min. in Bessis' movie of
apoptotic cells (Bessis 1958)); therefore, it is unobtrusive (rarely
prominent) in tissue sections (Weedon, Searle et al. 1979).
"In these days of molecular pathology it is well to remember
that the marvelous story of apoptosis was initiated by a very simple,
almost elementary morphological observation, accessible to the
microscopes of our great-grandfathers" (Majno and Joris 1995).
Molecular Regulation of Apoptoais
An evolutionary perspective
Examples of apoptosis have been described throughout evolution,
including bacteria, unicellular organisms, plants, and animals.
Recent findings (Ameisen 1996) indicate that apoptosis as a cell death
program does exist in unicellular organisms and bacteria in contrast
to earlier comments(Vaux and Haecker 1994), which suggested that such
mechanism for cell suicide probably had not evolved in single-celled
organisms.

A morphologically and biochemically similar process to

apoptosis has been described in at least four unicellular organisms,
including the kinetoplastic parasites Trypanosoma cruzi and
Trypanosoma brucei rhodensiense, and in the free-living slime mold
Dictyostelium discoideum and the free-living ciliate, Tetrahymena
thermophila (Ameisen 1996).

This program could be elicited in these

organisms by environmental stress (such as starvation) as well as by
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extracellular signals, which, in the case of Trypanosoma, may come
from the multicellular host, and activate the cyclic AMP pathway
inducing differentiation to a reversible G0/Gi arrested stage.

In

bacteria, the autolysins that participate in cell division can also
induce self-destruction. So, if effectors of the cell cycle machinery
can also be effectors of the self-destruction of the cell in which
they operate, then the requirement for coupling cell survival to the
prevention of self-destruction, or apoptosis, is as old as the origin
of the cell (Ameisen 1996).
In plants, in order to conduct fluid, the cells from the xylem
must die, and so must the cells that make up the tadpole's tail and
the neurons that fail to form proper intercellular connections.

The

process of apoptosis has evolved through time not only for
morphogenetic and developmental reasons but also as a defense
mechanism, as a form of cellular altruism.

An example would be the

hypersensitivity response in plants in which a cell detecting a single
bacterium not only kills itself but alerts neighboring cells, which in
turn self-destruct (Vaux and Haecker 1994).
Caenorhabditis slogans- a model for the study of apoptosis
Caenorhabditis elegans is considered one the most important
models for the study apoptosis and molecular biology in multicellular
organisms.

It has a reproducible embryonic development which has been

precisely mapped.

Some 1090 somatic cells are eventually formed in

the adult of which 131 undergo programmed cell death (Ellis, Jacobson
et al. 1991).

Death of these cells is just as predictable as division

and differentiation occurring in development.

This organism has

provided valuable information about apoptosis in mammals since it
resembles this process in several areas, including its genetic
connections, and thus have become a very valuable model.

Mutant
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nematodes with defects in different parts of the cell death process
have allowed identification of the components of the genetic pathway.
Several genes involved at different stages in developmental
programmed cell death have been identified and classified according to
their function(Yuan and Horvitz 1992; Yuan, Shaham et al. 1993; Yuan
1995).

Genes involved in specification of cell death include egl-1,

ces-1, and ces-2.

Those

ced-3, ced-4, ced-8, and

involved in programmed cell death include
ced-1.

A single gene has been identified

for the suppression of cell death, ced-9.

Several genes have been

identified for the process of phagocytosis of dead cells, and include
ced-1, ced-2, ced-6, ced-5, ced-1, and ced-10.

And a single gene,

nuc-1, has been coded for digestion of dead cells.

Cloning and

sequencing of some of these genes revealed that ced-9 is homologous to
the Bcl-2 family of protein in mammals (Yuan 1995); that ced-3 is
homologous to interleukin-ip-converting enzyme (ICE) of cysteine
proteases(Yuan, Shaham et al. 1993); and that the deduced amino acid
sequence of ced-4 contains two potential calcium-binding binding
domains potentially related to unknown families of mammalian
proteins(Yuan and Horvitz 1992); however, no counterpart of the Reaper
equivalent, which is a very important protein in programmed cell death
in the fruit fly, Drosophila melanogaster, has been found in
Caenorhabditis elegans.
Signaling in Apoptosis
A cell can undergo apoptosis as a result of information received
from its environment, which is interpreted in the context of its
internal information, such as cell type, state of maturity, and
developmental history (Williams and Smith 1993) .

External information

may consist of appearance or disappearance of cytokines, hormones, and
growth factors, or of a change in intercellular interactions.
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Such

external information received or perceived is not exclusive in
eliciting apoptosis or survival of the cell.
Intracellular signals are often involved in the promotion of
proliferation or differentiation even though certain intracellular
signal pathways, such as the Fas-mediated pathway, are of particular
importance in controlling apoptosis.

The involvement of key molecules

in the induction of apoptosis or proliferation is a recurring theme
(PKC, p53, ceramide, c-myc) that reflects, at least in part, the
adaptation of many signaling pathways to the control of different
responses in different cell types and under different conditions.
Cell surface receptor-mediated mechanisms which control apoptosis
often act through a signal transduction system that involves
stimulation of the receptor, followed by activation of protein
kinase/phosphatase cascades, and release of second messengers to
upregulate or suppress the transcription of specific genes.
Accumulation of evidence suggests that these signaling systems can
often be redundant, can intersect, or can "crosstalk", greatly
altering the cellular response to a given stimulus.

The evidence also

suggests that often signaling pathways converge in to one, or at least
very few common final pathways.

For example, the bcl-2 family is

affected by a widespread spectra of apoptotic signals, which converge
at the point of action of the corresponding gene product(s).
Fas (APO-1, CD95)
Knowledge of the control of cell death and survival has been
gained through engaging members of the Fas/TNF receptor 1 (tumor
necrosis factor receptor 1, TNFR 1) family of cell-surface receptors
(Nagata and Goldstein 1995), which have provided a useful model for
the study of cell surface receptor-mediated control of apoptosis and
cell survival.

Induction of apoptosis through the Fas-Fas-L system is

considered particularly important in the regulation of the immune
system (Nagata and Goldstein 1995).

In addition, it is believed that
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interaction between Fas-ligand and Fas receptor mediates the apoptotic
cell death induced by engaging the T-cell receptor on T-lymphocyte
cell lines (Brunner, Mogil et al. 1995).
Intestinal epithelial cells that are produced in the crypts die
rapidly through apoptosis at the tips of the villi.

Recently, the

expression and function of Fas and FasL on the intestinal
intraepithelial lymphocytes and intestinal epithelial cells or
enterocytes in normal mice was examined(Inagaki-Ohara, Nishimura et
al. 1997).

It was found that both intestinal intraepithelial

lymphocytes and intestinal epithelial cells express Fas, but that only
intestinal intraepithelial lymphocytes expressed FasL.

In this study

it was concluded that the induction of apoptosis in enterocytes from
the tips of the villi may occur as a result of Fas/FasL-mediated
cytotoxicity induced by intestinal intraepithelial lymphocytes.
The primary structure of Fas, TNFR 1 and related proteins have a
death domain, which consists of a cytoplasmic region of 60 to 70 amino
acids, important in inducing apoptosis(Nagata and Goldstein 1995), and
homologous to Reaper protein(White, Grether et al. 1994) in Drosophila
melanogaster that is essential for programmed cell death in this fruit
fly.

Hale and coworkers, 1996, suggested that Fas, TNFR 1, and

potentially other proteins were produced evolutionarily by fusion of
exons encoding an inducer of cell death related to Reaper with those
encoding a surface receptor.

The resulting hybrid protein would then

allow induction of apoptosis through external stimuli by linking them
to a pre-existing cell death pathway.
Other proteins which may form part of the intracellular signals
induced by Fas have been identified recently; these include M0RT1/FADD
(Boldin, Varfolomeev et al. 1995)

(Chinnaiyan, O'Rourke et al. 1995),

TRADD (Hsu, Xiong et a l . 1995), and RIP (Stanger, Leder et al. 1995).
All three predicted gene products contain the death domain (Cleveland
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and Ihle 1995), and it is likely that these domains associate with the
death domain of Fas and/or TNFR1.
Protein Tyrosine Kinases

(PTK)

Protein Tyrosine Kinases (PTK) play a significant role in
receptor mediated cell signaling through growth factors with intrinsic
PTK activity, or through receptors which lack intrinsic PTK activity
but are able to recruit and/or activate intracellular PTK in response
to ligand stimulation.

Several review articles concerning

intracellular signaling by PTK have been published recently
(Ziemiecki, Harpur et al. 1994; Erpel and Courtneidge 1995).

Many

cytokine receptors ( receptors for interferons, and the majority of
the hematopoietic growth factors) do not have intrinsic tyrosine
kinase activity.

Oligomerization of the receptor following ligand

binding results in recruitment of PTK to the intracellular domain of
the receptor followed by activation of the signaling pathway of
phosphorylation. Protein Tyrosine Kinases involved in this cascade
include those from the Src family of PTK and from the Janus kinase
family (Jak) (Ziemiecki, Harpur et al. 1994; Erpel and Courtneidge
1995).

The Jak kinases have been associated with a number of cytokine

signaling pathways involved in the control of apoptosis(Ziemiecki,
Harpur et al. 1994; Yousefi, Green et al. 1994)

.

Some of the

cytokines so involved include interferons, interleukin-3 (IL-3),
leukemia inhibitory factor, granulocyte/monocyte-colony stimulating
factor (GM-CSF), erythropoeitin, and IL-2.

Erythropoeitin and IL-2

receptors are related receptors that act through tyrosine
phosphorylation of two distinct Jak kinases, Jak2 and Jakl,
respectively (Barber and D'Andrea 1994).
Several pieces of evidence for the increased involvement of PTK
in the signaling pathway control of apoptosis have been published.

It

was demonstrated that ionizing radiation promoted PTK activation that
is necessary for apoptosis in B cells (Uckun, Tuel-Ahlgren et al.
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1992).

Cells in which the active PTK, Abl (a member of the Src

family) was overproduced were resistant to apoptosis induced by growth
factor withdrawal and to apoptosis induced by chemotherapeutic agents
(Evans, Owen-Lynch et al. 1993).

The ability of chronic myelogenous

leukemia cell line K562 to undergo apoptosis was restored by antisense
abl expression (McGahon, Bissonnette et al. 1994).

In a study of

human leukemia (Owen-Lynch, Wong et al. 1995), continuous functioning
of the v-Abl was required for IL-3 independence,

phosphorylation of

phospholipase C (PLC), and for the Ras regulatory protein pl20 GTPaseactivating protein function.

In another study (Yao and Cooper 1995),

the requirement for phosphatidylinositol-3-kinase in the prevention of
apoptosis by nerve growth factor was demonstrated.

And it has been

shown that stimulation of apoptosis by the engagement of the T-cell
receptor involves the PTK p56lclc (Somma, Nuti et al. 1995) .
Other Kinasas
Serine/threonine kinases have also been implicated in the
control of apoptosis.

The p34cdc2 kinase controls cell entry into

mitosis by complexing with the cyclins A and B and initiating
dissolution of the nuclear membrane and chromatin condensation,
changes which are also noted in apoptosis (Shi, Nishioka et al. 1994).
Blocking of p34cdc2 activity prevented DNA fragmentation characteristic
of apoptosis (Shi, Nishioka et al. 1994).
The Ras signaling pathway
The regulation and function of Ras and Ras-related proteins have
been summarized recently (Khosravi-Far and Der 1994; Khosravi-Far,
Chrzanowska-Wodnicka et al. 1995).

Ras is a member of a superfamily

containing more than 50 small GTPases, functioning as GDP/GTPregulated switches.

They are implicated in the regulation of cellular

proliferation, differentiation, intracellular transportation
processes, and cytoskeletal organization.

The three Ras proteins, H-,

K-, and N-Ras, have a well studied role in signal transduction,
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linking receptor and non-receptor tyrosine kinases to down stream
serine/threonine kinases, including the mitogen-activated protein
(MAP)kinases.

Ras itself is immediately upstream of the protein

kinase encoded by the oncogene c-caf-1.
There
role in the

are indications that the Ras/Raf/MAP kinase cascade has a
inhibition of apoptosis. It has been demonstrated that the

Raf-1 kinase promoted the proliferation of IL-3-dependent myeloid
cells and suppressed apoptosis induced by IL-3 withdrawal (Cleveland,
Troppmair et al. 1994).

Interleukin-3 can stimulate the Ras

activation of MAP kinase via the Src homology-domain-containing (SHC)
protein and the GTPase-activating protein through their
phosphorylation
established

(Owen-Lynch, Wong et a l . 1995).

Roles have been

for Ras-related proteins in the signaling process relevant

to the inhibition of apoptosis, often centered on the regulation of
the Bcl-2 protein and in the consequences of such regulation (Wang,
Miyashita et al. 1994a; Wang, Millan et al . 1995).

Some studies have

implicated Ras-signaling in the regulation of bcl-2-inhibition of
hematopoietic cell apoptosis following growth factor deprivation
(Kinoshita, Yokota et al. 1995a; Kinoshita, Yokota et al. 1995b).

The

induction of mutated ras mRNA, using an inducible expression vector,
restored the levels of bcl-2 mRNA following IL-3 deprivation, and also
blocked the degradation of Bcl-2 protein that had been previously seen
following IL-3 deprivation (Kinoshita, Yokota et al. 1995b).

Rasval‘"

could induce mRNA encoding the Bcl-2-related protein Bcl-xL, though
neither the induction of Rasva112 nor IL-3 deprivation affected the
level of mRNA of another Bcl-2-related protein, Bax.

As the induction

of ras mRNA preceded that of the bcl-2 and bcl-xL mRNA, and was
sustained at a level which correlated with that for Bcl-2 and Bcl-xL
proteins, it was concluded that this mechanism of regulation of
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Bcl-2/Bcl-xL by Ras appeared to be fundamental to IL-3/GM-CSF
inhibition of apoptosis (Kinoshita, Yokota et al. 1995b).
Protein kinase C and Calcium
Surface receptors are coupled to the Ca2* signaling pathways
through G proteins and PTK, which activate phospholipases C (PLC) and
D (PLD) by the hydrolysis of phosphatidylinositol 4,5-bisphosphate
producing inositol trisphosphate and diacylglycerol.

Inositol

trisphosphate promotes the release of Ca2f from the endoplasmic
reticulum and Ca2*" influx through the plasma membrane; diacylglycerol
activates the serine/threonine kinase and the protein kinase C (PKC).
In thymocytes, chemicals that stimulate increases in PLC and
intracellular calcium concentration can induce endonuclease activation
and cell death (Smith, Williams et al. 1989).

It is known that the

PKC signaling pathway can interact with other signaling pathways.

PKC

activation results in the rapid phosphorylation and activation of cRaf kinase, which in turn activates the protein kinase cascade through
phosphorylation and activation of MAP kinases (Kyriakis, App et al.
1992).

Further analysis provided evidence for the interaction of PKC

and the protein kinase A signal transduction pathways (Ojeda, Folch et
al. 1995) .
This crosstalk between signaling pathways may account for the
apparent contradictions between the different molecules, such as PKC,
in the induction of proliferation and apoptosis.

These observations

in addition to the involvement of the phosphatidylinositol 4,5bisphosphate and the sphingomyelin metabolic pathways in the
activation of PKC, implicate PKC in the regulation of apoptosis in
many cells.

Experimental evidence suggesting that PKC is involved in

apoptosis as well as in cell differentiation and proliferation is
largely based in the use of phorbol esters as activators of PKC
(McConkey, Nicotera et al. 1994).

Incubation of thymocytes with

phorbol esters has been reported to induce and to block apoptosis
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(McConkey, Nicotera et a l . 1994).

Similarly, staurosporin can induce

apoptosis (Jacobson, Burne et al. 1993) and block phorbol esterinduced apoptosis (Munn, Beall et al. 1995).

Also, PKC activators,

such as 12-tetradecanoyl-phorbol 13-acetate, are able to inhibit
apoptosis induced by ceramide (Hannun and Obeid 1995) and nitric oxide
(Messmer, Lapetina et a l . 1995).

These observations add to the

complex interactions of the several pathways regulating apoptosis.
Some reports have demonstrated a relationship between increased
cytosolic calcium and apoptosis.
of the IgG receptor,

Azzoni, 1995, observed that coupling

FcyRIII-A, on IL-2-activated natural killer cells

leads to stimulation of PTK p56lclt; this was followed by increased
release of calcium from intracellular stores, and ultimately induced
apoptosis in these cells; subsequently, it was concluded that such
increase in intracellular calcium was necessary for Fcg-receptormediated signaling, including transcription of other cytokine genes
(Azzoni, Anegon et al. 1995).
Other reports have not detected such increases in intracellular
calcium concentration. No correlation was found between early
increases in intracellular calcium concentration and apoptosis in
thymocytes treated with gliotoxin, which may act through Ras, and
thapsigargin, an inhibitor of endoplasmic reticulum calcium ATPase
(Beaver and Waring 1994).
Perhaps, the real importance of the role of calcium and its
consequences in apoptosis lies in the occurrence of more subtle
changes in redistribution of its intracellular levels.
Ceramide
Ceramide is a hydrophilic component of all sphingolipids.

Its

role in the induction of proliferation and apoptosis was recently
reviewed

(Kolesnick and Fuks 1995) as well as its role as a signaling

molecule (Hannun and Obeid 1995)

(Pushkareva, Obeid et al. 1995)
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(Wright and Kolesnick 1995).

Ceramide is a second messenger that is

released after hydrolysis of membrane sphingolipids, especially
sphingomyelin, and that activates a protein kinase cascade.

Ceramide

inhibits growth and induces differentiation of leukemia cells,
modulates protein phosphorylation, and regulates gene transcription.
The IL-1, interferon-g, and tumor necrosis-a cytokine-stimulated
pathways are likely to involve ceramide

(Hannun and Obeid 1995).

Activation of the sphingomyelin pathway with the subsequent release of
ceramide mimics the apoptotic effects of TNF-a (Jarvis, Kolesnick et
a l. 1994).

Ceramide appears to target the downstream, stress-

activated protein kinase (SAPK) pathway, a proposed key target for the
control of apoptosis (Rowan and Fisher 1997).

But the ceramide/SAPK

signaling may not be sufficient to for induction of apoptosis by
themselves.

It has been shown that Bcl-2 and cysteine protease

inhibitors effectively block ceramide-induced apoptosis (Zhang, Alter
et al. 1996).

Other signaling molecules, such as

phosphatidylinositol-3 kinase, can also give protection against
apoptosis and not be involved in the ceramide/SAPK pathway (Vemuri and
McMorris 1996).
Cyclic Adenosine 3',5'-Monophosphate (cAMP)
Cyclic adenosine 3',5'-monophosphate (cAMP) acts mostly through
cAMP-dependent kinase (Spaulding 1993).

Increases of cAMP could

either stimulate apoptosis, probably through a calcium-dependent
protein kinase, or inhibit apoptosis; therefore, elevations in cAMP,
as in other signaling pathway components, may have different effects
on different cells.

This dual cAMP signaling occurs via cAMP-

dependent protein kinase A (PKA), which exists as two isoenzymes,
type-I and type-II, respectively.

Each PKA isoenzyme is composed of

two catalytic subunits and an inhibitory regulatory subunit (RI, RII)
containing two binding sites (A, B) for cAMP.

The type of PKA

isoenzyme involved in signaling is dictated by whether RI or RII is
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combined with the catalytic domain subunit (RI-type-I, RII-type-II).
Maintenance of the ratio between RI and RII is critical for the
maintenance of homeostasis in normal cells, and departures from this
balanced ratio is important in the pathogenesis of various human
diseases, including cancer (Ally, Tortora et al. 1988; Cho-Chung
1990).

In a recently published study, the effects of cAMP analogs

were studied on the malignant human glioma cell line A-172 and primary
glioma cell cultures and found that modulation of the cAMP/PKA pathway
induce decreased proliferation, increased differentiation, and
subsequent apoptosis of these cells (Chen, Hinton et al. 1988).

In a

study of apoptosis-defective mutants, it was demonstrated that
apoptosis induced by cAMP, dexamethasone, and ionizing radiation,
merge into a common pathway prior to the point where Bcl-2 exerts its
antiapoptotic effect (McConkey, Nicotera et al. 1994).
Oxygon Radicals and Oxidative Stress
Oxidative stress is important in both cytotoxicity and in
cellular activation.

The role of oxygen radicals and oxidation in

apoptosis have been reviewed(McConkey, Nicotera et al. 1994); Hydrogen
peroxide can activate the transcription of the nuclear factor NFk B(McConkey,

Nicotera et al. 1994). It has been suggested that

reactive oxygen species could be important in apoptosis(Hockenbery,
Oltavi et al. 1993).

In a study where apoptosis was induced in

neurons after deprivation of nerve growth factor (NGF), a transient
increase in reactive oxygen species was noted, and that superoxide
dismutase protected such cells against apoptosis(Greenlund, Deckwerth
et al. 1995).

In another study it was reported that thymocyte

apoptosis could be inhibited by chemicals with antioxidant
properties(Slater, Nobel et al. 1995).
Evidence that oxygen radicals are not generally required for
apoptosis has been provided(Jacobson and Raff 1995; Muschel, Bernhard
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et al. 1995); these investigators concluded that apoptosis induced by
withdrawal of growth factor and the protection provided against
apoptosis by Bcl-2 did not require reactive oxygen species.
Nitric oxide is also important in inducing apoptosis in some
situations(Mannick, Asano et al. 1994),
1995).

(Messmer, Lapetina et al.

It has been suggested that nitric oxide could amplify calcium-

induced gene transcription in neural cells, and that nitric oxidesignaling may be linked to the expression of bcl-2{Genaro, Hortelano
et al. 1995).
Insulin Growth Factor-1 and Insulin Growth Factor-1 Recaptor
Several pieces of evidence support a direct role for inhibition
of apoptosis by insulin growth factor-1 (IGF-1) receptor activation
(see summary by Rubin and Baserga 1995).

It has been demonstrated

that IGF-1 can prevent apoptosis induced by over expression of c-myc
in rat-1 fibroblasts, in IL-3-dependent hematopoietic cells after IL-3
removal, of BALB/c3T3 fibroblasts after exposure to the topoisomerase
inhibitor, etoposide, or simply after serum deprivation of contactinhibited quiescent cultures.

The mechanism of action by which IGF-1

receptor protects cells is poorly understood.

It is suggested that

IGF-1 exerts its antiapoptotic actions through phosphorylation of pre
formed cytosolic mediators whose synthesis is regulated by other
growth factors (Rubin and Baserga 1995).
Influence of Feed on Rodent Liver Apoptosis
Feeding regimens have been found to have a profound effect on
the occurrence of apoptosis in normal and hyperplastic rodent liver
(reviewed by Bursch, Grasl-Kraupp et a l . 1994) .

Prolonged fasting or

severe starvation increases the rate of apoptosis in rat liver.

In

contrast, food uptake exerts an inhibitory effect on the occurrence of
apoptosis during the regression of liver hyperplasia (Schulte-Hermann,
Bursh et al. 1988; Grasl-Kraupp, Bursh et al. 1994).

It was noted

that the extent and kinetics of the food-mediated inhibition of
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apoptosis is very similar to that seen after mitogen treatment
experiments, and that the energy uptake itself was the most effective
factor in mediating such inhibitory effect on apoptosis, rather than
the dietary components of the diet.

In addition, the cyclic eating

behavior of rats seems to result in a diurnal rhythm of cell turnover,
with a peak of apoptoses occurring shortly before feeding and the peak
of cell proliferation occurring at about 12 hours later (SchulteHermann 1977).
Regulation of Apoptosis by Transforming Growth Factor-^
Transforming Growth Factor-p (TGF-P) is a potent growth inhibitor
and apoptotic inducer for hepatocytes via autocrine upregulation and
activation (Bursch, Grasl-Kraupp et al. 1994; Schulte-Hermann, GraslKraupp et al. 1995; Bauer 1996; Santoni-Rugiu, Jensen et al. 1998).
Furthermore, data has been presented recently to indicate that TGF-fJtreated normal cells are able to eliminate transformed cells by
induction of apoptosis (Bauer 1996), which supports the model that
control of transformed cells is performed by neighboring, normal
cells.

Moreover, the TGF-p-induced signal pathway in normal cells,

leading to the production of a short-lived apoptosis-inducing factor,
as well as the specific interaction of this factor with transformed
cells depend on the action of reactive oxygen species (Bauer 1996) .
Sensitivity to the induction of apoptosis seems to be a common feature
associated with the transformed state, independent of the originating
transforming principle (Bauer 1996) .

Therefore, tumor development

should require either interference with the process of apoptosis or
the acquisition of resistance to it (Bauer 1996).

One may see how

interfering substances, such as antioxidants, and how genetic systems,
such as the Bcl-2 pathway, may protect transformed cells form their
cellular environment as discussed in the extensive review by Bauer,
1996.
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Mammalian ced-9-Related Apoptosis-Modulating Genes
Several mammalian ced-9-related apoptosis-modulating genes have
been found to have significant amino acid sequence similarity.

This

most likely indicates that apoptosis control in mammals is one of
great complexity.

Involvement of similar gene families between

nematodes and mammals suggest that related genes may regulate cell
death in other pluricellular organisms, including fish.
Human genes encoding Ced-9 related proteins reported so far
include (not an inclusive list) bcl-2 (Tsujimoto and Croce 1986), bclx (Boise, Gonzctlez-Garcia et al. 1993), bax (Oltvai, Milliman et al.
1993),

mcl-1 (Kozopas, Yang

et al. 1993), bak

et al.

1995) (Farrow, White

et al. 1995)

(Chittenden,

Harrington

(Keifer, Brauer et al. 1995),

bak-2 (Keifer, Brauer et al. 1995), bak-3 (Keifer, Brauer et al.
1995), and bad (Kitada, Krajewska et al. 1998; Yang, Zha et a l .
1995a).
In addition to murine homologues of bcl-2, bcl-x, bax, mcl-1,
bak, and bad one additional protein which has not been reported in for
humans is Al (Lin, Orlofsky
et al.

et al. 1993).

The gene bfl-1 (Choi, Park

1995) may represent the human homologue of the mouse Al gene.

Bik (Boyd, Gallo et al. 1995) has also been reported as a deathinducing protein, which shares BH3, a 9 amino acid domain, with Bax
and Bak.
Conservation between humans and birds is shown by the presence
of homologues of at least of bcl-2 and bcl-x in chickens.

An

additional member of the family without known mammalian homologue,
NR-13, has been reported in the quail (Gillet, Guerin et al. 1995).
Mammalian viruses with genes encoding Ced-9/Bcl-2 related
proteins include: Epstein-Barr virus-BHRF-1 gene (Pearson, Luka et al.
1987); African swine fever virus LMW5-HL gene (Neilan, Lu et al.
1993), also known as A179L (Yanez, Rodriguez et al. 1995); Herpes
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saimiri-0RF16 gene (Smith 1995).

It has been suggested that these

viral proteins, as with other viral proteins that are unrelated to
Ced-9, prevent or delay apoptosis of infected cells in order to
prolong viral replication(Alnemri, Robertson et al. 1992).
Comparison of the amino acid sequences of these Ced-9-related
proteins has identified two well defined regions with similar
sequences designated BH1 and BH2 (Oltvai, Milliman et al. 1993;
Williams and Smith 1993; Yin, Oltvai et al. 1994).

It has been shown

that by changing amino acids in either BH1 or BH2 region, the ability
of the human Bcl-2 protein to inhibit apoptosis is blocked(Sato,
Hanada et a l . 1994)

(Yin, Oltvai et al. 1994).

In the nematode Caenorhabditis elegans, the ced-9 gene product
only encodes for a negative regulator (i.e., an inhibitor) of cell
death(Yuan 1995).

On the other hand, mammalian ced-9-related gene

families encode for both positive (promoter) and negative (inhibitor)
regulators of cell death.

Bcl-2 is a negative regulator; for example,

it prevents IL-3-dependent cells from undergoing apoptosis after
deprivation of IL-3 (Vaux, Cory et al. 1988).

Bcl-Xj., the largest

protein product of the human bcl-x gene, is a negative regulator, as
it prevents IL-3-dependent cells from undergoing apoptosis after
withdrawal of IL-3 (Boise, Gonz&lez-Garcia et al. 1993).

Bcl-xs, the

smallest protein product of the human bcl-x gene, is a positive
regulator, as it allows apoptosis to proceed in IL-3-dependent cells
after deprivation of IL-3, even in the presence of Bcl-2 (Boise,
Gonz&lez-Garcia et al. 1993).
Different tissues show differential expression of Bcl-xL and Bclxs. Most tissues express Bcl-xL, but tissues with a high rate of
apoptosis also express variable levels of Bcl-xs (Boise, Gonz&lezGarcia et al. 1993; Krajewski, Krajewska et al. 1994a).
Human Mcl-1 protein is a negative regulator of cell death and,
like Bcl-2 and Bcl-xL, can delay death of cells over-expressing c-Myc
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(Reynolds, Yang et al. 1994).

Mcl-1 is expressed in epithelial cells

that are more differentiated than those expressing Bcl-2 and in
various types of muscle, lymph node germinal centers, and
differentiating myeloid cells(Krajewski, Bodrug et al. 1995).

Mcl-1

has a short half life of about an hour (Yang, Kozopas et al. 1995b),
that may allow rapid modulation of the susceptibility of
differentiating cells to apoptosis (Krajewski, Bodrug et al. 1995).
The principal product of human bax, Baxa, opposes the action of
Bcl-2, and its overexpression allows apoptosis to proceed after IL-3
withdrawal from IL-3-dependent cells even in the presence of
dysregulated expression of Bcl-2 (Oltvai, Milliman et al. 1993).

Bax

is expressed more widely in adult mouse than Bcl-2, especially in cell
types that have a high rate of apoptosis (Krajewski, Krajewska et al.
1994b).
Like Bax, Bak accelerates apoptosis of IL-3-deprived cells and
partially blocks Bcl-2 inhibition of apoptosis (Chittenden, Harrington
et al. 1995).

Bak also accelerates apoptosis in growth factor-

deprived neurons and blocks the protective effect of E1B 19-kDa
protein (Farrow, White et al. 1995), but it appears to be able to
inhibit apoptosis of serum-deprived Epstein-Barr virus transformed
cell lines

(Keifer, Brauer et al. 1995).

The human and murine bad products promote apoptosis like Bax and
Bak.

Bad allows apoptosis to proceed in IL-3-dependent cells after

withdrawal of IL-3, but not in the presence of Bcl-2 (Yang, Zha et al.
1995a; Kitada, Krajewska et al. 1998) .

Bad can influence the relative

ability of Bcl-xL and Bcl-2 to prevent apoptosis

(Yang, Zha et al.

1995a; Kitada, Krajewska et al. 1998).
The murine A 1 gene is induced by granulocyte/monocyte-colony
stimulating factor (GM-CSF) and its role in regulation of apoptosis
has not been reported (Lin, Orlofsky et al. 1993).
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Transgenic mice
Homozygous ced-9 loss-of-function mutant alleles are lethal in
Caenorhabditis elegans
development (Yuan 1995).

because of massive cell death during embryonic
Use of transgenic mice deficient in Bcl-2 or

Bcl-x or Bax have provided sufficient evidence to suggest that in
mammals, different members of the family of ced-9-related genes are
responsible for controlling developmental cell death in different
tissues.
Bcl-2P

Homozygous bcl-2 null mice (one that lacks both Bcl-2a and
splicing variants) develop nearly normal, but abnormalities

become evident after birth in various tissues due to defects in
survival of particular cell types (Nakayama, Negishi et al. 1994)
(Sorenson, Rogers et al. 1995).

Developmental abnormalities are noted

in the kidney as polycystic kidneys, due to excessive apoptosis during
metanephric development, and in the small intestine as accelerated
loss of epithelial cells and reduced number of mitotic precursors.
Abnormalities are also noted in the development of lymphoid tissue as
splenic and thymic atrophy due to increased lymphocyte sensitivity to
apoptosis.

Another abnormality noted is the development of

hypopigmented coat in mice after the first hair follicle cycle due to
a defect in melanocyte survival. Homozygous bcl-x null mice die at
about day 13 due to massive apoptosis of hematopoietic cells,
hepatocytes, and of central nervous system post-mitotic neurons;
otherwise, the mice appeared normal(Motoyama, Wang et al. 1995).
Homozygous bax-null mice are viable and show nearly normal
development; however, these mice show T- and B-cell hyperplasia; the
females show excess granulosa cells in atretic ovarian follicles; and
males are infertile since they lack mature sperm and have massive
apoptosis of germinal cells(Knudson, Tung et al. 1995).
One may conclude that none of these genes, bcl-2,

bcl-x, or

bax, play the same critical role in the control or modulation of
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developmental cell survival in mammals as the

ced-9 gene does in the

nematode Caenorhabditis elegans ; thus, in mammals each gene may be
needed for the survival or deletion of a particular cell in a
particular organ at a determined time.
Control of Bcl-2 and Bax by the Tumor Suppressor p53 Gene
The tumor suppressor gene, p53, is implicated in cell cycle
arrest and apoptosis following DNA damage(Kastan, Onyekwere et al.
1991).

p53 is a positive regulator of bax expression and a negative

regulator bcl-2 expression, and p53 null-mice have high levels of Bcl2 and lower levels of Bax than normal mice in several tissues
(Miyashita, Krajewski et al. 1994b)

(Selvakumaran, Lin et al. 1994).

p53 also causes up-regulation of bax expression following DNA damage
with ionizing radiation (Selvakumaran, Lin et al. 1994; Miyashita,
Krajewski et al. 1994b).
Studies of homodimer and heterodimer formation by ced-9-related
proteins have allowed investigation of how the internal state of a
cell may control the apoptotic response through the ratio of apoptosis
inhibiting to apoptosis promoting proteins (Sato, Hanada et al. 1994)
(Chittenden, Harrington et al. 1995).

The Bcl-2/Bax ratio in a cell

acts as a "rheostat", which regulates its susceptibility to
apoptosis(Korsmeyer, Shutter et al. 1993);

p53 can shift or reset

this "rheostat" following DNA damage by repressing bcl-2 and inducing
bax expression (Selvakumaran, Lin et al. 1994; Miyashita, Harigai et
al. 1994a; Miyashita, Krajewski et al. 1994b; Miyashita and Reed
1995) . Alternatively, the ratio of Bcl-xL/Bcl-xs might be the one
altered or shifted by differential mRNA alternative splicing of Bcl-x
(Boise, Gonzalez-Garcia et al. 1993).
In general, the ratio of apoptosis-suppressing (Bcl-2, Bcl-xL,
Mcl-1) to apoptosis-promoting (Bax, Bcl-xs, Bak, Bad) Ced-9-related
proteins in mammalian cells may through their differential expression
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control their susceptibility to undergo apoptosis.

Thus, these

proteins may act by regulating the susceptibility of cells to
apoptosis during development and during differentiation of renewing
cell populations in different tissues.
Cellular Localization of Ced-9-Related Proteins
Bcl-2a is located on the cytoplasmic surface of the nuclear
envelope, outer mitochondrial membrane, and endoplasmic reticulum
(Jacobson, Burne et al. 1993; Krajewski, Tanaka et al. 1993; Akao,
Otsuki et al. 1994; Lithgow, van Driel et al. 1994).

Bcl-2fi, on the

other hand, is largely cytosolic (Tanaka, Saito et al. 1993).

Several

investigators have reported that Bcl-2 localizes strongly to the
nucleus during mitosis and associates with the chromosomes during
prophase, metaphase, and anaphase before disappearing at telophase
(Lu, Hanby et al. 1994; Willingham and Bhalla 1994).

Bcl-XL and Bcl-xs

are predominantly mitochondrial proteins(Fang, Rivard et al. 1994),
while Bcl-xL is located mainly at the periphery of the mitochondria
and nuclear envelope (Gonzdlez-Garcia, Perez-Ballestero et al. 1994).
The localization of Mcl-1 has been described as predominantly
mitochondrial with less nuclear association than Bcl-2(Krajewski,
Bodrug et al. 1995; Yang, Kozopas et al. 1995b).
Proteasas in Apoptosis
Interleukin-ip-Converting Enzyme

(ICE) and Caspases

Yuan, 1993, observed that Caenorhabditis elegans Ced-3 has
significant sequence similarity to the human interleukin-ip-converting
enzyme (ICE), and that this similarity suggested a role for ICE or
ICE-like proteases in the control of apoptosis.
In mammals Ced-3 homologues are a family of at least 10 cysteine
proteases with aspartate specificity now called caspases (Alnemri,
Livingston et al. 1996; Goldstein 1997).

Caspase activation is a

widespread occurrence in apoptosis, and its overexpression is
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sufficient to induce apoptosis;

there are examples where caspase

inhibition is sufficient to block apoptosis
Los, Van de Craen et al. 1995).

(Enari, Hug et al. 1995;

Caspases show strong preference for

cleavage at a peptide sequence with an Asp residue at the Px position;
these may be inactivated by the protease inhibitors N-tosyl-Lphenylalanine chloromethane and 3,4-dichloroisocoumarin (Wilson, Black
et al. 1994);

and can also be inhibited by CrmA, a 38-kDa protein

encoded by the cowpox virus (Ray, Black et al. 1992), which can
inhibit apoptosis.
The expanding caspase family consists of proteins with sequence
similarity to Ced-3/caspases.

The TX protein (Faucheu, Diu et al.

1995) has the highest sequence similarity to Ced-3/caspases; it shows
proteolytic activity against caspases and itself but not against
proIL-lb.

Transfection of TX into COS cells induces apoptosis.

expressed in all adult human tissues, except in the brain.

TX is

Other

names for TX include ICErell-II (Munday, Vaillancourt et al. 1995) and
Ich-2 (Karnens, Paskind et al. 1995).
The nedd-2 gene is highly expressed during embryonic development
of mouse brain and down regulated in the adult brain; it encodes for a
caspase protein, and its overexpression results in apoptosis in mouse
fibroblast and mouse neuroblastoma cell lines (Kumar, Tomooka et al.
1992; Kumar, Kinoshita et al. 1994).

Human homologues are Ich-1L and

IchlS; overexpression of Ich-1L induces apoptosis in Rat-1 fibroblasts,
and overexpression of Ichls inhibits apoptosis in Rat-1
fibroblasts(Wang, Miura et al. 1994b).
The 70-kDa Ul-specific small ribonucleoprotein is specifically
cleaved in apoptotic cells to a 40-kDa protein by an unidentified
caspase-like protease(Casiola-Rosen, Miller et al. 1994).

A caspase-

like protease that can cleave poly(ADP-ribose)polymerase (PARP) has
been shown to play an important role in the early stages of apoptosis
(Nicholson, Ali et al. 1995).

PARP is involved in DNA repair and in
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the supervision of genome structure and integrity.

The cleavage of

PARP results in nuclear and DNA fragmentation (Lazebnik, Kaufmann et
al. 1994).

PARP exerts a negative regulatory effect

over a Ca^/Mg2*-

dependent endonuclease implicated in the internucleosomal DNA cleavage
that occurs in apoptosis; loss of PARP function could result in
activation of this nuclease in dying cells(Arends, Morris et al.
1990).
CPP32 (or Yama, after the Hindu god of death) has been
identified as the precursor of the protease apopain, which cleaves
PARP (Fernandes-Alnemri, Litwack et al. 1994; Tewari, Quan et a l .
1995a)

(Nicholson, Ali et al. 1995).

The cytotoxic T-lymphocyte-

derived granzyme-B can also cleave CPP32 be into its active form,
apopain(Darmon, Nicholson et al. 1995).
The mammalian gene mch-2 , also related to the ced-3 gene, has
been cloned from human Jurkat T-lymphocytes (Fernandes-Alnemri,
Litwack et al. 1995); its product, Mch-2, has highest sequence
similarity to CPP32.

Mch-2 is more related to Ced-3 than any other

member of the caspase family and can also cleave PARP.
Caspases seem to have an active role in Fas-mediated and TNFinduced apoptosis.

Induction of apoptosis by anti-Fas antibody is

inhibited by caspase tetrapeptide inhibitors, and anti-Fas antibody
fails to induce apoptosis in c.aspase-deficient thymocytes from
caspase-knockout mice (Kuida, Lippke et al. 1995).

Their involvement

in Fas-mediated apoptosis has been demonstrated in several cell lines
including the B-cell lymphoma BJAB and

human MCF-7 breast carcinoma

cell lines (Tewari and Dixit 1995) , W4 and human Jurkat cell lines
(Enari, Hug et al. 1995), and the L929-APO-1 and B-lymphoblastoid SKW
6.4 cell lines (Los, Van de Craen et al. 1995).
The involvement of the caspase family in apoptosis induced by
other mechanisms has been evaluated.

Protease inhibitors, which

preferentially inhibit caspases and caspase-like proteases, have been
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used to block apoptosis of human myeloid leukemia U937 cells induced
by TNF and anti-Fas antibodies as well as that induced by etoposide
and camptothecin(Mashima, Naito et al. 1995). A caspase-knockout mouse
has been produced which displayed an apparently normal phenotype for
the first 16 weeks of life;

this suggested that caspases are not

required during development, and that normal negative selection of
auto-reactive T-cells appears to occur in the absence of caspases
(Kuida, Lippke et al. 1995).

It has been demonstrated that the lack

of caspases in isolated caspase-deficient thymocytes, which conferred
resistance to anti-Fas antibodies, had no effect on apoptosis induced
by glucocorticoids, aging, or ionizing radiation, nor on ATP-induced
macrophage apoptosis, thus, suggesting that caspases by themselves do
not have an essential role in apoptosis in all situations (Kuida,
Lippke et a l . 1995; Li, Allen et al. 1995).
In contrast, Bcl-2 and caspases probably affect or are involved
in the same apoptosis pathway (Miura, Zhu et al. 1993; Goldstein
1997).

In the study done by Miura and coworkers, 1993 (Miura, Zhu et

al. 1993), it was demonstrated that cell death of Rat-1 fibroblasts
caused by caspase overexpression could be suppressed by bcl-2
overexpression, and suggested that either caspase/ICE lies upstream of
Bcl-2 or that they act in concert.
Based on the information available from several published
reports(Miura, Zhu et al. 1993; Chinnaiyan, O'Rourke et al. 1997;
Goldstein 1997; Kluck, Bossy-Wetzel et al. 1997; Wu, Wallen et al.
1997; Yang, Liu et al. 1997), an apoptosis cascade could be divided
into several stages.

First, death-triggering extracellular agents

induce a series of multiple signaling pathways that convey into a
central control and execution point.

At this point, activation of

Ced-3/caspases occurs, a step that is under the regulation of Ced9/Bcl-2 proteins; presumably the Ced-4 homologue is also involved at
this stage.

Because Bcl-2 is mainly localized on the mitochondrial
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membrane, it is suggested that the mitochondria may play an important
part at this level.

This is followed by a downstream caspase

activation cascade that leads eventually to the characteristic
morphological and biochemical features of apoptosis.

It has recently

been shown that Ced-4 (or its mammalian counterpart) participates as
the molecular link between the family of Bcl-2 and the caspases
(Chinnaiyan, O'Rourke et al. 1997; Wu, Wallen et a l . 1997).
Chinnaiyan, 1997, demonstrated that overexpression of transfected, C.
elegans Ced-4 into mammalian cells leads to apoptosis, and that this
process could be blocked by the overexpression of Bcl-xL and by caspase
inhibitors.

Thus, indicating that in mammalian cells Ced-4 causes

apoptosis through caspase activation, a process under the modulation
by the Bcl-2 family members. Chinnaiyan, 1997,

also demonstrated a

direct physical interaction between the proteins Ced-4 and Ced-9 (or
Bcl-xL) and the proteins Ced-4 and Ced-3 (or the mammalian caspases ICE
and FLICE, but not the CPP32 or Mch-2 proteins). Wu, 1997, showed that
the expression of Ced-4 was diffuse in the cytoplasm when Ced-4 was
expressed in isolation, whereas it formed a compact granular pattern
when Ced-9 was co-expressed with Ced-4, and that Ced-4 shifted from
the cytosol to the mitochondria upon expression of Ced-9.
of Chinnaiyan's findings, 1997,

But because

which showed that the binding of Ced-

9 to Ced-4 did not prevent the binding of Ced-4 to Ced-3, when Ced-9
directs Ced-4 to the mitochondria, Ced-9 must also bring Ced-3 there
as well.

During such event, Ced-9 also modifies Ced-4 to ultimately

prevent Ced-3/caspase activation and subsequent apoptotic structural
alterations.
Considering all of this information, a simple overview of the
events involved may be summarized as follows;

Ced-9/Bcl-2, at the

mitochondrial membrane, binds and modulates Ced-4, which in turn binds
to Ced-3/caspases.

This binding of Ced-3/caspases may lead to caspase

activation if Ced-4 is not bound by Ced-9/Bcl-2.

To this simple
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scheme other observations may be added.

For instance, Bcl-2 appears

to drag the signaling molecule Raf-1 kinase.

Bad, which is

proapoptotic though heterodimerization with either Bcl-2 or Bcl-xL, can
be phospholrylated by Raf-1 (Wang, Rapp et al. 1996) at the
mitochondrial membrane.

Phosphorylated Bad can not heterodimerize

with Bcl-2, allowing, thus, Bcl-2-driven survival.

Therefore,

postranslational modifications of some members of the Bcl-2 family can
regulate cell death in a mitochondrial environment.
However, Ced-4 may not be the only intermediate between Bcl-2
proteins and caspases.

Cytochrome-c (Cyt-c) released from the

mitochondria may also be as important (Kluck, Bossy-Wetzel et al.
1997; Yang, Liu et al. 1997).

These investigators showed that Bcl-2

regulates the release of Cyt-c from the mitochondria, and such event
is required for further caspase activation and subsequent apoptotic
effects.
Another possible indirect connection between Bcl-2 proteins and
caspases via mitochondria has been suggested (Kroemer, Zamzami et a l .
1997).

A loss of mitochondrial membrane potential occurs during cell

death.

The permeability transition leads to the release of a

molecule, called AIF (apoptosis-inducing factor)

(Bauer 1996;

Goldstein 1997; Kroemer, Zamzami et al. 1997), which appears to act as
a caspase-inhibitor-sensitive protease, leading to caspase activation
and apoptosis.

Such permeability transition can be blocked by caspase

inhibitors under certain circumstances, thus, suggesting that it may
require the first steps of the caspase activation cascade (Kroemer,
Zamzami et al. 1997) .

The control of caspase activation by Bcl-2 may

not account for all of its possible effects on apoptosis, however.
Bcl-xL by itself is able to form ion channels in membranes

(Minn,

Velez et al. 1997), and hyperexpression of Bax can lead to caspaseindependent apoptosis (Xiang, Chao et al. 1996).

The effects of the

Bcl-2 family members may parallel those of perforin, a channel-forming
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molecule in granules of cytotoxic T-lymphocytes, which kill target
cells after granule exocytosis.

At high concentrations, perforin is

able to destroy the target cell by itself, through accidental cell
death rather than through an apoptotic cell death.

At lower

concentrations, however, perforin allows another granule protein, the
serine esterase granzyme B, to leave an unidentified target cell
organelle to activate caspases and, subsequently, apoptosis (Froelich,
Orth et al. 1996).

Both Bcl-2 family proteins and perforin are

channel-formers, can by themselves trigger cell death at high
concentrations, and both, at lower concentrations, can lead to the
release from intracellular organelles of molecules (Cyt-c and granzyme
B, respectively) that will lead to caspase activation and apoptosis
(Goldstein 1997) .

Moreover, it was recently demonstrated that

caspases, specifically caspase-3 (CPP32), can cleave the loop domain
of Bcl-2 and further activate downstream caspases as a Bax-like
effector and contribute to further amplification of the caspase
cascade leading to apoptosis (Cheng, Kirsch et a l . 1997).

Although

Bcl-2 is presumed to inhibit caspase activation by acting upstream of
caspases, Bcl-2 may also be a downstream death substrate of caspases,
suggesting the existence of a feedback loop between Bcl-2 and caspases
(Cheng, Kirsch et a l . 1997).

The observation that Bcl-2 cannot

inhibit apoptosis in some situations implies that specific caspases
may bypass the pathway inhibited by Bcl-2.

In this scenario, Cheng

and co-workers, 1997, concluded that activation of a subset of
caspases that are insensitive to Bcl-2 may also promote cleavage of
Bcl-2, not only inactivating its antiapoptotic function but also
enhancing apoptosis.
Further Involvement of Proteases in Apoptosis
Other proteases expressed during apoptosis include calpain,
cathepsin B and D, collagenase, tissue type and urokinase type
plasminogen activators, and pre-existing 24-kDa protease (Guenette,
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Mooibroek et al. 1994; Squier, Miller et al. 1994; Wright, Wei et al.
1994).

Calpain is activated prior to the appearance of morphological

changes of apoptosis and DNA fragmentation in dexamethasone treated
thymocytes (Squier, Miller et al. 1994).

In-vitro substrates for

calpain include cytoskeletal proteins, growth factor receptors,
transcription factors, and signal transducing enzymes.

Cathepsin-B is

a thiol protease, whose expression is increased in apoptotic
epithelial cells in regressing rat prostate and mammary glands
(Guenette, Mooibroek et al. 1994).

This protease is necessary for the

destruction of extracellular matrix and degradation of basement
membrane components, including collagen, fibronectin, and
proteoglycans.

Urokinase-type plasminogen, a serine protease, may be

involved in mediating apoptosis induced by tumor necrosis factor (TNF)
(Kumar and Baglioni 1991).

Plasminogen activator inhibitor type-2

(PAI-2), whose only known target is urokinase-type plasminogen
activator, induces resistance to TNF-induced apoptosis.

Pre-existing

24-kDa protease is involved in TNF- and UV light-induced DNA
fragmentation in U937 histiocytic lymphoma cells as well as in BT20
breast carcinoma, HL-60 myelocytic leukemia cells, and 3T3 fibroblasts
(Wright, Wei et al. 1994).
Serine and cysteine proteases are implicated as mediators of
apoptosis in a variety of cells including thymocytes (Weaver, Lach et
a l . 1993), promyelocytic leukemic HL-60 cells (Bruno, Del Bino et al.
1992), and T-lymphocytes (Sarin, Adams et al. 1993).

Several serine

and cysteine protease inhibitors have been used to investigate the
involvement of such proteases in apoptosis.

Some of these protease

inhibitors include N-tosyl-L-lysine chloromethane, N-tosyl-Lphenylalanine chloromethane, phenylmethylsulfonyl fluoride, and
dichloro isocoumarin. Inhibition of proteases were required for
internucleosomal cleavage, cell shrinkage, and plasma membrane
changes, thus, suggesting that cysteine and/or serine proteases were
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effectors of early apoptotic changes(Weaver, Lach et al. 1993;
Fearnhead, Rivett et al. 1995).
Proteolysis may be a common event in apoptosis; proteins shown
to be cleaved during apoptosis include: PARP (Lazebnik, Kaufmann et
al. 1994), laminin B (Neamati, Fern&ndez et al. 1995),

70-kDa protein

(Casiola-Rosen, Miller et al. 1994), topoisomerases I and II, histone
HI (Kaufmann 1989), protein kinase Cbl, cPLa2 (Voelkel-Johnson,
Entingh et al. 1995), fodrin (Martin, O'Brien et al. 1995), and 58-kDa
protein kinase PITSLRE (Lahti, Xiang et al. 1995).
Survivin, a Mew Cancer Anti-Apoptosis Gene
In addition to bcl-2, a novel class of apoptosis inhibitors
related to the Baculovirus lap gene has been recently identified in
human, mouse, and Drosophila melanogaster (Adida, Crotty et al. 1998).
Recently, a gene, which encodes for a structurally unique IAP
apoptosis- inhibitor protein, designated survivin, has been identified
(Ambrosini, Adida et al. 1997); survivin inhibits apoptosis induced by
interleukin-3 growth factor withdrawal when transfected into B-cells
(Ambrosini, Adida et al. 1997).

Unlike Bcl-2 or other IAP proteins,

survivin is undetectable in adult tissues but becomes prominently
expressed in all of the most common human cancers of the lung, colon,
breast, pancreas, and prostate, and in about 50 % of high-grade nonHodgkin's lymphomas in-vivo (Adida, Crotty et al. 1998).

Survivin is

differentially expressed in embryonic and fetal tissues and is
believed to contribute to tissue homeostasis and differentiation in a
manner independent of that of Bcl-2 (Adida, Crotty et al. 1998).
Aberrations of such developmental process may result in expression of
survivin in neoplastic cells (Adida, Crotty et al. 1998).
Other Oncogenes Modulating Apoptosis
Other oncogenes modulating apoptosis include 1) genes encoding
the GTP-binding protein Ras, the kinases Raf and Abl;

2) the cellular
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transcription factors AP-1, Rel, Myc, E2F, Nur 77;
proteins latent membrane protein-1

and 3) the viral

(LMP-1) , Tax, large T-antigen, El

A/B, and E7.
Signaling molecules
The ras genes encode a family of small guanine-nucleotidebinding proteins involved in signal transduction.

Mutations which

activate Ras proteins and give them oncogenic potential result in the
protein being constitutively present in the GTP-bound, active state
(Barbacid 1987; Saez, Chan et al. 1994).

These same mutations also

confer to these proteins the ability to inhibit apoptosis. The H-ras
protein can rescue cells from c-Myc-mediated apoptosis in a serum
deprived environment(Wyllie, Rose et al. 1987), and overexpression of
activated ras can inhibit apoptosis in the IL-3-dependent murine
myeloid cell line H7 after withdrawal of IL-3(Moore, Boswell et al.
1993).
Transcription Factors
Expression of Myc is important for cell proliferation, and it i
also involved in apoptosis induction.

Myc interacts with the

retinoblastoma protein pRb, and it is able to override pRb-induced
cell cycle arrest (Green, Mahboubi et al. 1994).

In the presence of

certain growth-promoting cytokines, such as IL-2, cell proliferation
occurs when Myc expression is induced; overexpression of Myc results
in uncontrolled cell proliferation (Green, Mahboubi et al. 1994).
Continued expression of Myc under conditions of growth arrest, as in
murine myeloid cells and Rat-1 fibroblasts deprived of growth factors
will induce apoptosis in a p53-dependent manner (Askew, Ashmun et al.
1991; Evan, Wyllie et al. 1992; Hemerking and Eick 1994) since c-Myc
is a transcription factor of p53 (Reisman, Elkind et al. 1993).
Induction of apoptosis, however, is dependent on the association of
Myc with Max (Green, Mahboubi et al. 1994), and it is suppressed by
Bcl-2 (Bissonnette, Echeverri et al. 1992; Fanidi, Harrington et al.
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1992).

Expression of Myc is not required for all forms of apoptosis

such as that induced by glucocorticoids and transforming growth
factor-p (Warner, Ludlow et al. 1991; Shi, Glynn et al. 1992).

Thus,

myc can not be considered the ultimate death gene since the cellular
decision to proliferate or die in response to myc overexpression seems
to be influenced by other signal stimuli.
Cell surface immunoglobulin-mediated apoptosis of the B-cell
line WEHI231 involves regulation of the c-myc expression by both Rel
and NFkB, which have binding sites in the myc promoter (Lee and
Bernstein 1995a).

The Rel family of protooncogenes, which includes

the transcription factor NFkB, functions both to promote and to
inhibit apoptosis (Huguet, Enrietto et al. 1994).

The effects of

rel

overexpression are cell-type specific, and the overexpression of c-rel
and v-rel have different effects in the same cell type.
Overexpression of c-rel in primary avian fibroblasts leads to
transformation, but c-rel overexpression in bone marrow cells leads to
apoptosis;

and v-rel expression in bone marrow cells leads to

transformation(Huguet, Enrietto et a l . 1994).

In addition, v-rel also

blocks apoptosis in chicken spleen cells by preventing degradation of
the Rel inhibitor protein IkB(White, Roy et al. 1995).
Myb protein also transactivates Myc (Cogswell, Cogswell et al.
1993).

Myb expression is highest in hematopoietic cells, and its

downregulation leads to inhibition of proliferation; in neuroblastoma
cells its downregulation also leads to apoptosis(Piacentini, Raschella
et al. 1994b).

The expression of c-myb oncogene increases after

induction of apoptosis in IL-2-dependent cells after growth factor
withdrawal (Cheng, Liu et al. 1995).

As for Myc, Myb-induced

apoptosis is, at least, cell type specific

and dependent on the

presence of other signal stimuli.
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The AP-1 transcription factor is formed by the expression of the
protooncogenes encoding Fos and Jun; their expression is rapidly and
transiently induced by

IL-2 and IL-6-dependent mouse myeloma cell

lines after induction of apoptosis by growth factor deprivation
(Colotta, Polentarutti et al. 1992).

It was suggested that fos and

jun have an active role in the onset of apoptosis.

After treatment of

mouse myeloma cell lines with antisense oligonucleotide against fos
and jun, either alone or in combination, the cells were protected
against apoptosis (Colotta, Polentarutti et al. 1992).
A functional link was established between fos-transformed cells
and apoptosis by the observation that a large portion of fostransformed rat fibroblasts died through apoptosis after growth factor
deprivation.

Non-transformed rat fibroblasts did not die (Smeyne,

Vendrell et al. 1993).
Activation of AP-1 is also related to the massive apoptosis that
occurs in mammary gland epithelium during post-lactation
involution(Marti, Jehn et al. 1994).

Such involution-related

apoptosis can occur in a p53-dependent or independent manner; a p53independent pathway may be influenced by the levels of Epidermal
Growth Factor (EGF) and insulin(Merlo, Basolo et al. 1995).
Another transcription factor, E2F (Zhu, Enders et al. 1995), is
known to modulate apoptosis through its interaction with pRb, a 105kDa phosphoprotein known to act as a cell regulator (DeCaprio, Ludlow
et al. 1989).

The transcription factor E2F interacts with the

hypophosphorylated form of pRb at the G0/Gi phase (DeCaprio, Ludlow et
al. 1989), which is believed to be active during growth suppression.
This transcription factor, E2F, is required for transcription of cell
genes that participate in growth control and DNA synthesis, such as cmyc, c-myb, cdc2, thymidine kinase, dehydrofolate reductase, and DNA
polymerase-a (Nevins 1992).

Overexpression of E2F drives quiescent
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cells into the S phase, prevents cycling cells from exiting the cell
cycle, transforms rat embryo fibroblasts, and ultimately leads to
apoptosis(Kowalik, DeGregori et al. 1995).

Recent data suggested that

coexpression of c-myc and Tumor Necrosis Factor (TNF) a leads to a
selective growth advantage for hepatic pre-neoplastic cells by
disruption of the E2F/pRb pathway and by Transforming Growth Factor
(TGF) a-mediated reduction in apoptosis (Santoni-Rugiu, Jensen et al.
1998).
A nuclear steroid hormone receptor transcription factor that is
required for apoptosis is Nur77, since it can suppress the expression
of downstream genes involved in such process(Liu, Smith et al. 1994).
In order for apoptosis to occur, Nur77 must first bind to DNA
(Yazdanbakhsh, Choi et al. 1995).

Other Nur77 family members, with a

similar DNA binding sequence, have been identified; these include
human protein TINUR, which also has been shown to be induced during
apoptosis (Okabe, Takayanagi et al. 1995), a neuronal protein NOR-1
(Ohkura, Hijikuro et al. 1994), and the human protein TR3, which
contains a novel enhancer element in the promoter region that may be
important in the regulation of apoptosis (Uemura, Mizokami et al.
1995).
Therefore, the general pattern emerging from oncogenic
transcription factor modulation of apoptosis is one in which
overexpression of factors may induce an apoptotic response.

The

ultimate effect of these factors, whether oncogenic or apoptotic, is
linked through overlapping patterns of protein transactivation
produced.

The following are some examples that reiterate this

transactivation: 1) E2F regulates the expression of myb and myc(Nevins
1992);

2) Myb and AP-1 regulate the expression of myc(Cogswell,

Cogswell et al. 1993);

3) Fas-receptor gene, which is upregulated

following T-cell activation, has been found to have both a Myb
consensus sequence (Cheng, Liu et al. 1995) and an AP-1 consensus
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sequence in its promoter (Emlen, Niebur et al. 1994).

One may ask

then, does this interaction between Myb and AP-1 with the Fas receptor
promoter result in increased Fas receptor expression?; 4) E2F and Myc
interact with pRb(DeCaprio, Ludlow et a l . 1989; Zhu, Enders et al.
1995);

5) overexpression of Myb and Rel can either induce or suppress

apoptosis depending on cell type and even within the same cell type
under different stimuli or conditions(Huguet, Enrietto et al. 1994;
Cheng, Liu et al. 1995);

and 6) Myb protein also transactivates Myc

(Cogswell, Cogswell et al. 1993).

All of the above examples suggest

that the cellular response to transcription factor overexpression
depends on other signals, which are cell-type specific and, perhaps,
cell-cycle-dependent (Hale, Smith et a l . 1996).
Viral Oncoproteins
The Epstein-Barr virus latent membrane protein 1 (LMP-1),
involved in the transformation of EBV-infected B-cells and epithelium,
also protects the cells from apoptosis (Henderson, Rowe et al. 1991).
LMP-1 inhibits apoptosis in B-cells by inhibiting bcl-2 (Henderson,
Rowe et al. 1991), but not in epithelial cells (Dawson, Eliopoulos et
al. 1995); for example, when LMP-1 is genetically introduced in
gastric carcinoma cells, it modulates their malignant potential
possibly by enhancing apoptosis (Sheu, Chen et a l . 1998).

LMP-1 also

induces expression of A20, an apoptosis-suppressor gene, in B-cells
following stimulation of the CD40 receptor (Tewari, Wolf et al.
1995c).
Tax, a viral oncoprotein of the human T-cell leukemia virus 1
(HTLV-1), seems to have both apoptotic inducing and suppressing
capabilities.

Tax expression leads to activation of the NFkB-like

factors, induction of myc expression, and upregulation of A20
(Laherty, Perkins et al. 1993).

Overexpression of tax in Jurkat cell

leads to apoptosis, the level of which dependents on the duration of
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tax stimulation; apoptosis resulting from a short-term exposure to tax
stimulation is dependent on prior T-cell activation, while apoptosis
resulting from long-term exposure to tax stimulation is T-cell
activation-independent (Chlichlia, Moldenhauer et al. 1995).

These

observations support the idea that tax may function to inhibit
apoptosis through modulation of the CD28-CD3/TCR co-stimulatory
pathways(Schwartz 1992).
Tumor Suppressors and Apoptosis
Properties of Wild-Type p53
The term p53 originally referred to a 53-kilodalton
phosphoprotein, the product of a 20-kilobase gene on the short arm of
human chromosome 17 (Harris 1996; Sidransky and Hollstein 1996).
Normal (wild-type) p53 suppresses out growth of genetically damaged
cells in two ways: by causing a pause in the cell cycle, and by
promoting exit from the cell cycle altogether through apoptosis
(Murnane 1995; Harris 1996; Sidransky and Hollstein 1996)] .

Its

inactivation represents the most common genetic lesion in human
cancers (Hollstein, Sidransky et al. 1991).

In 1992, the p53-null

mice was developed(Donehower, Harvey et al. 1992).

The p53 protein

possess features of a transcription factor (Levine, Momand et al.
1991); and it may act either as an activator of transcription when
bound to DNA directly, or it may repress transcription when associated
with a promoter region via the TATA binding protein (Horikoshi, Usheva
et al. 1995).

The C-terminal region of the p53 protein is required

for sequence specific DNA binding, and the N-terminal region has a
potent transactivation domain (Zambetti and Levine 1993) .

p53

activation promotes differentiation and apoptosis in myeloid leukemia
cells (Yonish-Rouach, Resnitzky et al. 1991).

p53 can also function

as a cell cycle regulator that can induce cell cycle arrest following
DNA damage (Kastan, Onyekwere et al. 1991) .
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Call Cycle Arrest and Induction of Apoptosis by pS3 in Response
to DMA Damage
Ionizing radiation can result in transient arrest of mammalian
cells at the Gi and G2 phases of the cell cycle (Kuerbitz, Plunkett et
al. 1992; Murnane 1995) and in apoptosis (Cohen, Duke et al. 1992;
Liebermann, Hoffman et al. 1995; Levine 1997).

The level of

intracellular p53 protein rises following exposure to ionizing
radiation resulting in cell cycle arrest at the Gi phase (Kuerbitz,
Plunkett et al. 1992).

The observation that cells with mutant p53

genes arrest in G2 suggested a role for p53 as a GI cell cycle control
checkpoint (Kuerbitz, Plunkett et al . 1992).

This checkpoint allows

time for the cell to repair its DNA damage or to commit apoptosis if
the damage is severe (Lane 1992), thus, preventing propagation of
extensive DNA damage to daughter cells and stopping potential
progression to cancer, hence, the name "guardian of the genome" (Lane
1992).
In normal cells, DNA strand breaks appear to be the necessary
signal for induction of a p53-mediated apoptotic response since other
forms of DNA damage, such as that produced by alkylating agents, like
ethyl methanesulfonate or EMS, do not result in the accumulation of
p53 (Lee and Bernstein 1993).
Protein inhibitors, such as cycloheximide, abrogate the
accumulation of p53 following ionizing radiation, and the DNA damageinduced-increase in the level of p53 appears to be due to a posttranscriptional stabilization mechanism(Kastan, Onyekwere et al.
1991).
Patients with ataxia telangiectasia, a genetic disorder which
predispose these patients to cancer, have a defect in the induction of
p53 in response to DNA damage caused by ionizing radiation(Kastan,
Zhan et al. 1992). The induction of p53 following ionizing radiation
probably requires gene products, which are either missing or defective
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in such disease, that may function upstream of p53 signal transduction
pathway (Hale, Smith et al. 1996).
The role of p53 as a transcription factor may be the mechanism
by which p53 leads to Gi arrest following DNA damage.

The radiation-

induced increased levels of p53 leads to upregulation of several
proteins, including p21WAF1/CIP1, GADD45, and MDM2

(Canman and Kastan

1995).
The p2iwflF1/CIP1 protein is a downstream effector in p53-dependent Gx
checkpoint, which acts as a potent inhibitor of cyclin dependent
kinases that govern the cell cycle, resulting in cell cycle arrest at
the Gi/S phase (el-Deiry, Harper et al. 1994), a critical checkpoint.
The p 2 iMAF1/CIP1 may also interfere with DNA synthesis directly by binding
to proliferating cell nuclear antigen (PCNA)

(Flores-Rozas, Kelman et

al. 1994; Waga, Hannon et al. 1994), an essential factor in DNA
replication.

Other mechanisms independent of p53-transactivation can

also elevate the levels of p 2 lWAF1/CIP1 (Parker, Eichele et al. 1995) .
Induction of

GADD45

(growth arrest DNA damage) is believed to be

important in suppression of cell cycle progression, a process
dependent on normal p53 gene function (Zhan, Bae et a l . 1994).

Like

p21WAF1/cpn, GADD45 also binds to PCNA and inhibits DNA synthesis [Smith,
1994 #269].

The MDM2 expression contributes indirectly to the control

of the cell cycle through a feedback loop to p53 itself, acting as a
negative modulator by binding and suppressing its transcriptional
activity (Chen, Oliner et al. 1994).

MDM2 causes downregulation of

p53-dependent genes with concomitant re-entry into the cell cycle
presumably after the DNA damage has been repaired.
In addition to cell cycle arrest, a frequent consequence of
mammalian DNA damage is apoptosis

(Cohen, Duke et al. 1992).

often, but not always, occurs through a p53-dependent pathway.

This
The

action may be dependent on the cell itself and the circumstances that
surrounds it. Immature thymocytes from normal and from p53-null mice
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underwent apoptosis in response to glucocorticoids or to activation
with phorbol ester and ionomycin (Lowe, Schimitt et al. 1993).

In

contrast to control mice cells, immature thymocytes deficient in p53
were resistant to apoptosis by ionizing radiation or by the DNAdamaging topoisoraerase XI inhibitor, etoposide (Clarke, Purdie et al.
1993).

Moreover, thymocytes which only had one wild-type p53 allele

exhibited intermediate sensitivity to apoptosis induction by ionizing
radiation when compared to normal thymocytes and to those from p53null mice (Clarke, Purdie et al. 1993), thus, suggesting a p53 dosedependent effect.
Bone marrow cells(Lotem and Sachs 1993) and intestinal
epithelial cells(Clarke, Gledhill et al. 1994) from p53-null mice were
resistant to radiation-induced apoptosis when compared to controls;
however, these cells could also undergo apoptosis in response to
different stimuli, indicating that p53-dependent and independent
apoptotic pathways may co-exist.
The presence or absence of growth factors may influence p53mediated Gt arrest or apoptosis.

Bone marrow-derived hematopoietic

cells are resistant to ionizing radiation-induced apoptosis when
cultured in the presence of growth factors, but arrest in Gi phase
(Collins, Marvel et al. 1992).

When these bone marrow-derived

hematopoietic cells are cultured without growth factors, apoptosis
occurs through a p53-dependent pathway(Blandino, Scardigli et al.
1995);

this has been found to be accelerated following DNA

damage(Canman and Kastan 1995).

Direct transcriptional regulation of

bcl-2 family members may also be involved in the induction of
apoptosis by p53.
Inhibition of Apoptosis by pRb
The functions of the retinoblastoma gene product, pRb, are to
control cell cycle progression and suppress apoptosis, and, along with
other pRb-related proteins, play a major role in determining whether
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cells respond to a given stimulus by undergoing growth arrest or
apoptosis.

Mice homozygous for mutant pRb die between days 10-14 of

gestation, with increased levels of cell division and apoptotic cell
death in hematopoietic cells and nervous systems(Clarke, Maandag et
al. 1992).

In addition, it has been observed that inappropriate

apoptosis also occurs in the ocular lens of pRb-null mice
(Morgenbesser 1994).
SAOS-2 osteosarcoma cells, which are p53 and pRb deficient, were
protected from radiation-induced apoptosis in a p53-independent
mechanism after transfection of pRb when compared to non-transfected
controls (Hass-Kogan, Kogan et al. 1995).

In contrast, SAOS-2

osteosarcoma cells transfected with a mutant form of pRb, one that
fails to bind to adenovirus E1A protein or the transcription factor
E2F, are not protected from apoptosis(Hass-Kogan, Kogan et al. 1995).
One way in which pRb may protect cells from radiation-induced
apoptosis is by induction of a quiescent state in which the cells are
less sensitive to apoptosis (Clarke, Maandag et al. 1992).
Interactions of p53 and pRb With Viral Proteins
Several studies indicate that certain viruses encode for
oncoproteins that bind pRb and p53, and impair their normal function
to accomplish its replicative strategy.

The SV40 large T antigen, the

adenovirus E1A, and the human papilloma virus (HPV) E7 proteins bind
to the hypophosphorylated form of pRb and inactivate it (DeCaprio,
Ludlow et al. 1988; Whyte, Buchkovich et al. 1988; Dyson, Howley et
al. 1989).

Moreover, interaction of E1A and pRb results in apoptosis

(Rao, Debbas et al. 1992).

The sequences from E1A required for pRb

binding and transformation are the same ones responsible for E1Amediated apoptosis (Hass-Kogan, Kogan et al. 1995).

Thus, it is

likely that blocking of the pRb-mediated cell cycle control at the Gj
phase may be required to push the infected cell into S phase and
initiate viral DNA replication.
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The E1A oncoprotein, acting as a transcription factor, competes
with

d 53

for interaction with the same domain of the TATA binding

domain (TBP)

(Horikoshi, Usheva et al. 1995), since p53 inhibits

transcription when bound to TBP.

Part of the E1A's ability to induce

cell proliferation and bring about apoptosis lies in the ability to
disassociate p53 from TBP, and activate p53-repressed genes(Horikoshi,
Usheva et al. 1995).

It demonstrated that the adenovirus E1B 19-kDa

protein, which does not bind to p53, inhibits p53-dependent apoptosis
mediated by E1A, thus allowing replication of viral genome(Debbas and
White 1995; Sabbatini, Chiou et al. 1995).

The SV40 large T antigen,

adenovirus E1B 55-kDa protein, and HPV E6 protein target p53 function
by binding to it either directly or indirectly(Levine 1990).

It was

proposed then that each of these viral proteins bind to p53 at
different regions inhibiting both of its transcriptional and
functional properties(Prives and Manfredi 1993).

Epstein-Barr virus

(EBV) exhibits a p53- and pRb-independent mechanisms to drive resting
B-cells into proliferation without disruption of the cell's ability to
undergo apoptosis in a p53-dependent manner following damage of their
DNA (Allday, Sinclair et al. 1995).
The p53 Signaling Pathways
The signaling pathways of p53 connect with tumor both
suppressors and oncogenes known to influence the cell cycle machinery.
Alterations in components either upstream or downstream of p53 may be
analogous to inactivation of p53 itself, preventing all or part of
the entire pathway from functioning and leading to deregulation of
cell cycle controls, genomic instability, and the development of
cancer(Agarwal, Taylor et al. 1998).
The components of the p53 signaling pathway were summarized by
Agarwal, 1998.

p53 accumulates and is modified and activated in

response to signals generated by a variety of genotoxic stresses.
Several proteins, including ATM, the product of the ataxia
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telangiectasia gene, PARP (poly(ADP-ribose) polymerase), FAS (Fanconi
anemia syndrome), BLS (Bloom's syndrome), and NBS (Nijmejen breakage
syndrome), are involved in activation, but the pathways that lead to
modification are largely unknown.

The Ras-Map kinase pathway is

involved in establishing basal levels of p53 and may also affect
function.

Some of the cellular functions affected by p53 can be

compromised by deregulated expression of Myc, Bcl-2, E1B, or E2F.

The

control of p53 activity includes an autoregulatory loop involving
Mdm2.

The intact set of p53-dependent pathways helps to maintain

genomic integrity by eliminating damaged cells, either by arresting
them permanently or through apoptosis.

p53 also helps to regulate

entry into mitosis, spindle formation, and centromere integrity, cell
cycle checkpoints that are likely to be involved in preventing DNA
damage from occurring (Agarwal, Taylor et al. 1998).
ING1, A New Tumor Suppressor Gene Candidate
Overexpression of the growth inhibitor and candidate tumor
suppressor called p33:NG1, like p53, can arrest cells at the G0/G1 phase
of the cell cycle(Garkavtsev, Kazarov et al. 1996), and it has been
recently demonstrated that it can also modulate apoptosis in serumstarved P19 teratocarcinoma cells and in rodent fibroblast cell lines
which overexpress human c-myc protein (Helbing, Veillette et al.
1997).
Cellular Consequences of Apoptosis
Nuclear Changes and DNA Fragmentation
The precise mechanisms by which chromatin condensation and
nuclear envelope breakdown occur during apoptosis are unknown.
Nuclear laminin are intermediate filaments that associate with the
inner nuclear membrane. They organize the nucleoskeleton and provide a
framework for the attachment of chromatin to the nuclear envelope.
has been observed that nuclear laminin loses its integrity upon
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It

phosphorylation by p34cdc2 kinases during the chromatin breakdown that
occurs in mitosis(Peter, Nakagawa et al. 1990).
however,

During apoptosis,

laminin disassembly occurs by proteolysis, which is

apparently an irreversible event

(Kaufmann 198 9). Glucocorticoids

promote thymocyte laminin B-l degradation (Neamati, Fernandez et al.
1995).

The protein responsible for this glucocorticoid-promoted

degradation, Lam-P, is distinct from prICE (Earnshaw 1995a).

Lamp-1

binds to a specific DNA sequence motif, called matrix attachment
regions.

These regions are spaced at 20 to 50 kilobase pairs and are

believed to mediate the interaction of chromatin with the nuclear
matrix. It has been suggested that nuclear laminin degradation
promotes formation of large DNA fragments by allowing the release of
matrix attachment regions and providing access for endonucleases to
act on the DNA(Neamati, Fernandez et al. 1995).
A biochemical hallmark of apoptosis is the formation of distinct
oligonucleosomal fragments, usually of 180-200 base pair (bp) length
that result from the internucleosomal cleavage of DNA.

Larger and

smaller oligonucleosomal fragments have also been reported
(Oberhammer, Wilson et al. 1993; Solis-Recendez, Perani et al. 1995).
Topoisomerase II is believed to be important in the adherence of
matrix attachment regions to a chromosomal 50 kb chromatin-loop
domain.

It has been implicated as a nuclease involved in chromatin

fragmentation (Arends and Wyllie 1991; Sun

and Cohen 1994). However,

it was suggested that topoisomerase II does not seem
the active formation of 50 kb fragments in

to be involved in

HL-60 and MOLT-4

cells(Beere, Chresta et a l . 1995).
It is widely believed that DNA cleavage characteristic of
apoptosis is the result of an endogenous, neutral, Ca2+ and Mg2*dependent endonuclease capable of inducing double strand breaks at
internucleosomal sites (Arends, Morris et al . 1990); such endonuclease
is also inhibited by zinc and produces 3'-OH DNA breaks (Earnshaw
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1995b).

Several candidates have been recognized:

Polzar et al. 1993); DNase-II

DNase-I (Peitsch,

(Barry and Eastman 1993); Nuc-18 (Caron-

Leslie, Schwartzman et al. 1991); Nuc-1 (Yuan 1995); 27-kDa nuclease
(Ribeiro and Carson 1993); and Nuc-40 and Nuc-58

(Deng and Podack

1995).
DNase-I has Ca2* and Mg2+-dependent endonuclease activity, with an
optimum pH of 7.5 (range is 5.5-9.0).

It is localized mainly in the

endoplasmic reticulum and perinuclear Golgi complex.

DNase-I is

specifically inhibited by actin, and antibodies directed against it
reduce DNA laddering in thymocytes (Polzar, Peitsch et al. 1993).

It

induces morphological and biochemical changes observed during
apoptosis in transfected COS cells (Polzar, Peitsch et al. 1993) .
DNase-II is located primarily in lysosomes but is also in the
nucleus.

It is Caz+ and Mg2+-independent and requires an acid

environment for activation, with a pH optimum of 5.5 (range 3.0-7.0).
DNase-II can cause apoptotic DNA laddering in CHO cells (Barry and
Eastman 1993).

It is probably an unlikely candidate for the apoptotic

nuclease because it generates 5'-OH DNA fragments, and it is not
inhibited by zinc, which is known to inhibit DNA fragmentation
(McGowan, Fernandes et al. 1994).

Zinc also inhibits the

intracellular acidification required for DNase-II activity which may
be an alternative means by which it inhibits DNA fragmentation
(Morana, Li et al. 1994).
Nuc-18 was isolated from apoptotic thymocyte nuclei and is
induced by the glucocorticoid receptor (Caron-Leslie, Schwartzman et
al. 1991).

It is a neutral endonuclease induced by dexamethasone and

dependent on calcium and magnesium for its activity.

Nuc-18 may exist

in a complex with a repressor protein, which separates from it after
glucocorticoid treatment.

Its nuclear localization and cation

dependence supports its possible role in apoptosis.

Nuc-18 shows
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sequence similarity to cyclophillin A and related proteins for the
immunosuppressive drug cyclosporin.
Another candidate, the 27-kDa nuclease isolated from human
spleen cell nuclei (Ribeiro and Carson 1993), has a pH optimum of 8.0,
is Ca2+/Mg2‘-dependent, and zinc inhibits its activity.

This nuclease

is able to produce mono- and oligonucleosomal DNA fragmentation
characteristic of apoptosis.

Nuc-40 and Nuc-58 were identified from

the extract of IL-2-depndent CTLL2 cells (Deng and Podack 1995).
Nuc-58 has Ca2+/Mg2+-dependent activity and is found primarily in the
cytosol.
activity.

Nuc-40 is mainly a nuclear nuclease with a Mg2+-dependent
Nuc-1 is associated with, but not essential for, DNA

fragmentation and cell death in Caenorhabditis elegans . Nuc-1 is
also expressed by the engulfing cell, rather than by the dying cell
itself (Yuan 1995).
Cytoplasmic Changes in Apoptosis
The main feature of the cytoplasmic changes that occur in
apoptosis is the formation of apoptotic bodies after shrinkage and
fragmentation of the cell.

Such event probably occurs due to

rearrangement of the microfilament network of the cell. The
microtubule-disrupting agents, colchicine and vinblastine, as well as
noconazole were used to induce apoptosis in HL-60 cells, and it was
suggested that disruption of the microtubule network initiates a
series of events that lead to apoptosis(Martin and Cotter 1990).
Tissue-type or type II transglutaminase are cytosolic proteins of
80-kDa that accumulate selectively in cells undergoing apoptosis
(Piacentini, Davies et al. 1994a).

Transglutaminases belong to a

family of Ca2‘-dependent glutamine and glutamyl transferases
(Piacentini, Davies et al. 1994a).

Five transglutaminases have been

identified in humans (Greenberg, Birckbichler et al. 1991):
transglutaminase (TGase 2),

1) tissue

2) blood coagulation factor XIII, 3)

TGase 4, 4) keratinocyte transglutaminase (TGase 1), and 5) epidermal
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transglutaminase (TGase 3).

These transglutaminases appear to have

different functions, but all are important in the protection of cell
and tissue integrity.

The mRNA levels of tissue transglutaminase

(TGase 2) are highly elevated at the onset of apoptosis along with
cytosolic calcium, which is needed for enzyme activation (Piacentini,
Davies et al. 1994a).

Crosslinking of intracellular proteins

stabilizes the cytoplasm of dying cells, thus, preventing leakage of
intracellular elements into the extracellular environment.
Immunological characterization of the crosslinked matrix indicate that
it is composed of actin, annexin-II, vinculin, fibronectin, and others
(Knight, Hand et al. 1993).
Call Membrane Alterations in Apoptosis
There are extensive cell membrane
apoptosis.

alterations that occur in

There is detachment from neighboring cells, from the

culture substrate in-vitro or from the extracellular matrix in-vivo.
Specialized structures, like microvilli, are lost as well.

Cell

surface markers, like the avba vitronectin receptor, CD36, and
thrombospondin, as well as changes in membrane sugars and lipid
composition are important in assuring swift recognition by phagocytic
cells (Savill, Fadock et al. 1993; Savill 1995) avoiding leakage of
cellular contents into the extracellular environment, thus, avoiding
an inflammatory response and subsequent tissue damage.
A variety of cells, in addition to resident tissue macrophages,
may participate in the removal of apoptotic bodies through
phagocytosis, and are sometimes referred to as "non-professional
macrophages".

The observation that phagocytosis of apoptotic bodies

was inhibited by peptides and proteins containing an arginine-glycineaspartic acid (RGD) sequence (Savill, Dransfield et al. 1990), first
implicated integrins in the recognition of apoptotic neutrophils by
macrophages.
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A change in the lipid composition of the plasma membrane allows
recognition of apoptotic cell by phagocytes.

Normally anionic

phosphatidylserine is found in the inner plasma membrane, while
neutral phospholipids sphingomyelin and phosphatidylcholine are on the
outer membrane bilayer.

During apoptosis phosphatidylserine is

exposed on the outer membrane surface, which appears to be important
in eliciting a phagocytic response (Fadock, Voelker et al. 1992).
Lipocortin-1, which is upregulated in apoptotic cells occurring in
mammary regression, binds to calcium ions and phosphatidylserine, and
is implicated in the phosphatidylserine-elicited phagocytosis (McKanna
1995).

Apoptotic cells also bind to annexin-V, a calcium-dependent

phospholipid binding protein with high affinity for phosphatidylserine
(Homburg, de Hass et al. 1995).
The reduced anionic charge that apoptotic cells have implies
loss of terminal sialic residues, which may unmask other sugar
residues, such as N-acetylglucosamine and N-acetylgalactosamine, and
could interact with a phagocytic recognition lectin on the macrophage
surface (Duval, Wyllie et al. 1985).
as the CD16 (FcyRIII)

A role for other receptors, such

(Dransfield, Buckle et al. 1994), in the

recognition of apoptosis has been suggested.
In the nematode Caencrhabditis elegans there are seven genes
downstream of the ced-3 and ced-4 control point involved with the
process of phagocytosis of dying cells (Ellis, Jacobson et al. 1991),
the existence of which suggest that several different mechanisms may
be employed in the elimination of

apoptotic bodies in mammalian

tissues.
Because apoptosis is associated with cell surface membrane
alterations, it has been suggested that there is an association
between apoptosis and cell surface tissue factor procoagulant
activity(Greeno, Bach et al. 1996).

Such an association may help to
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regulate the flux of cells into tissues being remodeled by apoptosis
since there is a linkage between the coagulation system with wound
healing and neoplasia (Greeno, Bach et al. 1996) .
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CHAPTER 2. IMMUNOHISTOCHEMICAL DETECTION OF APOPTOSIS IN THE LIVER
OF FUNDULUS GRANPIS AFTER EXPOSURE TO N-METHYL-N *-NITRO-NNITROSOGUANIDINE AND 2-AMINOFLUORENE
Introduction
Apoptosis is now accepted as a critical element in the
repertoire of cellular responses,

but there is still an incomplete

picture of the multiple features and complex intracellular processes
involved.

In multicellular organisms homeostasis is maintained

through a balance between cell proliferation and cell death.
Dysfunction in the maintenance of this balance is believed to be
important in the pathogenesis of neoplasia.

This makes the study of

apoptosis an active area of research in today's multidisciplinary
biological sciences.
Although fish have become a popular model for cancer studies,
only a few published articles have referred to the process of
apoptosis in fish (Soutscheck and Zupanc 1996; Bjoerklund, Johansson
et al. 1997) and only one article has related apoptosis to
preneoplastic hepatic lesions in the English Sole model (Malins,
Polissar et a l . 1996).
In order to examine the balance between cell proliferation and
cell death in the livers of fish exposed to the alkylating agent, nmethyl-n'-nitro-n-nitrosoguanidine

(MNNG), or to the polycyclic

aromatic hydrocarbon, 2-aminofluorene (2-AF), apoptosis was evaluated
by immunohistochemical (IHC) detection methods.

To perfect

methodology for these IHC techniques in fish, several preliminary
studies were required, however.
The studies reported here include (1) a study to determine the
stability of MNNG in saltwater, as required in our fish model,

(2) the

suitability of different fixatives, on IHC identification in fish
tissues, and (3) finally, the determination of apoptotic frequencies
in livers of fish subjected to short and long term exposures.
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Materials and Methods
Experimental Design
To determine the stability of MNNG in saltwater to which fish
would be exposed over a time course in later experiments, the compound
was added at a concentration of 34 pM to 5 parts per thousand (ppt)
saltwater, and the solution was sequentially analyzed by highperformance liquid chromatography (HPLC).
Livers from fish exposed to MNNG were fixed in 1 of 3 different
fixatives; buffered 10 % formalin, methacarn, or Strek's fixative.
Livers were then processed by routine techniques and subjected to IHC
staining techniques to identify apoptotic events.

The overall tissue

morphology and clarity and specificity of staining characteristics
were subjectively compared to determine the most suitable fixative for
use in later experiments.
Finally, groups of fish were exposed to MNNG or 2-AF at two
different time durations and at two different concentrations, and
apoptotic activity was quantitatively determined.
Fish and Housing
For this study Fundulus grandis fish was chosen as a model for
chemically-induced liver cell injury because it lives in brackish
waters along the Gulf coast of the southeastern United States, where
the Mississippi river meets the Gulf of Mexico.

This fish serves as

an environmentally sensitive species for aquatic pollution in this
region.

This fish is well adapted to laboratory conditions, and it

has been used previously as a model for studies of chemical
carcinogenesis (Hawkins, Overstreet et al. 1988).
For the initial experiments, three groups of 32 Fundulus grandis
juvenile fish each were kept in separate aquarium tanks, each
containing 30 L of 5 ppt saltwater, pH 8.4, and maintained between 26
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to 28°C.

Fish tanks were kept within a laminar flow hood during the

duration of the experiment.
For the long term experiments, three groups of 300 Fundulus
grandis juvenile fish each were kept in separate aquarium tanks, each
containing 540 L of 5 ppt saltwater, pH 8.4, and maintained between 26
to 28° C in a recirculation system (see figure 2.1).

Fish from group 1

were treated as control fish and were kept in a separate room from
exposed fish in groups 2 and 3; these were kept in a high-hazard,
exposure room.

All fish used came from Gulf Coast Minnows, Inc.,

Thibodaux, Louisiana.

suoretd
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Figure 2.1. Sample Diagram of the Recirculation System Used.
Arrows indicate the water flow direction.
Rationale for Using the Liver as the Target Organ
In teleost fish and mammals the liver serves as the major site
of deactivation or detoxification of some xenobiotics as well as a
site for activation of other compounds into their toxic (active) form
by the cytochrome P450-mediated, mixed function oxidase system.
Toxicologic pathology of the liver has been reviewed in both mammalian
(Arias, Jakoby et a l . 1988) and teleost fish species (Hinton, Teh et
al. 1992).
Compounds Usod
The direct acting alkylating agent, n-methyl-n’-nitro-nnitrosoguanidine (MNNG), belongs to the N-nitroso group of chemical
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agents, which includes the N-nitrosamides, N-nitrosamines, and others.
As reviewed by Margison and O'Connor (Margison and O'Connor 1979),
compounds belonging to this group are known to be carcinogenic in many
animal species and for a variety of different tissues; these compounds
are teratogenic and mutagenic and can have an effect on the synthesis
of DNA, RNA, and proteins.

The chemical MNNG has been used freguently

in fish to induce neoplasia in liver and other tissues (Hawkins,
Overstreet et al. 1988; Bunton 1994; Bunton and Wolfe 1996).
The genetic toxicity of the polycyclic aromatic hydrocarbon 2aminofluorene (2-AF) has been recently reviewed (Heflich and Neft
1994).

The compound 2-AF, along with the compound 2-

acetylaminofluorene, are among the most intensely studied of all
chemicals and mutagens.

Research concerns are centered on the

metabolism of 2-AF and the interaction of the metabolites with DNA and
the carcinogenic and mutagenic responses that are associated with the
resulting DNA damage (Widlack, Widlack et al. 1993; Heflich and Neft
1994).

The levels of hemoglobin adduct and hepatic- and urinary

bladder-DNA adduct levels in Syrian hamsters administered 2-AF has
also been studied (Flammang, Yerukon et al. 1992) .
Dosing Rationale and Route of Administration
The dosing of the compounds used, MNNG and 2-AF, was based on a
parts per million (ppm) basis since most of the published literature
has used this conventional method for reporting concentration of a
chemical compound.

The concentrations used in these experiments were

calculated and reported on a molar basis for each of the compounds.
The dose used for MNNG was based in the lowest published concentration
for MNNG-induced neoplasia in fish, which is 1 ppm or 6.7 pM (Bunton
and Wolfe 1996; Couch and Harshbarger 1985) .

Initially, an equimolar

concentration of MNNG and 2-AF was considered, but because of the poor
solubility of 2-AF, route of exposure (feed), amount of feed consumed
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daily by the fish, and the assurance of a well distribution of the
compound in the feed, a higher dose was chosen, which consisted of
6.9 mM 2-AF.
The route of administration chosen for MNNG was that of an
aqueous medium because of its higher solubility in water which was
aided by using dimethyl sulfoxide (DMSO) as a solvent.

Because of the

poor solubility of 2-AF in water, the route of administration chosen
for this compound was in the feed.

Appendix 2.A shows general

chemical data for both of these compounds.
Determination of MNNG Stability in Saltwater
A 100 pi sample from a 34 pM MNNG solution in distilled water
(pH = 7.01) was injected into the HPLC machine to establish baseline
Ultra-Violet (UV) light spectrum.

This was followed first by a 100 pi

injection of 5 ppt saltwater alone, then by a 100 pi 34 pM MNNG
solution in 5 ppt saltwater (pH = 8.56) into the HPLC instrument.

The

results were read immediately after injection, then every 10 minutes
thereafter for a total of 60 minutes.

Time 0 represents the time of

actual mixing and preparation of the solution.

Solvents used were

HPLC-grade acetonitrile and distilled water.
Preparation of Feed Containing 2-AF
To prepare a feed mix containing 6.9 mM 2-AF to be fed adlibitum for 5 consecutive days, several parameters had to be
determined.

First, the average consumption of feed in a dry matter

basis was estimated to be at least at 2 % of the body weight (NRC
1986) .

For all groups, the average body weight of fish sampled at

day 0 of the experiment was 3.0 g/fish.

The total estimated five-day

feed consumption for the 300 fish in the 2-AF exposed group was 0.1kg.
Molarity was calculated as grams of 2-aminofluorene/ molecular
weight of 2-aminofluorene (M.W.= 181.24) in 1 kg of feed (see appendix
2.A for general chemical data on 2-AF).

For a 6.9 mM 2-AF feed mix,

83

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

0.126 g of the compound were mixed with 0.1 kg of grounded feed after
diluting with 5 ml of 100 % ethyl alcohol.

The mixture was placed

overnight on a mechanical roller to assure a good distribution.

Based

on an average daily feed consumption of 2 % of the body weight, it was
estimated that each fish consumed at least 0.06 g of the feed mixture
per day or 7.56 x 10'fi g 2-AF/day.
Effect of Three Types of Fixative on ZCH Detection of Apoptosis
in Livers
Fish from each tank were exposed to 6.7 pM of MNNG saltwater
solution once daily for three consecutive days.

Groups of 4 fish were

sampled from each tank at days 0, 1, 2, 3, 6, 9, 12, and 15.

Fish

were euthanized by immersion in 0.4 % tricaine methanesulfonate
solution.

The coelomic cavity was injected with one of three

fixatives, methacarn, Strek Tissue Fixative (S.T.F., Strek's
Laboratories, Nebraska), and buffered 10 % formalin.

The body was

immersed in the respective fixative at a ratio of 1 : 20.

Whole-fish

specimens were processed and embedded in paraffin blocks.

Tissue

sections from each specimen were stained with hematoxylin and eosin
and evaluated

histologically.

From each of the sampling days ( 0, 1,

2, 3, 6, 9, 12, and 15), a fish specimen was randomly selected from
each of the three fixative groups, for a total of 24 fish specimens,
for immunohistochemical detection of apoptosis.
Immunohistochemical Detection o£ Apoptosis in Liver of Fish
Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
Fish from group 1 were treated as control fish and received no
treatment.

Fish in group 2 were exposed to 6.7 pM n-methyl-n'-nitro-

n-nitrosoguanidine (MNNG) solution one time, at day 0 of the
experiment, and remained within this tank for the rest of the
experiment.

Fish in group 3 were fed ad-libitum for five consecutive

days feed containing 6.9 mM of 2-aminofluorene (2-AF).

Twenty five

fish were sampled from each group at days 0, 3, 9, 21, 45, 90, and 180
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days of the experiment.
was recorded.

The total body weight of each 25-fish sample

Fish were euthanized by immersion in 0.4 % tricaine

methanesulfonate solution.

The liver was dissected from each fish and

submerged immediately in buffered 10 % formalin fixative solution;
the head was hemisected and placed in buffered 10 % formalin fixative
solution containing formic acid, a decalcifying agent.

The specimens

were left in fixative solution for 8 to 12 hours, then processed and
embedded in paraffin blocks.

Ten of the 25 fish specimens sampled

from each group were randomly selected for immunohistochemical
detection of apoptosis.

All 25 specimens sampled from each group were

stained with hematoxylin and eosin and evaluated histologically.
Inamnohistochamiol Technique for Identifying Apoptosis
in Tissues
The procedures described for the In-Situ Cell Death Detection
Kit, Peroxidase (POD)

(Boehringer-Mannheim, Indiana) for

immunohistochemical detection of apoptosis in tissue sections were
followed according to the manufacturer, with few modifications.
Briefly, after the sections were deparaffinized and rehydrated to
distilled water, the slides were incubated with 0.4 % pepsin solution
in 0.01 N HC1 for 10 minutes at 37° C.

Endogenous peroxidase was

blocked with 0.3 % H20= in methanol for 45 minutes, and the tissue
sections permeabilized with 0.1 % Triton X-100 in 0.1 % sodium citrate
for 2 minutes on ice.

The tissue DNA strand breaks were fluorescein-

labeled by adding 50 |il of terminal deoxynucleotidyl transferasemediated dUTP nick end-labeling (TUNEL) reaction mixture on the tissue
sample, and incubated in a humidified chamber for 60 minutes at 37° C.
To the tissue samples, 50 jxl of Converter-POD, which contained anti
fluorescein antibody Fab fragment from sheep conjugated with
horseradish peroxidase, were added on for signal conversion.

The

slides were incubated in a humidified chamber for 30 to 60 minutes at
37° C.

The chromogen, diaminobenzidine, was utilized.

The slides were
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counterstained with Mayer's hematoxylin, dehydrated, cleared, and
mounted on a resinous media.

For negative controls, fixed and

permeabilized tissue slides were incubated in 50 pi Label Solution
(without terminal transferase) instead of TUNEL reaction mixture.

For

positive controls, fixed and permeabilized tissue slides were
incubated with DNase 1 (l|ig/ml, 10 minutes at room temperature to
induce DNA strand breaks)

(Fehsel, Kolb-Bachofen et al. 1991;

Gavrieli, Sherman et al. 1992).
Cytometry
Using a squared (grid) graticule, the total number of
diaminobenzidine (DAB)-stained, positive liver cell nuclei was
recorded from a total of five randomly chosen fields counted at 40-X.
The average was recorded and divided by a conversion factor of 0.03132
mm2, which was obtained after calibrating the graticule for the 40-X
microscope objective lens.

The data was reported as number of

positive cell nuclei/mm2 of liver tissue.

The criteria described by

Gavrieli et al., 1992, for identifying positive-stained apoptotic
cells were used.

The type of cells counted included mainly

hepatocytes, but also biliary epithelial cells, endothelial cells, and
pancreatic epithelial cells were included in the counts.
Statistical Analysis
A regression analysis was done on the data obtained from the
HPLC machine to predict degradation time estimates for MNNG.

Two-

factor factorial analysis of variance for the data obtained from the
immunohistochemical detection of apoptosis was performed using the
following statistical model:

Yijk is N {|iij,cr2}, assume all observations

independent and equal variances; where i represents group- control,
MNNG, 2-AF; j represents days- 0, 3, 9, 21, 45, 90, 180; and k

represents counts- 1 through 210.

Values were considered significant

if the value of P was equal to or less than 0.005.

All of the
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statistical data analysis was performed using a Statistical Analysis
System (SAS) computerized program.
Results
MNNG Stability in Saltwater
High-performance liquid chromatography analysis detected three
peaks at different intervals during the first 7 to 8 minutes post
injection of the 34 pM MNNG saltwater solution (see figure 2.2).
Their retention time and area under the curve from each peak were
measured (see table 2.1).

The first two peaks were noted in both the

5 ppt saltwater solution and in the 34 pM MNNG plus 5ppt saltwater
solution.
MNNG.

The third peak was interpreted to correspond to that of

A histogram chart of area vs time (see histogram 2.1) and a

regression analysis were performed for peak number three (see appendix
B), which shows that a 34 pM MNNG solution in 5 ppt saltwater was
degraded by 70 minutes after its preparation.
Effect of Fixative on IHC Detection of Apoptosis in MNNG
Exposed Fish Livers
Of the three fixatives, methacarn, Strek's, and buffered 10 %
formalin, the best all-around fixation was provided by the formalin
solution.

The fixation was subjectively evaluated on preservation of

overall cellular and tissue morphology, retention of nuclei, lack of
tissue structural distortion, and differential staining
characteristics.

Most of the lesions in these livers were few and of

mild degree (see table 2.2).
mild in most fish.

Vacuolar and hyperplastic changes were

The most severe changes were found in three fish

livers and occurred at days 1, 2, and 12.

Day 1:

There were

scattered hypercellular foci of hepatocytes.

Individual hepatocytes

occurred in a tubulo-sinusoidal arrangement.

These had a

hyperchromatic, round to oval nuclei, with moderate anisokaryosis.
Mitotic figures and apoptosis varied from 0-2 per hpf.

Multinucleated
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Figure 2.2. Representative HPLC Peaks Obtained After Injection
of 34 (iM MNNG Saltwater Solution
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Table 2.1.

Data Summary of the HPLC Peaks, Retention Times, and Area
Under the Curve for 34 pM MNNG in 5ppt salt water

OBS

MNNG 5PPM IN SALT WATER
PEAK
TIME
RETTIME
(minutes) (minutes)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3

0
10
20
30
40
50
60
70
80
90
0
10
20
30
40
50
60
70
80
90
0
10
20
30
40
50
60
70
80
90

1.587
1.567
1.561
1.546
1.545
1.532
.

are;

371.41
205.91
277.46
329.18
352.77
391.13

,

,
.

2.502
2.519
2.522
2.511
2.524
2.510
•
.
.
.

7.164
6.761
6.240
6.096
5.840
5.584
.
.
.

241.80
38.01
36.97
37.92
38.17
39.14
.
.

729.92
494.89
371.66
271.38
201.87
159.62
.
.
,

*Area in electronic integrator area counts (unitless)

cells occurred occasionally.

The cytoplasm was eosinophilic with

increased numbers of small, clear vacuoles.

In addition, there were

few admixtures of mononuclear inflammatory cells, which were seen in
scattered areas.

Day 2:

There were widespread areas of hepatocytic

hypercellularity with scattered admixtures of lymphocytes, plasma
cells, and histiocytes.

Individual hepatocytes had similar nuclear

features as those described on day 1.
hepatocytes were also found.

Occasional multinucleated

Increased number of intracytoplasmic
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Histogram 2.1. Degradation of 34
MNNG in
5 ppt Saltwater : Peak No. 3
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clear vacuoles were also noted; the cytoplasm was more basophilic.

In

addition, scattered individual hepatocytic apoptosis occurred at 0-1
per hpf.

Day 12:

hypercellularity.

There were multiple, distinct foci of hepatocytic
Individual cells had mild nuclear pleomorphism,

with a densely eosinophilic cytoplasm, and a few clear
intracytoplasmic vacuoles.

Apoptosis occurred at 1-2 per hpf,

especially in areas associated with mild admixtures of mononuclear
inflammatory cells, most of which are noted primarily in perivascular
spaces. In addition to the changes described above, in other fish,
inflammation of the liver was the main histological feature observed.
This varied from mild to moderate to severe, and it was recognized
throughout the experiment.

The predominant cell types were a mixture

of lymphocytes, eosinophilic granular cells, and fewer macrophages.
Granulomas also occurred throughout the experiment; these were
characterized by distinct, well demarcated collections of epithelioid
macrophages with degenerated, brown/gold pigment in the center.

A

thin fibrous capsule surrounded the granulomas, with discrete
admixtures of lymphocytes, and macrophages.

In some fish granulomas
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Table 2.2. Summary of Micros :opic Findings in the Liver of Fish
Exposed to 6.7 pM MNNG
Day of experiment

0

1

2

3

6

9 12 15 Total
75
21
96

9 11 8
11 10 10 7 9
3 1 4 1 2 2 5 3
12 12 12 12 12 12 12 12

Fish with no lesions
Fish with lesions
Total Number of Fish

Types and Frequency of Hepatic lesions Recognized:
0
1
3
0
1
0
0

Hyperplastic
Vacuolar
Inflammatory, Mixed
Granulomas
Apoptotic Necrosis
Coagulative Necrosis
Neoplasia

were multiple and/or coalescing.

1
1
1
2
1
0
0

4
4
2
3
3
0
0

1
1
1
1
1
0
0

2
1
2
2
2
0
0

2
2
2
1
2
0
0

5
5
5
5
1
0
0

18
18
18
17
14
0 1 0
0 | 0

3
3
2
3
3

1
1
I
I
|

Acid-fast staining was negative for

acid-fast bacilli or other organisms.
The most important parameter evaluated in these tissues was the
immunohistochemical identification of apoptotic nuclei, especially in
the liver, and the three fixatives varied widely in their suitability
for this procedure (see histogram 2.2).

The number of positive cell

nuclei per 1 mm2 of liver tissue varied from 0 to 2637 in the tissues
fixed in methacarn.

Those for tissues fixed in S.T.F. varied from 0

to 281, and for the tissues fixed in 10 % formalin counts varied from
447 to 945.
In the methacarn-fixed tissues, all cells from the various
tissues present were labeled positive, regardless of the day of the
experiment.

The pepsin tissue digestion step was harsher on

methacarn-fixed tissues

when compared to those fixed in S.T.F. or

formalin.

the methacarn-fixed specimen collected at day

Moreover, on

10 %

0 of the experiment, no apoptosis counts could be obtained from the
liver tissue since no liver tissue was left on the slide afterthe
pepsin digestion step.

The cellular detail from tissues fixed in
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S.T.F. was greatly obscured with the chromogen, diaminobenzidine; the
cell margins, cytoplasm, and nuclei stained strongly with DAB.

In

some well-fixed areas, there was some differential staining between
positively and negatively labeled apoptotic cells when compared to
control fish.

Cells from tissues fixed in buffered 10 % formalin had

good differential staining between positive and negatively stained
apoptotic cells when compared to control fish (see figure 2.3).

Less

tissue artifact and a better ability to withstand the harsh, pepsin
digestion step was also noted.

Histogram 2.2. Effect of Fixative on
Immunohistochemical Detection of Apoptosis in
Livers of Fish Exposed to 6.7 pM MNNG
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Immunohistochemical Detection of Apoptosis in the Liver of Fish
Exposed to 6.7 pM MNNG or 6.9 mM 2-AF
Mean hepatic immunohistochemical detection of apoptosis in
Fundulus grandis was performed in 210 fish specimens of a total of 52b
fish sampled from the three groups (see table 2.3).

In the 2-AF
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exposed fish group, the mean hepatic immunohistochemical detection of
apoptosis ranged from 986 nuclei per 1 mm2 of tissue on day 21 to 2599
nuclei per 1 mm2 of tissue on day 45 of the experiment.

In the MNNG

exposed fish group, the mean hepatic immunohistochemical detection of
apoptosis varied from 665 nuclei per 1 mm2 of tissue on day 180 to 2257
nuclei per 1 mm2 of tissue on day 45 of the experiment.

The control

fish had a mean hepatic immunohistochemical detection of apoptosis
that varied from 1359 nuclei per 1 mm2 of tissue on day 3 to 2296
nuclei per 1 mm2 of tissue on day 4 5 of the experiment.

The

distribution of the apoptotic frequencies are illustrated in the
histogram 2.3.

Figure 2.3.
Representative apoptotic labeling features in
formalin fixed liver tissue from a fish exposed to 6.7 pM MNNG.
Apoptotic
hepatocyte
nuclei
are
labeled
by
a
brown
diaminobenzidine chromogen deposit. (Hematoxylin, 500X)
Two-factor factorial analysis of variance showed no significant
group by day interaction (P=0.165; see appendix 2.C.1); thus,
individual main effects of group and day were evaluated.

By looking

at the least-square means table (see appendixes 2.C.2 and 2.C.3), at
day 180, significant differences (P=0.005) were found in the apoptotic
cell counts between the control fish and those treated with MNNG, but
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not between fish treated with MNNG and 2-AF, or between 2-AF treated
fish and controls.
Histologic evaluation of 525 fish livers revealed a total of 153
livers with lesions, of which 37 were noted in the control group, 55
in the MNNG-exposed group, and 61 in the 2-AF-exposed group.

The

frequency and type of liver lesions found in each group sample per day
of experiment are summarized in table 2.4.
In the control group, most of the lesions found were
inflammatory, and most were recognized by day 3 of the experiment.
Most of the inflammatory lesions were mild and consisted of
perivascular and pericholangial admixtures of lymphocytes,
eosinophilic granular cells, and histiocytes.

Some fish had

granulomas, which occurred as distinct collections of epithelioid
macrophages surrounding golden-brown material and necrotic debris; a
thin fibrous capsule is noted at the periphery of the granulomas with
focal collections of lymphocytes.
Hepatocytes in adjacent areas had cytoplasmic vacuolar changes,
which consisted of increased number of variably sized, clear vacuoles.
Apoptosis was noted mainly in areas associated with mononuclear
inflammatory cell infiltrates.

A total of 6 fish livers had a

distinct, discrete non-expansile nodular collection of densely
eosinophilic hepatocytes (eosinophilic focus), which maintained the
normal tubulo-sinusoidal architectural arrangement of adjacent
hepatocytes (see figure 2.4).

No neoplastic changes were found in any

of the control fish livers.
In the MNNG-exposed group, there were about equal numbers of
hyperplastic, inflammatory, and vacuolar changes noted in the liver
specimens examined.

Inflammatory changes were similar to but milder

than those described for the control fish group, and their frequency
was spread throughout the experiment.

Hyperplastic changes were more

frequently noted on days 45, 90, and 180 of the experiment.

These
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were characterized by discrete hepatocytic hyperceiluiar clusters or
nodules that varied to widespread or diffuse hepatocytic
hypercellularity, with increased cytoplasmic basophilia and vacuolar
change.

The discrete, nodular collections of hepatocytes with

basophilic cytoplasm were recognized as basophilic foci (see figure
2.5).

Hepatocytic megalocytosis and megalokaryosis were frequently

recognized in hyperplastic lesions from several specimens (see figure
2.6).

The normal tubulo-sinusoidal architectural arrangement was

maintained in all hyperplastic changes, however.
throughout these hyperplastic changes.

Apoptosis was noted

Two liver neoplasms were

recognized, at days 9 and 180, respectively.

The microscopic features

of the neoplasm found at day 9 were consistent with a
cholangiocellular carcinoma (see figure 2.7), which was characterized
by expansile proliferation of pleomorphic polygonal cells arranged in
tubular structures within a fibrous stroma.

The hyperchromatic nuclei

was round to oval with moderate anisokaryosis.
rare and apoptosis vary from 1-2 per hpf.
eosinophilic and vacuolated.

Mitotic figures are

The cytoplasm was

The histologic features of the neoplasm

noted at day 180 were commensurate with a hepatocellular carcinoma
(see figure 2.8); the predominant features consisted of a discrete
focus of neoplastic pleomorphic hepatocytic cells with loss of normal
architectural tubulo-sinusoidal arrangement.

The nuclei were

eccentrically located, round to oval, and hypochromatic with marked
anisokaryosis, and prominent amphophilic nucleoli.
were not seen.

Mitotic figures

The cytoplasm was basophilic with a few eosinophilic

vacuoles.
In the 2-AF-exposed group, inflammatory changes were also spread
throughout the experiment, and the features were similar to those
described above.

Hepatocytic hyperplasia was also noted in the liver
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Table 2.4. Mean Hepatic Immunohistochemically Detected
Apoptotic Nuclei per mm2 of Liver Tissue From Fish Exposed
6.7 pM MNNG or 6.9 mM 2-AF
6.9 mM 2-AF-Expoaed Group
Day

Mean

Std. Dev.

% RSD*

0
3
9
21
45
90
180

1045
1808
1106
986
2599
1506
1285

215
1107
667
543
1184
467
840

20.57
61.23
60.31
55.07
45.56
31.01
65.37

Std. Dev.

% RSD

1048
573
650
724
689
837
950

55.72
42.16
42.02
53.20
30.01
55.84
58.61

Control Group
Day
0
3
9
21
45
90
180

Mean
1881
1359
1547
1361
2296
1499
1621

6.7 pM MNNG-Exposed Group
Day

Mean

Std. Dev.

% RSD

0
3
9
21
45
90
180

1070
1485
1502
892
2257
1180
665

288
898
972
357
457
681
696

26.92
60.47
64 .71
40.02
20.25
57 .71
104.66

* % RSD = (Std. Dev./Mean) 100 %
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Histogram 2.3. Mean Immunohistohamical Detection
of Apoptosis in the Liver of JTundulus grandis
Fish Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
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and it occurred more frequently at day 45 and resembled those
described for the fish exposed to MNNG (see figure 2.9).

Again, the

association of apoptosis with areas of inflammation and hyperplasia
was recognized.

Neoplastic changes were noted in two livers, one at

day 45 and one at day 180.

The microscopic features of these tumors

resembled those described for cholangiocellular carcinoma in the fish
liver from the MNNG-exposed group, with the exception that the tumor
noted at day 180 of the experiment was more anaplastic and aggressive
with multiple neoplastic microsatellites within the liver (see figure
2 .10) .

The total body weight of the entire fish group sampled each time
doubled by the end of the experiment.

The range of the total sample

weight, which consisted of 25 fish per sample, varied from 75 grams at
day 0 to 150 grams at day 180 of the experiment (see histogram 2.4).
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Discussion
Degradation of MNNG
This experiment suggests that the total amount of n-methyl-n'-nitro-nnitrosoguanidine
minutes

since

(MNNG)

exposure to fish need not be longer than 70

the compound would be

totally degraded by that

time.

Observation of the area under the curve and of the retention time for
the saltwater MNNG solution suggest that this compound dissolves less
readily in saltwater than in distilled water.

It is known that this

compound is highly sensitive to light and that this may have also have
had an effect in its rapid degradation.

Other variables which could

have had an effect on the compound was the pH of the saltwater, which
for this experiment was 8.56.

The pH of the distilled water was 7.01.

Effect of Fixative on ZHC Detection of Apoptosis in Livers of
Fish Exposed 34 pM MNNG
Tissue morphology and immunohistochemical detection of apoptosis
were best preserved in the 10 % formalin fixed tissue group.

Aldehyde

fixatives, such as formalin and gluteraldehyde, preserve structure and
immobilize antigens to a much greater degree than do coagulant
fixatives, such as alcohols (methacarn), and are the most commonly
used fixatives for immunohistochemistry (Larsson 1993).

Coagulant

fixatives are often used to preserve immunoreactivities of large
proteins such as immunoglobulins, filament proteins, and receptors
(Larsson 1993).

The mode of tissue fixation of Strek's tissue

fixative is unknown.
Perhaps the most interesting finding was the widespread, intense
immunohistochemical detection of apoptosis of tissue fixed in
methacarn.

An explanation for this finding can not be given precisely

at this time.

Several questions come to mind:

Is the reaction of

this coagulative fixative with the cellular DNA similar to that of the
DNase-I used to induce DNA strand breaks in the positive controls?
so, what component of the mixture, which consists of 60 % methanol,
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If

Table 2.4. Summary of the Types and Frequency of Hepatic Lesions
Recognized in Fundulus grandis fish per sample per group
Control
Fish Livers With Lesions
Fish Livers With No Lesions

Total Number of Fish:

Day of
Experiment
0
3
12
6
19
13

9
7
18

21
4
21

45
1
24

90
1
24

180
6
19

Total
37
138
175

25

25

25

25

25

25

25

0
1
6
2
0
0
0
0

0
12
12
10
0
0
0
0

0
1
5
0
0
0
1
0

0
1
2
0
0
0
2
0

0
0
1
1
0
0
0
0

0
0
1
0
0
0
0
0

3
1
4
1
0
0
3
0

3
16
31
14

Day of
Experiment
0
3
6
4
19
21

9
12
13

21
2
23

45
9
16

90
9
16

180
13
12

Type of Hepatic Lesions
Hyperplastic
Vacuolar/Degenerative
Inflammatory, Mixed
Apoptotic Necrosis
Coagulative Necrosis
Neoplasia
Eosinophilic Foci
Basophilic Foci

MNNG
Fish Livers With Lesions
Fish Livers With No Lesions

Total Numbar of Fish:

0
0

6
0

25

25

25

25

25

25

25

Total
55
120
175

0
3
6
3
0
0
0
0

0
2
4
0
0
0
0
0

1
8
10
9
0
1
0
0

0
1
1
0
0
0
1
0

7
7
2
0
0
0
0
0

7
6
2
6
1
0
0
5

11
6
2
6
1
1
0
3

26
33
27
24
2
2
1
8

Day of
Experiment
0
3
5
9
16
20

9
6
19

21
10
15

45
13
12

90
10
15

180
8
17

25

25

25

25

25

25

25

Total
61
114
175

0
1
5
1
0
0
0
0

0
3
8
2
0
0
0
0

0
3
4
0
0
0
0
0

1
2
7
7
0
0
0
1

10
11
2
4
0
1
0
1

8
8
2
6
0
0
1
7

6
3
1
1
0
1
0
0

25
31
29
21
0
2
1
9

Type of Hepatic Lesions
Hyperplastic
Vacuolar/Degenerative
Inflammatory, Mixed
Apoptotic Necrosis
Coagulative Necrosis
Neoplasia
Eosinophilic Foci
Basophilic Foci

2-AF
Fish Livers With Lesions
Fish Livers With No Lesions

Total Number of Fish:
Type of Hepatic Lesions
Hyperplastic
Vacuolar/Degenerative
Inflammatory, Mixed
Apoptotic Necrosis
Coagulative Necrosis
Neoplasia
Eosinophilic Foci
Basophilic Foci
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Figure 2.4. Section of an eosinophilic focus found in the liver
of a control fish (Hematoxylin and eosin, 78.75X)

Figure 2.5. Section of a basophilic focus found in the liver of
fish exposed to 6.7 |oM MNNG (Hematoxylin and eosin, 200X)
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Figure 2.6. Representative example of hepatic megalocytosis and
megalokaryosis found in the liver of fish exposed to 6.7 |iM MNNG
(Hematoxylin and eosin, 500X)

Figure 2.7. Section of a probable cholangiocellular carcinoma
found at day 9 of the experiment in the liver of a fish exposed
to 6.7 pM MNNG (Hematoxylin and eosin, 78.75X)
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Figure 2.8. Section of a hepatocellular carcinoma found at day
180 in the liver of a fish exposed to 6.7
MNNG (Hematoxylin
and eosin, 200X)

Figure 2.9. Representative example of a section of liver with
diffuse hepatocellular hyperplasia found at day 45 in the liver
of fish exposed to 6.9 mM 2-AF (Hematoxylin and eosin, 200X)
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Figure 2.10.
Section of a probable cholangiocellular carcinoma
found at day 180 in the liver of a fish exposed to 6.9 mM 2-AF
(Hematoxylin and eosin, 200X).
Histogram 2.4. Variation of Total Sample Body
Weight of Fundulus gx-andls
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10'.-

formalin is a better fixative for preservation of tissue morphology
and for immunohistochemical detection of apoptosis than methacarn or
Strek's tissue fixatives.
IHC Detection of Apoptosis in Livers From Fish exposed to
6.7 pM MNNG or 6.9 mM 2-AF
The significant reduction in the immunohistochemical detection
of apoptosis between fish treated with MNNG and controls suggest that
the process of apoptosis is suppressed as a result of exposure to
MNNG.

It has been demonstrated that dysfunction of the process of

apoptosis is important in the pathogenesis of neoplasia (Bursch,
Oberhammer et al. 1992; Carson and Ribeiro 1993; Thompsom 1995;
Bosnian, Visser et a l . 1996; Duke, Ojcius et al. 1996).

This

alkylating agent, which is a known carcinogen that causes DNA damage,
has been related to neoplastic processes in fish, including fish such
as medaka (Oryzias latipes), Fundulus spp., and others (Moore and
Myers 1994; Bunton and Wolfe 1996).

The mechanism by which apoptosis

is suppressed as a result of MNNG exposure is unknown.

Possible

involvement of the product of the p53 gene will be evaluated in a
later chapter.
The absence of a significant difference found between fish
treated with MNNG and 2-AF suggests that the process of apoptosis is
affected also in fish treated with 2-AF.

However, no significant

differences were established between fish treated with 2-AF and those
from the control group in spite of finding two liver neoplasms.
It has been suggested that native fish, like Fundulus grandis,
may be less susceptible to carcinogens than laboratory-reared species,
such as medaka (Moore and Myers 1994) .

However, the decline through

time in the mean immunohistochemical detection of liver apoptosis as
well as the increased number of putative preneoplastic lesions, like
hepatocellular basophilic foci, megalocytosis, and karyomegaly in both
MNNG and 2-AF treatment groups, makes Fundulus grandis a potentially
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good model for the study of chemically-induced carcinogenesis.

It is

postulated that in longer or repeated exposure conditions, tumors
would be induced by these two compounds.
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CHAPTER 3. IMMUNOHISTOCHEMICAL DETECTION OF PROLIFERATING CELL
NUCLEAR ANTIGEN IN THE LIVER OF FUNDULUS GRANDIS AFTER EXPOSURE TO
N-METHTL-N'-NITRO-N-NITROSOGUANIDINE AND 2-AMINOFLUORENE
Introduction
In multicellular organisms homeostasis is maintained through a
balance between cell death and cell proliferation.

Dysfunction of

this balance is believed to be important in the pathogenesis of
cancer.

The assessment of cell proliferation has become a common

monitor of homeostatic host response to cell injury.
achieved in several ways.
figures in tissue sections,

This may be

Some of which include (1)counting mitotic
(2)measuring radioactive tritiated

thymidine uptake, or (3)measuring uptake of the non-radioactive
thymidine analog, bromodeoxyuridine (BrdU).

Another method for

determining mitotic activity is by immunohistochemical localization of
endogenous proteins, like proliferating cell nuclear antigen (PCNA),
the expression of which is closely related to cell replication (Hall,
Levison et al. 1990; Ortego, Hawkins et al. 1994).

In the past few

years fish have become popular models in the study of carcinogenesis.
But only in a few published articles has the mammalian PCNA
methodology been successfully used in fish (Hinton 1994; Ortego,
Hawkins et a l . 1994).
An application of PCNA for the assessment of cell proliferation
and possible promotional effects of the alkylating agent, n-methyl-n'nitro-n-nitrosoguanidine (MNNG), and of the polycyclic aromatic
hydrocarbon, 2-aminofluorene (2-AF) in liver and liver lesions of fish
exposed to these compounds was studied by immunohistochemical
methods.

(IHC)

To improve methodology of the IHC technique used, several

preliminary studies were needed.

These included a study to determine

the stability of MNNG in saltwater, a study to evaluate suitability of
different tissue fixatives on IHC localization of PCNA in fish
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tissues, and, lastly, a study to compare and evaluate cell
proliferation in fish liver subjected to exposure of MNNG and 2-AF.
Materials and Methods
Experimental Design
The study on the stability of MNNG in saltwater, to which fish
would be exposed over a time course in later experiments, was already
described in chapter 2.
To determine the most suitable tissue fixative for use in later
experiments, livers from fish exposed to MNNG were fixed in 1 of 3
different fixatives: 10 % formalin, methacarn, or Strek's tissue
fixative.

Livers were processed by routine techniques and subjected

to immunohistochemical labeling techniques to identify the endogenous
protein, proliferating cell nuclear antigen, using the clone PCNAPC10.

The overall tissue morphology and clarity and specificity of

staining characteristics were subjectively compared.
Finally, groups of fish were exposed to MNNG or 2-AF at two
different time durations and at two different concentrations, cellular
proliferative activity was quantitatively determined by cytometry and
tissue changes were evaluated histologically.
The following sections were already described in chapter 2:
fish and fish housing, rationale for using the liver as the target
organ, compounds used, dosing rationale and route of administration,
determination for the stability of MNNG in saltwater, preparation of
feed containing 2-AF, cytometry, and the statistical analysis.
The same procedures described in chapter 2 for evaluation of the
effect of three types of fixative on immunohistochemical detection of
apoptosis in livers from fish exposed to 6.7 pM of MNNG and for the
evaluation of immunohistochemical detection of apoptosis in liver of
fish exposed to 6.7 pM MNNG and 6.9 mM 2-AF were used, except that

108

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

additional, serial tissue sections were made for immunohistochemical
detection of PCNA.
Immunohistochemical Technique for Identifying PCNA
in Fish Tissues
After processing and embedding the tissues in paraffin, 2-3 nm
sections were cut and mounted on charged slides, then deparaffinized
and rehydrated to distilled water.

The tissue sections were stained

using the avidin-biotin complex method described by Hsu (Hsu, Raine et
al. 1981).

Antigen unmasking was performed in a pressure cooker (Shi,

Cote et al. 1977; Norton, Jordan et al. 1994) with
buffer, pH 6.0.

0.01 M Citrate

An avidin/biotin blocking step was used to block non

specific staining.

The primary antibody used was mouse anti-

proliferating cell nuclear antigen,PC-10 (Vector, California).
Biotinylated, horse anti-mouse (Vector) was used as the secondary
antibody.

For negative control normal mouse IgG was substituted for

the primary antibody.

For positive control a section of formalin-

fixed, paraffin-embedded human colon was used.

The entire staining

procedure was carried out at room temperature unless otherwise noted.
Briefly, endogenous peroxidase activity was blocked by immersing
slides in 0.3 % hydrogen peroxide in methanol for 30 minutes.

Slides

were rinsed in buffer, 10 mM Phosphate Buffer Saline + BRIJ (PBS-BRIJ,
Sigma), then incubated for 45 minutes with diluted normal horse serum;
the excess serum was removed, and diluted mouse anti-proliferating
cell nuclear antigen was placed on slides and incubated for 60
minutes.

The primary antibody was diluted according to information on

Primary Antibody Staining Evaluation Quality Control Sheet (1:100
dilution, DAKO).

Slides were rinsed in buffer (PBS-BRIJ) and the

Avidin (Avidin/Biotin Flush Kit) was applied for 15 minutes.

Slides

were rinsed in PBS-BRIJ buffer, and the Biotin (Avidin Biotin Flush
Kit) was applied for 15 minutes.

Slides were rinsed in PBS-BRIJ

buffer and the Avidin-Biotin Complex was applied and incubated on
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slides for 45 minutes at room temperature.

Slides were rinsed in PBS-

BRIJ buffer, and the chromogen, diaminobenzidine (DAB), was applied
for 5 to 10 minutes.
chromogen reaction.

Slides were rinsed in distilled water to stop
The slides were counterstained either with

Nuclear-Fast Red or Mayer's Hematoxylin, then dehydrated, cleared, and
mounted in a resinous media.
Results
Effect of Fixative on Immunohistochemical Detection of PCNA,
PC-10 in Livers of Fish Exposed to 6.7 pM MNNG
Detection of the proliferating nuclear cell antigen (PCNA), PC10
clone, was noted in normally proliferating tissues such as primary
filament epithelium of the gills, hematopoietic tissues, thymus,
retina, alimentary tract, liver, testis, and ovaries regardless of the
fixative used.

Results obtained from the effect of type of fixative

on immunohistochemical detection of PCNA in liver cells from fish
exposed to 6.7 pM MNNG are shown in table 3.1.

The range of positive

PCNA-labeled cell nuclei varied from 0 to 754 in the methacarn-fixed
tissues; from 0 to 358 in Strek's fixed tissues; and from 0 to 690 in
10 % formalin fixed tissues.

In liver tissues, where no PCNA-labeling

occurred or noted, most of the tissues fell off the slides during or
after the heat-activated antigen retrieval step.

Variation in the

intensity of nuclear staining was noted in all fixative groups.
Cytoplasmic staining was noted in both methacarn and Strek's fixed
tissues.

The greatest variation in number of PCNA-labeled cell nuclei

was seen in tissues in Strek's fixative.

The number of PCNA positive

cell nuclei from tissues fixed in 10 % formalin showed less variation
and showed a steady increase in positive PCNA-labeled nuclei, which
peaked by day 9 of the experiment.

The variation and distribution of

immunohistochemical detection of PCNA in liver tissues as a function
of type fixative used are best illustrated on histogram 3.2.

Figure
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3.1 shows representative PCNA staining characteristics obtained from
fish liver tissue fixed in 10 % formalin fixative.

Table 3.3.
Effect of Fixative on Immunohistochemical
Detection of PCNA in Livers from Fish Exposed to 6.7 ftM MNNG

Day of
Experiment

Fixative
Strek's

Methacarn

Formalin

(No. positive cell
(No. positive cell
nuclei/mm2 of tissue) nuclei/mm2 of tissue)

0
1
2
3
6
9
12
15

166
754
741
13
0
179
613
0

(No. positive cell
nuclei/mm2 of tissue)

249
6
0
6
38
358
64
38

140
140
153
166
332
690
383
0

Number of Positive Cell
nuclei /mn2 of Liver Tissue

Histogram 3.2. Immunohistochemical detection of PCNAPC10 in the liver of Fundulus grandis Fish Exposed to
6.7 pM MNNG in 5ppt Saltwater

0
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Days of Experiment
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Figure 3.1. Section of a 10 % formalin fixed liver tissue from
a fish exposed to 6.7 p M MNNG illustrating representative PCNAPC10 staining characteristics (Nuclear Fast Red, 200X)
Results of the quality of fixation obtained with the three
fixatives used, methacarn, Strek's, and 10 % formalin, as well as the
histological changes observed in these fish were described in the
corresponding section from chapter 2.
Immunohistochemical. Detection of PCNA in the Liver of Fish
Exposed to 6.7 JIM MNNG or 6.9 mM 2-AF
Hepatic immunohistochemical detection of PCNA-PC10 was performed
in a total of 210 fish specimens randomly selected from a total of 525
fish sampled from all of the different groups.

Mean numbers of PCNA-

labeled nuclei per mm2 of liver tissue per sampling day are shown in
table 3.3.

The means varied from 936 to 2849 in the 2-AF exposed fish

group; from 870 to 3220 in the MNNG exposed fish group; and from 895
to 2413 in the control fish group.

The histogram 3.3 illustrates the

comparative distribution of immunohistochemical detection of PCNA
between control fish and those exposed to 2-AF and MNNG.
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Analysis of the data obtained from immunolocalization of
proliferating cell nuclear antigen in the liver of Fundulus grandis
fish exposed to MNNG and 2-AF is summarized in appendixes 3.A to 3.C.
Two-factor factorial analysis of variance revealed significant
differences in group by sampling day interaction (P = 0.003), with
highly significant differences (P = 0.0001) obtained at day 9 of the
experiment between the PCNA least-square means of the treated fish
groups and that of the control fish group.

However, no significant

differences (P = 0.339) were found between the PCNA least-square means
of the MNNG and the 2-AF treated fish groups at day 9 of the
experiment.

In other words, the differences between the mean level of

immunohistochemically detected PCNA in the livers of treated versus
control fish were highly significant only at day 9 of the experiment
(group by day interaction) regardless of the compound used.

However,

no significant differences were found between the mean levels of
immunohistochemically detected PCNA in the livers of fish treated with
MNNG or 2-AF at day 9 of the experiment or at any other day.
Histologic evaluation of the 525 fish livers examined was
already described in chapter 2.
Discussion
Effect of Fixative on IHC Detection of PCNA in Livers of Fish
Exposed 6.7 |iM MNNG
Preservation of tissue morphology and application of the
mammalian methodology for the immunohistochemical localization of PCNA
was best preserved by 10 % formalin solution.

As discussed in chapter

2, aldehyde fixatives, such as formalin and gluteraldehyde, preserve
structure and immobilize antigens to a much greater degree than do
coagulant fixatives,

such as alcohols (methacarn), and are the most

commonly used fixatives for immunohistochemistry (Larsson 1993).
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Table 3.3.

Mean Hepatic Immunohistochemically Detected PCNA Positive
Nuclei per mm2 of Liver Tissue From Fish Exposed
to 6.7 pM MNNG or 6.9 mM 2-AF
6.9 mM 2-AF-Expoa ad Group

Day

Mean

Std. Dev.

% RSD*

0
3
9
21
45
90
180

1506
2784
2849
2414
1791
1078
936

880
1421
668
632
807
626
392

58.43
51.04
23.45
26.18
45.06
58.07
41.88

Control Group
Day

Mean

Std. Dev.

% RSD

0
3
9
21
45
90
180

1637
2413
1656
2111
1213
895
1058

1546
1190
635
598
394
505
644

94.44
49.32
38.35
28.33
32.48
56.42
60.87

6.7 pM MNNG-Expoaod Group
Day

Mean

Std. Dev.

% RSD

0
3
9
21
45
90
180

870
1881
3220
1839
1693
1533
1328

309
690
1433
742
536
1368
440

35.52
36.68
44 .50
40. 35
31.66
89.24
33.13

* % RSD = (Std. Dev./Mean) 100 %
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Histogram 3.3. Maan Iasaunohistochezaical dataction
of PCNA (PC-10) in the Liver of Fimdulus grandxa
Fish Exposed to 6.9 mM 2-AF or 6.7 jiM MNNG
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Ioununohistochemical Detection of PCNA in Livers From Fish
Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
The data obtained from the immunohistochemical detection of PCNA
suggests that after chemically-mediated cell injury, fish liver cells
respond by a significant increase in the level of PCNA expression that
peaks by day 9 of the experiment regardless of the chemical compound
used.

Histologically, however, peak number of hyperplastic changes

occurred by day 45 of the experiment in both MNNG and 2-AF treated
groups (see corresponding section on chapter 2).

Therefore, the

expression and detection of PCNA as an index of proliferation occurs
much earlier than histologic evidence of proliferation (hyperplasia)
is noted.

It is interesting to note that it is also at day 45 of the

experiment when the greatest detection of apoptosis was noted in this
experiment (see chapter 2).

These observations, taken together, may

represent a balanced homeostatic response of the liver of Fundulus
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grandis as a result of exposure to MNNG or 2-AF.

Concurrent use of a

marker for cell death, or apoptosis, with one of proliferation greatly
enhances the assessment of the effect of these compounds on liver cell
proliferation and on the study of hepatic carcinogenesis.
These experiments indicate that PCNA, PC-10, can be effectively
used as an index of cell proliferation in liver and liver lesions
found in Fundulus grandis fish.

And application of the mammalian

methodology for immunolocalization of PCNA in fish tissues are
consistent with previously published reports (Hinton 1994; Ortego,
Hawkins et al. 1994).

Also, that Fundulus grandis may be a useful

model for the study of liver cell proliferation and chemical
carcinogenesis.
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CHAPTER 4. DETECTION OF p53 IN THE LIVER OF FUNDULUS GRANDIS AFTER
EXPOSURE OF N-METHYL-N'-NITRO-N-NITROSOGUANIDINE AND 2-AMINOFLUORENE
Introduction
Damage to the cellular DNA can result in either restoration of
its genomic integrity, or in activation of the cell's own suicide
mechanism,

apoptosis, resulting in the elimination of the affected

cell from the rest of the population.

The normal (wild type) p53 gene

protein suppresses the division of genetically damaged or altered
cells by causing a pause in the cell cycle and by promoting exit from
it through apoptosis (Sidransky and Hollstein 1996).

This function of

p53 as "guardian of the genome" may extend to a role in initial
monitoring and repair of DNA damage in addition to direct control of
cell growth and death (Lane 1992).

The structural evolution of the

p53 gene protein was reviewed and summarized by Soussi(Soussi, Caron
de Fromentel et al. 1990).

Comparison of the predicted amino acid

sequences of the p53 gene protein from human, monkey, rat, chicken,
Xenopus spp., and rainbow trout revealed five highly conserved
domains.

Rainbow trout p53 showed 90 % homology to the human p53

sequence within these five domains (Van Beneden and Ostrander 1994).
Detection of p53 protein in some fish cell lines has also been
demonstrated (Smith, Yeleswarapu et al. 1991).

Immunohistochemical

detection of p53 protein (PAb 421 p53 protein clone) has been reported
in the fish Rivulus ocellatus marmoratus (Goodwin and Grizzle 1994a;
Goodwin and Grizzle 1994b).

Just recently, the p53 gene was cloned in

the Japanese medaka (Oryzias latipes) and the mutational hotspots in
MNNG-exposed fish were evaluated (Krause, Rhodes et al. 1997) .
In this study, immunohistochemical studies were performed to
evaluate and compare the detection and expression of p53 in liver and
liver lesions from fish exposed to the alkylating agent, n-methyl-n'nitro-n-nitrosoguanidine (MNNG) and to the polycyclic aromatic
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hydrocarbon, 2-aminofluorene (2-AF).

Preliminary studies required,

however, to improve the methodology employed consisted of: a)studies
on the stability of MNNG in saltwater since the fish species used
lives in saltwater, b) studies on the suitability of various tissue
fixatives on immunohistochemical detection of p53, c) studies on the
suitability of various commercially available anti-p53 antibody
clones, and lastly, d) a study on the sequential expression and
immunohistochemical detection of p53 protein in livers and liver
lesions of fish exposed to MNNG and to 2-AF.
Materials and Methods
Experimental Design
The study on the stability of MNNG in saltwater, to which fish
would be exposed over a time course in later experiments, was already
described in chapter 2.
To determine the most suitable tissue fixative and anti-p53
antibody clone for use in later experiments, livers from fish exposed
to MNNG were fixed in 1 of 3 different fixatives: 10 % formalin,
methacarn, or Strek's tissue fixative.

Livers were processed by

routine techniques and subjected to immunohistochemical (IHC) labeling
techniques to identify the endogenous p53 protein using the following
anti-p53 antibody clones: DO-1, DO-7, PAb 240, PAb 421, and CM-1.

The

overall tissue morphology and clarity and specificity of staining
characteristics were subjectively compared.

Finally, groups of fish

were exposed to MNNG or 2-AF at two different time durations and at
two different concentrations, and the immunohistochemical detection of
p53 was quantitatively determined by cytometry.
The following sections were described previously in chapter 2:
fish and fish housing, rationale for using the liver as the target
organ, compounds used, dosing rationale and route of administration,
determination for the stability of MNNG in saltwater, preparation of
feed containing 2-AF, cytometry, and the statistical analysis.
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The same procedures described in chapter 2 for evaluation of the
effect of three types of fixative on immunohistochemical detection of
apoptosis in livers from fish exposed to 6.7 pM of MNNG and for the
evaluation of immunohistochemical detection of apoptosis in liver of
fish exposed to 6.7 (iM MNNG and 6.9 mM 2-AF were used, except that
additional, serial tissue sections were made for immunohistochemical
detection of p53.
Method for IHC Detection of p53 Protein in Fish Tissues
Following tissue processing and paraffin embedding, serial
sections 2-3 urn thick were cut and mounted on charged slides, then
deparaffinized and rehydrated to distilled water.

The tissue sections

were stained using the avidin-biotin complex method described by Hsu
(Hsu, Raine et al. 1981).

Antigen unmasking was performed in a

pressure cooker (Shi, Cote et al. 1977; Norton, Jordan et al. 1994)
with 0.01M Citrate buffer, pH 6.0.

The entire staining procedure was

carried out at room temperature unless otherwise noted.

Briefly,

endogenous peroxidase activity was blocked by immersing slides in 0.3%
hydrogen peroxide in methanol for 30 minutes.

For the anti-p53

monoclonal antibody proteins, PAb 240, PAb 421, DO-1, and DO-7, the
slides were covered with 2 % normal horse serum (1:50), and for the
anti-p53 polyclonal antibody protein, CM-1, the slides were covered
with 2 % normal goat serum (1:50); all were incubated for 45 minutes.
An avidin/ biotin blocking step was used to block non-specific
staining.

The primary antibody for the p53 monoclonal proteins, mouse

anti-p53 (various clones), was applied on the slides and incubated
overnight at 4 °C at a dilution rate of 1:150 for p53 clone PAb 240,
1:10 for p53 clone PAb 421, 1:100 for p53 clone DO-1, and 1:50 for p53
clone DO-7.

The primary antibody used for the p53 polyclonal protein,

CM-1, was rabbit anti-p53 CM-1 diluted 1:100.

Normal mouse IgG

(Vector, California) and normal rabbit IgG (Vector) diluted at the
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same concentration as their respective primary antibodies were
substituted for primary antibody for the negative controls.

A canine

control was established as dual positive and negative control with SV40 transformed and untransformed altered canine tracheal cells (ACT-8
and ACT-8/SV40 cells, provided by Dr. Tierney, Inhalation Toxicology
Research Institute, New Mexico) and normal canine liver tissue
section.

Biotinylated horse anti-mouse (1:200) and biotinylated goat

anti-rabbit were incubated for 30 minutes (1:200).

The avidin-biotin

complex was prepared according to manufacturer's directions and
applied for 45 minutes.

Slides were rinsed in PBS between each step,

except between the normal goat or normal horse sera and primary
antibody steps.

The chromogen, diaminobenzidine, was utilized.

The

slides were counterstained either with Mayer's hematoxylin or NuclearFast Red, then dehydrated, cleared, and mounted in a resinous media.
Rasults
Effect of Three Types of Fixatives on Immunohistochemical
Detection of p53 Protein in Liver Tissue Using Five anti-p53
Antibody Clones
No detection of distinct nuclear DAB staining was found in any
of the liver specimens tested with the anti-p53 monoclonal (PAb 240,
PAb 421, DO-1, and DO-7) or polyclonal antibodies (CM-1), regardless
of the fixative used.

However, throughout the entire length of the

experiment, distinct nuclear staining was noted with the monoclonal
anti-p53 antibody PAb 240 in the epithelium of gills, oral mucosa, and
epidermis of the whole-fish specimens fixed in
figures 4.1, 4.2, and 4.3).

10

% formalin (see

Using a squared (grid) graticule, the

total number of DAB-stained gill epithelial cell nuclei was counted
from a total of 5, randomly chosen fields counted at 40-X; the average
was divided by a conversion factor of 0.1770 mm, and reported as
number of cells per linear mm of tissue ( see table 4.1).
The number of p53 positive cell nuclei/linear mm of gill tissue
varied from

86

to 485 in the formalin fixed specimens, and from 0 to
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626 in the methacarn fixed tissues.

No immunohistochemical detection

of p53 was recognized in any of the Strek's fixed tissues.
Distribution of the p53 immunohistochemical detection on gill tissues
are best illustrated in the histogram 4.2.

Results on the quality of

fixation obtained with the three fixatives used, methacarn, Strek's,
and

10

% formalin, as well as the histological changes observed in

these fish were described in the corresponding section from chapter

2

.

Immunohistochemical Detection of p53 protein (PAb 240) in the
Liver of Fish Exposed to 6.7 |iM MNNG and 6.9 mM 2-AF
Mean levels of immunohistochemically detected hepatic p53
protein per experimental day sampled from fish exposed to MNNG and 2AF are shown on table 4.3, and the statistical analysis of the data
obtained are shown in appendixes 4.A to 4.C.

In the 2-AF exposed fish

Figure 4.1.
Representative p53-PAb 240 Staining of the Gills
(Formalin Fixed Tissue, Hematoxylin, 200X)
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Figure 4.2. Representative p53-PAb 240 Staining of Oral Mucosa
From Fish (Formalin Fixed Tissue, Hematoxylin, 200X)

Figure 4.3. Representative p53-PAb 240 Staining of The
Epidermis From Fish Skin (Formalin Fixed Tissue, Hematoxylin,
200X)
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Table 4.1 Effect of Type of Fixative on IHC Detection of p53 (PAb
240) in the Gills From Fish Exposed to 6.7
MNNG

Day of
Experiment

Fixative
Strek's

Methacarn
(No. of positive
cell nuclei/ mm of

Formalin

(No. of positive
cell nuclei/ mm

(No. of positive
cell nuclei/ mm of

0

0

0

86

1
2
3

0
188
162
0
626
215
345

0
0
0
0
0
0
0

320
231
244
130
180
485
350

6

9
12
15

Histogram 4.2. Imminohistochamical detection of
p53 (PAb 240) in tbe Gills of Fundulus grandis Fish
Exposed to 6.7 (lM MNNG
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group the mean sample p53 levels varied from 0 to 21; those from the
MNNG exposed fish group varied from 1 to 75; and those for fish in the
control group varied from 1 to 4.

The highest level of p53 positive

nuclei was detected on the experiment day 180 in the MNNG exposed fish
group.

The difference in the population means between this MNNG

exposed fish group and those from the 2-AF exposed and the control
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fish groups is highly significant (P=0.0001) .

Two factor factorial

analysis of the p53 least-square means revealed highly significant
group by day interaction (P=0.0001).

A close look at the group main

effect, revealed highly significant (P=0.0001) differences between the
MNNG exposed fish and the control fish groups.

However, the least-

square means of the 2-AF and the MNNG exposed fish groups were not
significantly different, nor were the least-square means of the 2-AFexposed fish and the control fish groups.

Sampling-day main effect

least-square means showed highly significant differences between
sampling-day 180 and the rest of the sampling days.

Moreover, the

least-square means of the MNNG exposed fish at sampling day 180 was
significantly different (P=0.0001) from the least-square means of the
2-AF-exposed fish and of the control fish groups regardless of the day
sampled.

Immunohistochemical detection of p53 in the liver of fish

exposed to MNNG and 2-AF is illustrated in the histogram 4.3.
Histologic evaluation of the 525 fish livers examined was
already described in chapter 2.

Figure 4.4 illustrate staining for

p53 PAb 240 obtained in the liver of a fish exposed to 6.7 jiM MNNG at
day 180 of the experiment.
Discussion
Effect of Three Types of Fixatives on Immunohistochemical
Detection of p53 Protein in Liver Tissue Using Five anti-p53
Antibody Clones
Tissue morphology and immunohistochemical detection of p53 were
best preserved in the 10 % formalin fixed tissue.

Use of aldehyde and

coagulant fixatives for immunohistochemistry was discussed in chapter
2.

Manufactures of some of the anti-p53 proteins used (DO-1 and PAb-

240) suggested the use of methacarn as the fixative of choice.

It was

suggested that the clone PAb-421 be used on frozen sections, usually
post-fixed in paraformaldehyde solution.
clones were suggested to be used on

10

The rest of the p53 protein

% formalin as the fixative of
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Table 4.3. Mean He_patic Immunohistochemically Detected p53
Positive Nuclei per mirr of Liver Tissue From Fish Exposed to
6.7 pM MNNG or 6.9 mM 2-AF
6.9 mM 2-AF-Exposed Group
Day

Mean

Std. Dev.

% RSD*

0

0

0

0.00

3
9

9
4

11
9

122.22
225.00

21

0

0

0.00

45
90
180

8

15
4
25

187.50
200.00
119.05

Std. Dev.

% RSD

2
21

Control Group
Day

Mean

0
3
9
21
45
90
180

1
3
3
2
1
4
3

3
4
4
4
4
10
5

300.00
133.33
133.33
200.00
400.00
250.00
166.67

6.7 pM MNNG-Exposed Group
Mean

Std. Dev.

% RSD

0

1

3
9

2

4
3

6

10

400.00
150.00
166.67

21

1

2

200.00

45
90
180

1

2

200.00

5
73

10

200.00

63

86.30

Day

* % RSD = (Std. Dev./Mean) 100 %
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Histogram 4.3. Immunohistochemical Detection of
p53 (PAb 240) in the Liver of Fundulus grandis Fish
Exposed to 6.7 (iM MNNG and 6.9 mM 2-AF
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choice.

The mode of fixation of Strek's tissue fixative is unknown,

and it has not been recommended for use by any of the reagent
manufacturers.

The immunohistochemical detection of the p53 protein,

using the anti-p53 monoclonal antibody PAb 240, in the nuclei of the
epithelium from the gills, oral mucosa, and epidermis of Fundulus
grandis was unexpected.

It is believed that although wild type p53

protein has a short half-life, mutations stabilize the protein
allowing to be detected by immunohistochemistry (Fisher, Gillet et a l .
1994).

It was thought that all immunohistochemically detected protein

was mutant, as suggested by several reports (Smith, Yeleswarapu et al.
1991; Lang, Maurer et al. 1992; Piug, Flejou et al. 1992; Porter, Gown
et al. 1992; Goodwin and Grizzle 1994a; Goodwin and Grizzle 1994b).
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Figure 4.4. Section of liver from a fish exposed to 6.7 pM MNNG
at experimental day 180 stained for p53 PAb 240. Note the
distinct nuclear deposition of the chromogen diaminobenzidine.
(Nuclear Fast Red, 200X).
This may not necessarily be so.

As discussed by Fisher (Fisher,

Gillet et al. 1994), increase in expression of the normal p53 protein
can occur in response to DNA damage (Kastan, Onyekwere et al. 1991;
Hall, McKee et al. 1993; Rasbridge, Gillet et al. 1993), and it has
been shown that excessive amounts of normal p53 may be detected by
immunohistochemistry (Hall, McKee et al. 1993; Rasbridge, Gillet et
al. 1993)).

Why did the epithelial cells from the gills, oral mucosa,

and epidermis express apparently normal, wild type p53 protein in both
exposed and unexposed fish?

Why not in the liver cells?

It was

expected that positive p53 nuclear staining would be found in the
liver of Fundulus grandis by day 9 of the experiment.

This was

demonstrated by Goodwin and Grizzle (Goodwin and Grizzle 1994a;
Goodwin and Grizzle 1994b), who used the monoclonal anti-p53 protein
PAb 421 (Oncogene, Calbiochem) on frozen liver sections from the spot
fish (Rivulus marmoratus ocellatus) exposed to diethylnitrosamine;
however, their description failed to describe whether the staining for
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p53 was nuclear or cytoplasmic.

It is recognized that the tissue

processing methods employed in this study were different from those
used by these researchers (Goodwin and Grizzle 1994a; Goodwin and
Grizzle 1994b), however.
Immunohistochemical Detection of p53 in the Liver of Fish
Exposed to 6.7 pM MNNG and 6.9 mM 2-AF
Sequential evaluation of hepatic immunohistochemical detection
of the p53 protein in three groups of Fundulus grandis fish (control,
MNNG-exposed, and 2-AF-exposed) revealed statistically significant
differences in their levels of detection.

The highest level of p53

protein was detected in the MNNG exposed fish group on experimental
day 180.

Differences in the population means between this MNNG

exposed fish group and that of the 2-AF exposed and control fish
groups were highly significant (P = 0.0001).
The data obtained in this experiment suggest several points;
first, that the anti-p53 PAb 240 monoclonal antibody protein may be a
reliable marker of the p53 protein that occurs in Fundulus grandis
fish; second, that MNNG-mediated cell injury induces changes in the
DNA that may lead to increased levels of the p53 gene product due to
either an increase in its expression/activity, or a decrease in its
degradation; third, that there is a difference between the detected
levels of p53 protein in the MNNG and 2-AF exposed groups, and in the
MNNG exposed and control groups.

No difference was found between the

detected levels of p53 protein in the 2-AF exposed and control groups.
This finding of increased detection of p53 in the MNNG exposed
group is consistent with previous findings discussed in chapters
3,

2

and

where evidence of suppression of apoptosis and increased net-cell

proliferation in the liver of fish subjected to this compound was
presented.

These findings along with the increased occurrence of

putative preneoplastic changes noted histologically (basophilic foci,
megalocytosis, and karyomegaly) in this same MNNG exposed fish
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population, suggest that tumors with mutated p53 gene would develop,
in time, in the livers of these fish.

Based on these events, a

general scheme on the possible mechanisms of MNNG carcinogenesis may
be put together as shown in figure 4.5.

Because similar histological

changes were noted in the 2-AF exposed fish group in the absence of
increased p53, it is expected that the neoplastic process which may
occur as a result of exposure to this compound may not initially
involve changes in the modulation of the p53 gene product, but that
other mechanisms of carcinogenesis may be involved.
Biochemical Modifications
and DNA Damage
Adduct Formation

Stimuli by MNNG

Increased Activity/ Levels
of Mutant (?) p53, or
Decreased Degradation of
p53 Protein

(+)

Proliferation

Apoptosis

Genomic
Instability

Cancer

Figure 4.5. General Scheme on the Possible Mechanisms of MNNG
Carcinogenesis. Following stimuli by MNNG, a series of
biochemical modifications or reactions occur that leads to
direct DNA damage and
adduct formation. This leads to
increased accumulation of p53 protein as a result of a possible
mutation of the p53 gene, an increase in its activity, or a
decrease in its degradation. This leads to inhibition of
apoptosis, loss of the cell cycle control, and a positive
proliferation signal. Inhibition of apoptosis and positive
signal for proliferation leads to genomic instability and
subsequently, cancer (Legend: (+) = positive effect;
(-) = inhibitory effect).
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CHAPTER 5. CONCLUDING REMARKS
In this study, host response was measured through sequential
immunohistochemical detection of apoptosis, PCNA, and p53 in livers of
fish exposed to MNNG and 2-AF.

Preservation of tissue morphology and

application of mammalian methodologies for the immunohistochemical
detection of apoptosis, PCNA-PC10, and p53-PAb240 were best preserved
by buffered

10

% formalin solution.

The experiment suggests that the process of apoptosis in fish
livers is suppressed as a result of exposure to MNNG.

The lack of

significant differences found in immunohistochemical detection of
apoptosis between fish treated with MNNG and 2-AF suggests that the
process of apoptosis is also affected in fish treated with 2-AF.
After chemically-mediated cell injury, fish liver cells respond
by a significant increase in the level of PCNA expression that peaks
by day 9 of the experiment regardless of the chemical compound used,
MNNG or 2-AF.

This resulted in hyperplastic changes that peaked on

day 45 of the experiment in both MNNG and 2-AF treated groups.
Therefore, the expression and detection of PCNA as an index of
proliferation occurs much earlier than histologic evidence of
proliferation (hyperplasia).

However, it was also at day 45 of the

experiment when the greatest detection of apoptosis was noted.

These

observations, taken together, may represent a balanced homeostatic
response of the liver of Fundulus grandis as a result of exposure to
MNNG or 2-AF.

Therefore, concurrent use of a marker for cell death,

or apoptosis, with one of proliferation greatly enhances the
assessment of the effect of these compounds on liver cell
proliferation and on the study of hepatic carcinogenesis.

These

experiments indicate that PCNA, PC-10, can be effectively used as an
index of cell proliferation in liver and liver lesions found in
Fundulus grandis fish.
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Sequential immunohistochemical detection of the p53 protein
using anti-p53 PAb 240 monoclonal antibody protein revealed
significant differences in their levels of detection.

The highest

level of p53 protein was detected in livers from fish exposed to MNNG
on experimental day 180.

Differences in the population means between

this MNNG exposed fish group and that of the 2-AF exposed and control
fish groups were highly significant.
The data obtained in this experiment suggest that the anti-p53
PAb 240 monoclonal antibody protein may be used as a marker of the p53
protein that occurs in Fundulus grandis fish; that MNNG-mediated cell
injury induces changes (mutations) in the cellular DNA that may lead
to increased levels of p53; and that there is a significant difference
between the levels of p53 protein induced by the alkylating agent,
MNNG, and the polycyclic aromatic hydrocarbon, 2-AF, vs controls.
This finding of increased detection of p53 in the MNNG exposed
group is consistent with previous findings discussed in chapters

and

2

3, where evidence of suppression of apoptosis and increased net-cell
proliferation
presented.

in

the

These

liver of

findings

fish subjected

along

with

the

to

this

increased

putative preneoplastic changes noted histologically
megalocytosis,
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in time,
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occurrence

of

(basophilic foci,

MNNG

exposed

fish

suggest that tumors with mutated p53 gene would develop,

in the livers of these fish.

Because similar histological

changes were noted in the 2-AF exposed fish group in the absence of
increased p53,
occur

as

it is expected that the neoplastic process which may

a result

of

exposure

to

this

compound

may

not

involve changes in the modulation of the p53 gene product,

initially
but that

other mechanisms of carcinogenesis may be involved.
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APPENDIX 2.A.

GENERAL INFORMATION OF MNNG AND 2-AF

14466
Name:
Guanidine, N-methylN' -nitro-N-nitrosoSynonym: MNNG
LF:
CH3 N(N=0) C(=NH) NHNOj
MF:
C2 H5 N5 0 3
CAS RN: 70-25-7
BEIL RN: 1779490
BEIL REF.: 4-04-00-0338 6
MERK NO. : 6017
HDOC NO. : 13370
MW:
147.09
SOL.: DMSO 3
MS:
NIST 52438 30(100)
43
(70)
72 (64)
42 (61)
55
(35)
57 (34)
44 (33)
15
(26) 56 (22) 29 (18)
IR:
SADG 21386 3380 3260
1620
1530 1460 1430 1370
1250
1220
1080
900
790
640
'H NMR:
SAD 9194
3.3
9.7
DMSOde

13741
Name: 9H-Fluorene-2-amine
MF: C 13 Hn N
CAS RN: 153-78-6
BEIL RN: 1945861
BEIL REF.: 4-12-00-03370
HODOCNO.:
12711
MW: 181.24
MP [ °C]: 131.5 °C
COLOR: pi or nd ( dil al)
SOL:
H20 1;
ETOH 3;
ETH 3;
3; CS2 3
MS:
NIST 25380
181(100)
180(
152 (17)
182 (14)
90 ( 14)
(8 ) 165 (7) 76 ( 7)
151 (6 )
(5)
IR:
mCOB 3800
2940
1610
1390
1320
1280
1120
830
740
UV: SAD 54 286 MeOH
'H NMR:
SAD 15452
3.5 3.7
6.7 7.3 CDC13

(Lide And Milne 1994)
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ETC
66)

153
163
1470
770
6. 6

APPENDIX 2.B.

REGRESSION ANALYSIS OF PEAK NUMBER 3 (MNNG)

MNNG 5PPM IN SALT WATER
--------

PEAK=3---------

Model: MODEL1
Dependent Variable: AREA
Analysis of Variance
Sum of
Squares

DF

Source

Mean
Square

1 209647.64437 209647.64437
4 17733.83617
4433.45904
5 227381.48053

Model
Error
C Total

66.58423
371.55667
17.92034

Root MSE
Dep Mean
C.V.

R-square
Adj R-sq

F Value

Prob>F

47.288

0.0023

0.9220
0.9025

Parameter Estimates
Variable
INTERCEP
TIME

Obs
1
2
3
4
5
6
7
8
9
10

Dep Var
AREA
729.9
494.9
371.7
271.4
201.9
159.6

.

Predict
Value
754.6
645.2
535.7
426.3
316.8
207.4
97.9252
-11.5273
-121.0
-230.4

Sum of Residuals
Sum of Squared Residuals
Predicted Resid SS (Press)

Parameter
Estimate

Standard
Error

T for HO:
Parameter=0

Prob > |T|

754.640667
-10.945257

61.98654023
1.59166742

12.174
-6.877

0.0003
0.0023

DF

Std Err
Predict
61.987
48.190
36.179
28.324
28.324
36.179
48.190
61.987
76.610
91.665

Lower95%
Mean
582.5
511.4
435.3
347.6
238.2
106.9
-35.8720
-183.6
-333.7
-484.9

Upper95'4
Mean

Lower95%
Predict

Upper95%
Predict

926.7
779.0
636.2
504.9
395.5
307.8
231.7
160.6
91.7229
24.0702

502.1
417.0
325.3
225.4
115.9
-3.0171
-130.3
-264.1
-402.8
-545.0

1007.2
873.4
746.1
627.2
517.7
417.8
326.1
241.0
160.8
84.1269

Residual

.
84.7319
-40.8455
-54.6230
-45.4504
-5.5078
61.6948

0
17733.8362
59394.1395
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.

APPENDIX 2.C.I. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF APOPTOSIS (ISCDL) IN THE LIVER OF FUNDULUS GRANDIS

Class Level Information
Class

Levels

Values

GROUP

3

2-AF control mnng

DAY

7

0 3 9 21 45 90 180

Number of observations in data set = 210
Dependent Variable: ISCDL
Source

DF

Sum of
Squares

Mean
Square

F Value

Pr > F

Model

20

47221840.98

2361092.05

4.16

0.0001

Error

189

107188948.99

567137.30

Corrected Total

209

154410789.97

R-Square

C.V.

Root MSE

ISCDL Mean

0.305820

51.09966

753.0852

1473.758

Source

DF

Type I SS

Mean Square

F Value

Pr > F

GROUP
DAY
GROUP*DAY

2
6
12

4516440.07
33124284.70
9581116.21

2258220.04
5520714.12
798426.35

3.98
9.73
1.41

0.0202
0.0001
0.1651

Source

DF

Type III SS

Mean Square

F Value

Pr > F

GROUP
DAY
GROUP*DAY

2
6
12

4516440.07
33124284.70
9581116.21

2258220.04
5520714.12
798426.35

3.98
9.73
1.41

0.0202
0.0001
0.1651
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APPENDIX 2.C.2. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF APOPTOSIS (ISCDL) IN THE LIVER OF FUNDULUS GRANDIS
Least Squares Means
ISCDL
Std Err
Pr > ITI
LSMEAN
LSMEAN
HO:LSMEAN=0
1476.32732
90.01090
0.0001
1652.07079
90.01090
0.0001
1292.87539
0.0001
90.01090

GROUP
2-AF
control
mnng

LSMEAN
Number
1
2
3

Pr > |T| HO: LSMEAN(i )-LSMEAN(j )
i/j
1
2
3
1
.
0.1690 0.1512
2 0.1690
.
0.0053
3 0.1512 0.0053
NOTE: To ensure overall protection level, only probabilities associated with
pre-planned comparisons should be used.
DAY

ISCDL
LSMEAN

Std Err
LSMEAN

Pr > |T|
HO:LSMEAN=0

0
3
9
21
45
90
180

1332.05620
1550.65985
1385.16390
1079.60834
2383.88677
1394.63601
1190.29374

137.49391
137.49391
137.49391
137.49391
137.49391
137.49391
137.49391

0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

LSMEAN
Number
1
2
3
4
5
6
7

Pr > |T| HO: LSMEAN (i)=LSMEAN(j)
1
i/j
1
2 0..2623
3 0..7851
4 0.,1958
5 0.,0001
6 0.,7479
7 0.,4669

2
0.2623
0.3958
0.0164
0.0001
0.4233
0.0654

3
0.7851
0.3958
0.1178
0.0001
0.9612
0.3175

4
0.1958
0.0164
0.1178
0.0001
0.1069
0.5699

5
0.,0001
0.,0001
0.,0001
0.,0001
0,,0001
0.,0001

6
0.7479
0.4233
0.9612
0.1069
0.0001

.
0.2946

7
0.4669
0.0654
0.3175
0.5699
0.0001
0.2946
•

Least Squares Means
GROUP

DAY

ISCDL
LSMEAN

Std Err
LSMEAN

Pr > IT1
HO: LSMEAN=0

2-AF
2-AF
2-AF
2-AF
2-AF
2-AF
2-AF
control
control
control
control
control
control
control
mnng
mnng
mnng
mnng
mnng
mnng
mnng

0
3
9
21
45
90
180
0
3
9
21
45
90
180
0
3
9
21
45
90
180

1045.33845
1807.79055
1106.00256
985.95147
2598.65901
1505.74713
1284.80205
1881.22607
1359.51468
1547.25415
1360.79182
2296.29631
1498 .72286
1620.68964
1069.60409
1484.67432
1502.23499
892.08173
2256 .70500
1179.43805
665.38953

238.14645
238.14645
238.14645
238 .14645
238.14645
238.14645
238.14645
238.14645
238.14645
238.14645
238.14645
238 .14645
238.14645
238 .14645
238.14645
238.14645
238 .14645
238.14645
238.14645
238 .14645
238 .14645

0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

0.0001
0.0002
0.0001
0.0001
0.0057

LSMEAN
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
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APPENDIX 2.C.3. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF APOPTOSIS (ISCDL) IN THE LIVER OF FUNDULUS GRANDIS
E > |TI HO: LSMEAN(i)-LSMEAN(j)
Pr
1
i/j1
1
2 0.0247
3 0.8572
4 0.8602
5 0.0001
6 0.1732
7 0.4779
8 0.0139
9 0.3521
10 0.1378
11 0.3501
12 0.0003
13 0.1799
14 0.0892
15 0.9426
16 0.1937
17 0.1765
18 0.6496
19 0.0004
20 0.6910
21 0.2607

2
0.0247
0.0385
0.0156
0.0199
0.3710
0.1221
0.8276
0.1848
0.4401
0.1860
0.1486
0.3600
0.5792
0.0296
0.3386
0.3654
0.0072
0.1842
0.0636
0.0008

3
0.8572
0.0385
0.7219
0.0001
0.2367
0.5961
0.0224
0.4525
0.1917
0.4503
0.0005
0.2451
0.1281
0.9141
0.2623
0.2409
0.5261
0.0008
0.8276
0.1924

4
0.8602
0.0156
0.7219

5
0.0001

0.0199
0.0001
0.0001

0.0001

0.1244
0.3760
0.0085
0.2688
0.0972
0.2671
0.0001

0.1295
0.0610
0.8041
0.1403
0.1270
0.7808

6
0.1732
0.3710
0.2367
0.1244
0.0014

0.0014
0.0001

0.0344
0.0003
0.0021

0.0003
0.3704
0.0013
0.0041
0.0001
0.0011

0.0013
0.0001

0.0002

0.3112

0.5663
0.3424

0.0001

0.0001

0.5126
0.2663
0.6646
0.9020
0.6674
0.0199
0.9834
0.7333
0.1969
0.9502
0.9917
0.0700
0.0269
0.3338
0.0134

7
0.4779
0.1221

0.5961
0.3760
0.0001
0.5126
0.0782
0.8247
0.4368
0.8217
0.0030
0.5261
0.3199
0.5236
0.5536
0.5193
0.2451
0.0044
0.7547
0.0675

8
0.0139
0.8276
0.0224
0.0085
0.0344
0.2663
0.0782
0.1230
0.3226
0.1240
0.2193
0.2575
0.4401
0.0169
0.2405
0.2619
0.0037
0.2663
0.0385
0.0004

9
0.3521
0.1848
0.4525
0.2688
0.0003
0.6646
0.8247
0.1230
0.5779
0.9970
0.0060
0.6798
0.4390
0.3904
0.7106
0.6722
0.1668
0.0084
0.5935
0.0407

Pr > |TI HO: LSMEAN(i )-LSMEAN(j )
10
i/j1
1 0.1378
2 0.4401
3 0.1917
4 0.0972
5 0.0021
6 0.9020
7 0.4368
8 0.3226
9 0.5779
10
11 0.5805
12 0.0273
13 0.8856
14 0.8276
15 0.1578
16 0.8528
17 0.8938
18 0.0532
19 0.0365
20 0.2762
21 0.0095

11
0.3501
0.1860
0.4503
0.2671
0.0003
0.6674
0.8217
0.1240
0.9970
0.5805
0.0060
0.6826
0.4413
0.3884
0.7134
0.6750
0.1656
0.0085
0.5909
0.0403

12

0.0003
0.1486
0.0005
0.0001
0.3704
0.0199
0.0030
0.2193
0.0060
0.0273
0.0060
0.0189
0.0463
0.0003
0.0169
0.0194
0.0001
0.9065
0.0011

0.0001

13
0.1799
0.3600
0.2451
0.1295
0.0013
0.9834
0.5261
0.2575
0.6798
0.8856
0.6826
0.0189

14
0.0892
0.5792
0.1281
0.0610
0.0041
0.7333
0.3199
0.4401
0.4390
0.8276
0.4413
0.0463
0.7176

0.7176
0.2042
0.9668
0.9917
0.0733
0.0256
0.3443
0.0142

0.1034
0.6868
0.7254
0.0318
0.0605
0.1917
0.0051

15
0.9426
0.0296
0.9141
0.8041
0.0001
0.1969
0.5236
0.0169
0.3904
0.1578
0.3884
0.0003
0.2042
0.1034

.

0.2193
0.2005
0.5987
0.0005
0.7447
0.2316

16
0.1937
0.3386
0.2623
0.1403
0.0011
0.9502
0.5536
0.2405
0.7106
0.8528
0.7134
0.0169
0.9668
0.6868
0.2193

17
0.1765
0.3654
0.2409
0.1270
0.0013
0.9917
0.5193
0.2619
0.6722
0.8938
0.6750
0.0194
0.9917
0.7254
0.2005
0.9585

0.9585
0.0801
0.0230
0.3659
0.0159

0.0716
0.0262
0.3391
0.0138

0.0001
0.3946
0.5017

0.0016

0.0001
0.1286

.

18
0.6496
0.0072
0.5261
0.7808
0.0001
0.0700
0.2451
0.0037
0.1668
0.0532
0.1656
0.0001
0.0733
0.0318
0.5987
0.0801
0.0716

MEAN(i)=:LSMEAN(j )
19
i/j
.0004
1
.1842
2
.0008
3
.0002
4
.3112
5
.0269
6
7 .0044
.2663
.0084
9
.0365
10
.0085
11
.9065
12
.0256
13
.0605
14
.0005
13
.0230
16
.0262
17
.0001
18

20

21

0.6910
0.0636
0.8276
0.5663

0.2607
0.0008
0.1924
0.3424

0.0001

0.0001

0.3338
0.7547
0.0385
0.5935
0.2762
0.5909

0.0134
0.0675
0.0004
0.0407
0.0095
0.0403

0.0011

0.0001

0.3443
0.1917
0.7447
0.3659
0.3391
0.3946

0.0142
0.0051
0.2316
0.0159
0.0138
0.5017

19
20
21

0.0016
0.0001

0.1286

NOTE: To ensure overall protection
level, only probabilities associated
with pre-planned comparisons should be
used.
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APPENDIX 3.A. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNAL) IN THE LIVER
OF FUNDULUS GRANDIS

Class Level Information
Class

Levels

Values

GROUP

3

2-AF control mnng

DAY

7

0 3 9 21 45 90 180

Number of observations in data set = 210
Dependent Variable: PCNAL
Source

DF

Sum of
Squares

Mean
Square

F Value

Pr > F

Model

20

91711371.81

4585568.59

6.11

0.0001

Error

189

141832388.85

750435.92

Corrected Total

209

233543760.67

R-Square

C.V.

Root MSE

PCNAL Mean

0.392695

49.56140

866.2770

1747.887

Source

DF

Type I SS

Mean Square

F Value

Pr > F

GROUP
DAY
GROUP*DAY

2
6
12

4066533.13
64340161.04
23304677.64

2033266.57
10723360.17
1942056.47

2.71
14.29
2.59

0.0692
0.0001
0.0033

Source

DF

Type III SS

Mean Square

F Value

Pr > F

4066533.13
64340161.04
23304677.64

2033266.57
10723360.17
1942056.47

2.71
14.29
2.59

0.0692
0.0001
0.0033

GROUP
DAY
GROUP*DAY

2
6
12
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APPENDIX 3.B. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNAL) IN THE LIVER
OF FUmXJLVS GRANDIS
Least Squares Means
PCNAL
Std Err
Pr > |TI
LSMEAN
LSMEAN
H0:LSMEAN=O

GROUP
2-AF
control
mnng

1908.31965
1568.96551
1766.37475

103.53991
103.53991
103.53991

LSMEAN
Number

0.0001

0.0001
0.0001

Pr > IT| HO: LSMEAN)i)=LSMEAN(j)
i/j
1
1
.
2 0.0215
3 0.3336

2
3
0.0215 0.3336
.
0.1792
0.1792

NOTE: To ensure overall protection level, only probabilities associated with
pre-planned comparisons should be used.
DAY

PCNAL
LSMEAN

Std Err
LSMEAN

Pr > ITI
HO:LSMEAN=0

0
3
9
21
45
90
180

1337 .59047
2359 .30184
2574 .92550
2121 .54108
1565 .77267
1168 .79523
1107 .27969

158.,15983
158..15983
158..15983
158..15983
158..15983
158..15983
158..15983

0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

LSMEAN
Number
1
2
3
4
5
6
7

Pr > |T| HO: LSMEAN)i)“LSMEAN(j)
1
i/j
1
2 0..0001
3 0..0001
4 0,.0006
5 0..3090
6 0,.4514
7 0..3045
GROUP

DAY

2-AF
2-AF
2-AF
2-AF
2-AF
2-AF
2-AF
control
control
control
control
control
control
control
mnng
mnng
mnng
mnng
mnng
mnng
mnng

0
3
9
21
45
90
180
0
3
9
21
45
90
180
0
3
9
21
45
90
180

2
0.0001
0.3363
0.2891
0.0005
0.0001
0.0001

3
0.0001
0.3363

4
0.0006
0.2891
0.0441

0.0441
0.0001
0.0001
0.0001

0.0138
0.0001
0.0001

5
0..3090
0.,0005
0.,0001
0..0138
0.,0775
0.,0418

6
0.4514
0.0001
0.0001
0.0001
0.0775
.
0.7836

Least Squares Means
Std Err
PCNAL
LSMEAN
LSMEAN

Pr > |T|
HO:LSMEAN=0

273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085
273.94085

0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0008
0.0001
0 .0001
0.0001
0.0001
0.0001
0.0013
0.0002
0.0017
0.0001
0.0001
0 .0001
0.0001
0.0001
0.0001

1505.74713
2784.16349
2848.65902
2414.43167
1791.18773
1077.90549
936.14304
1636.65389
2412.51597
1655.81098
2111.11110
1213.28226
895.27458
1058.10982
870.37038
1881.22606
3220.30650
1839.08046
1692.84802
1533.20562
1327.58619

7
0 .3045
0 .0001
0 .0001
0 .0001
0 .0418
0 .7836
•
LSMEAN
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
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APPENDIX 3.C. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNAL) IN THE LIVER
OF FUNDULUS GRANDIS
Pr > ITI HO: LSMEAN(i)“LSMEAN(j)
i,/j
1
.
1
2 0.0012
3 0.0007
4 0.0200
5 0.4622
6 0.2708
7 0.1431
8 0.7358
9 0.0203
10 0.6989
11 0.1198
12 0.4512
13 0.1167
14 0.2494
15 0.1027
16 0.3337
17 0.0001
18 0.3907
19 0.6297
20 0.9436
21 0.6461

2
0.0012
0.8680
0.3411
0.0112
0.0001
0.0001
0.0034
0.3386
0.0040
0.0840
0.0001
0.0001
0.0001
0.0001
0.0208
0.2617
0.0156
0.0054
0.0015
0.0002

3
0.0007
0.8680
0.2638
0.0069
0.0001
0.0001
0.0020
0.2617
0.0024
0.0585
0.0001
0.0001
0.0001
0.0001
0.0134
0.3386
0.0099
0.0032
0.0008
0.0001

4
0.0200
0.3411
0.2 638

.
0.1093
0.0007
0.0002
0.0461
0.9961
0.0517
0.4346
0.0022
0.0001
0.0006
0.0001
0.1703
0.0389
0.1392
0.0641
0.0240
0.0056

5
0.4622
0.0112
0.0069
0.1093
0.0672
0.0285
0.6904
0.1104
0.7271
0.4100
0.1374
0.0218
0.0600
0.0185
0.8165
0.0003
0.9017
0.7999
0.5063
0.2329

6
0.2708
0.0001
0.0001
0.0007
0.0672
0.7148
0.1509
0.0007
0.1374
0.0083
0.7271
0.6379
0.9593
0.5928
0.0395
0.0001
0.0509
0.1141
0.2414
0.5200

7
0.1431
0.0001
0.0001
0.0002
0.0285
0.7148
0.0722
0.0002
0.0648
0.0028
0.4753
0.9161
0.7532
0.8654
0.0156
0.0001
0.0208
0.0523
0.1250
0.3136

8
0.7358
0.0034
0.0020
0.0461
0.6904
0.1509
0.0722

9
0.0203
0.3386
0.2617
0.9961
0.1104
0.0007
0.0002
0.0466

0.0466
0.9606
0.2222
0.2759
0.0572
0.1370
0.0494
0.5286
0.0001
0.6019
0.8848
0.7897
0.4260

0.0523
0.4375
0.0023
0.0001
0.0006
0.0001
0.1719
0.0384
0.1405
0.0648
0.0244
0.0056

Pr > |TI HO: LSMEAN(i)“LSMEAN(j)
i/j
1
2

3
4
5
6
7
8
9
10
11
12

13
14
15
16
17
18
19
20
21

10

11

12

,6989
,0040
,0024
,0517
,7271
,1374
,0648
.9606
,0523

0.1198
0.0840
0.0585
0.4346
0.4100
0.0083
0.0028

0.4512
0.0001
0.0001
0.0022
0.1374
0.7271
0.4753
0.2759
0.0023
0.2548
0.0215

.2414
,2548
.0511
.1245
.0440
.5614
.0001

.6367
.9239
.7520
.3979

0.2222

0.4375
0.2414

0.0072
0.0016
0.5536
0.0047
0.4834
0.2817
0.1374
0.0445

14
0.2494
0.0001

15
0.1027

0.0001
0.0001

0.0001

0.0001

0.0006
0.0600
0.9593
0.7532
0.1370
0.0006
0.1245
0.0072
0.6892
0.6747

0.0001

0.0218
0.6379
0.9161
0.0572
0.0001

0.0511
0.0020

0.4128

0.0215
0.0020

13
0.1167
0.0001

0.0001

0.0185
0.5928
0.8654
0.0494
0.0001

0.0440
0.0016
0.3772
0.9488
0.6285

0.4128
0.6892
0.3772
0.0863

0.6747
0.9488
0.0117

0.6285
0.0349

0.0098

0.0001

0.0001

0.0001

0.0001

0.1079
0.2173
0.4100
0.7683

0.0158
0.0409
0.1013
0.2659

0.0452
0.1030
0.2216
0.4875

0.0133
0.0351
0.0887
0.2394

16
0.3337
0.0208
0.0134
0.1703
0.8165
0.0395
0.0156
0.5286
0.1719
0.5614
0.5536
0.0863
0.0117
0.0349
0.0098

17
0.0001

0.2617
0.3386
0.0389
0.0003
0.0001
0.0001
0.0001

0.0384
0.0001

0.0047
0.0001
0.0001
0.0001
0.0001

0.0007
0.0007
0.9135
0.6274
0.3702
0.1546

18
0.3907
0.0156
0.0099
0.1392
0.9017
0.0509
0.0208
0.6019
0.1405
0.6367
0.4834
0.1079
0.0158
0.0452
0.0133
0.9135
0.0005

0.0005
0.0001
0.0001

0.0001

0.7063
0.4308
0.1883

Pr > IT| HO: LSMEAN(i)“LSMEAN(j)
i/j
1
2

3
4
5
6

7
8

9
10
11
12

13
14
15
16
17

19
0.6297
0.0054
0.0032
0.0641
0.7999
0.1141
0.0523
0.8848
0.0648
0.9239
0.2817
0.2173
0.0409
0.1030
0.0351
0.6274

20

21

0.9436
0.0015
0.0008
0.0240
0.5063
0.2414
0.1250
0.7897
0.0244
0.7520
0.1374
0.4100
0.1013
0.2216
0.0887
0.3702

0.6461

0.0001

0.0001

0.0001

18 0.7063 0.4308 0.1883
0.6808 0.3470
19
0.5962
20 0.6808
21 0.3470 0.5962
NOTE: To ensure overall protection
level, only probabilities associated
with pre-planned comparisons should
be used.

0.0002
0.0001

0.0056
0.2329
0.5200
0.3136
0.4260
0.0056
0.3979
0.0445
0.7683
0.2659
0.4875
0.2394
0.1546
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APPENDIX 4.A. STATISTICAL DATA ANALYSIS FOR miUNOHISTOCHEMICAL
DETECTION OF P53 PAB 240 PROTEIN (P53L) IN THE LIVER OF
FUNDULUS GRAND IS
General Linear Models Procedure
Class Level Information
Class

Levels

GROUP

3

2-AF control mnng

DAY

7

0 3 9 21 45 90 180

Values

Number of observations in data set = 210
Dependent Variable: P53L
Source

DF

Sum of
Squares

Mean
Square

F Value

Pr > F

Model

20

50320.12300

2516.00615

9.75

0.0001

Error

189

48774.52515

258.06627

Corrected Total

209

99094.64816

R-Square

C.V.

Root MSE

P53L Mean

0.507799

224.3292

16.06444

7.161102

Source

DF

Type I SS

Mean Square

F Value

Pr > F

GROUP
DAY
GROUP*DAY

2
6
12

3775.08691
22816.63963
23728.39647

1887.54345
3802.77327
1977.36637

7.31
14.74
7.66

0.0009
0.0001
0.0001

Source

DF

Type III SS

Mean Square

F Value

Pr > F

GROUP
DAY
GROUP’DAY

2
6
12

3775.08691
22816.63963
23728.39647

1887.5434b
3802.77327
1977.36637

7.31
14.74
7.66

0.0009
0.0001
0.0001
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APPENDIX 4.B. STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF P53 PAB 240 PROTEIN (P53L) IN THE LIVER OF
FUNDULUS GRAHDIS
Least Squares Means
P53L
Std Err
Pr > |T|
LSMEAN
LSMEAN
HO :LSMEAN=0

GROUP
2-AF
control
mnng

6.4313081
2.3718299
12 .6801678

1.9200680
1.9200680
1.9200680

LSMEAN
Number

0.0010

0.2183
0.0001

Pr > IT| HO: LSMEAN(i)=LSMEAN(j )
i/j
1
1
.
2 0.1366
3 0.0225

2
3
0.1366 0.0225
.
0.0002
0.0002

NOTE: To ensure overall protection level, only probabilities associated with
pre-planned comparisons should be used.
DAY
0
3
9
21

45
90
180

P53L
LSMEAN

Std Err
LSMEAN

Pr > |TI
H O :LSMEAN=0

0.8514261
4.4699872
4.2571307
0.8514261
3.4057045
3.8314176
32.4606213

2.9329523
2.9329523
2.9329523
2.9329523
2.9329523
2.9329523
2.9329523

0.7719
0.1292
0.1483
0.7719
0.2470
0.1930
0.0001

1
i/j
1
2 0.3841
3 0.4126
4 1.0000
5 0.5388
6 0.4734
7 0.0001

LSMEAN
Number

Pr > |TI HO: LSMEAN (i) “LSMEAN (j )
5
6
2
3
4
0.3841 0.4126 1.0000 0.5388 0.4734
0.9591 0.3841 0.7978 0.8778
0.9591
0.4126 0.8376 0.9184
0.5388 0.4734
0.3841 0.4126
0.9184
0.7978 0.8376 0.5388
0.9184
0.8778 0.9184 0.4734
0.0001 0.0001 0.0001
0.0001 0.0001

7
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

NOTE: To ensure overall protection level, only probabilities associated with
pre-planned comparisons should be used.
GROUP

DAY

2-AF
2-AF
2-AF
2-AF
2-AF
2-AF
2-AF
control
control
control
control
control
control
control
mnng
mnng
mnng
mnng
mnng
mnng
mnng

0

3
9
21
45
90
180
0

3
9
21
45
90
180
0

3
9
21
45
90
180

Least Squares Means
Std Err
P53L
LSMEAN
LSMEAN
5.0800223
- 0.0 0 0 0 0 0 0
5.0800223
8.9399744
4.4699872
5.0800223
5.0800223
- 0.0 0 0 0 0 0 0
5.0800223
8.3014048
2.5542784
5.0800223
5.0800223
20.7535120
5.0800223
1.2771392
5.0800223
2.5542784
5.0800223
2.5542784
5.0800223
1.9157088
5.0800223
1.2771392
5.0800223
3.8314176
5.0800223
3.1928480
5.0800223
1.2771392
5.0800223
1.9157088
5.0800223
5.7471264
5.0800223
0.6385696
5.0800223
0.6385696
5.0800223
5.1085568
5.0800223
73.4355040

Pr > |TI
HO :LSMEAN=0

LSMEAN
Number

1 .0 0 0 0

1

0.0801
0.3800
1.0000
0.1039
0.6157
0.0001
0.8018
0.6157
0.6157
0.7065
0.8018
0.4517
0.5304
0.8018
0.7065
0.2594
0.9001
0.9001
0.3159
0.0001

2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
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APPENDIX 4.C.
STATISTICAL DATA ANALYSIS FOR IMMUNOHISTOCHEMICAL
DETECTION OF P53 PAB 240 PROTEIN (P53L) IN THE LIVER OF
FUNDULUS GRANDIS
Pr > ITI HO: LSMEAN(i)=LSMEAN (j)
i/j
1
,
1
2 0.2149
3 0.5346
4 1.0000
5 0.2493
6 0.7226
7 0.0043
8 0.8591
9 0.7226
10 0.7226
11 0.7900
12 0.8591
13 0.5944
14 0.6572
15 0.8591
16 0.7900
17 0.4247
18 0.9293
19 0.9293
20 0.4779
21 0.0001

2
0.2149

.
0.5346
0.2149
0.9293
0.3752
0.1018
0.2875
0.3752
0.3752
0.3295
0.2875
0.4779
0.4247
0.2875
0.3295
0.6572
0.2493
0.2493
0.5944
0.0001

3
0.5346
0.5346
0!5346
0.5944
0.7900
0.0245
0.6572
0.7900
0.7900
0.7226
0.6572
0.9293
0.8591
0.6572
0.7226
0.8591
0.5944
0.5944
0.9293
0.0001

4
1.0000

0.2149
0.5346

,

0.2493
0.7226
0.0043
0.8591
0.7226
0.7226
0.7900
0.8591
0.5944
0.6572
0.8591
0.7900
0.4247
0.9293
0.9293
0.4779
0.0001

5
0.2493
0.9293
0.5944
0.2493
0.4247
0.0847
0.3295
0.4247
0.4247
0.3752
0.3295
0.5346
0.4779
0.3295
0.3752
0.7226
0.2875
0.2875
0.6572
0.0001

6
0.7226
0.3752
0.7900
0.7226
0.4247

.
0.0121
0.8591
1.0000
1.0000

0.9293
0.8591
0.8591
0.9293
0.8591
0.9293
0.6572
0.7900
0.7900
0.7226
0.0001

7
0.0043
0.1018
0.0245
0.0043
0.0847
0.0121
0.0073
0.0121
0.0121
0.0095
0.0073
0.0195
0.0154
0.0073
0.0095
0.0381
0.0056
0.0056
0.0307
0.0001

8
0.8591
0.2875
0.6572
0.8591
0.3295
0.8591
0.0073
0.8591
0.8591
0.9293
1.0000

0.7226
0.7900
1.0000

0.9293
0.5346
0.9293
0.9293
0.5944
0.0001

9
0.7226
0.3752
0.7900
0.7226
0.4247
1.0000

0.0121
0.8591

.
1.0000

0.9293
0.8591
0.8591
0.9293
0.8591
0.9293
0.6572
0.7900
0.7900
0.7226
0.0001

Pr > ITI HO: LSMEAN (i)=LSMEAN (j )
10
i/j
1 0.7226
2 0.3752
3 0.7900
4 0.7226
5 0.4247
6 1.0000
7 0.0121
8 0.8591
9 1.0000
.
10
11 0.9293
12 0.8591
13 0.8591
14 0.9293
15 0.8591
16 0.9293
17 0.6572
18 0.7900
19 0.7900
20 0.7226
21 0.0001

11
0.7900
0.3295
0.7226
0.7900
0.3752
0.9293
0.0095
0.9293
0.9293
0.9293

12
0.8591
0.2875
0.6572
0.8591
0.3295
0.8591
0.0073
1.0000
0.8591
0.8591
0.9293

0.9293
0.7900
0.8591
0.9293
1.0000
0.5944
0.8591
0.8591
0.6572
0.0001

0!7226
0.7900
1.0000
0.9293
0.5346
0.9293
0.9293
0.5944
0.0001

13
0.5944
0.4779
0.9293
0.5944
0.5346
0.8591
0.0195
0.7226
0.8591
0.8591
0.7900
0.7226
0.9293
0.7226
0.7900
0.7900
0.6572
0.6572
0.8591
0.0001

14
0.6572
0.4247
0.8591
0.6572
0.4779
0.9293
0.0154
0.7900
0.9293
0.9293
0.8591
0.7900
0.9293
0.7900
0.8591
0.7226
0.7226
0.7226
0.7900
0.0001

15
0.8591
0.2875
0.6572
0.8591
0.3295
0.8591
0.0073
1.0000
0.8591
0.8591
0.9293
1.0000
0.7226
0.7900
0.9293
0.5346
0.9293
0.9293
0.5944
0.0001

16
0.7900
0.3295
0.7226
0.7900
0.3752
0.9293
0.0095
0.9293
0.9293
0.9293
1.0000
0.9293
0.7900
0.8591
0.9293
0.5944
0.8591
0.8591
0.6572
0.0001

17
0.4247
0.6572
0.8591
0.4247
0.7226
0.6572
0.0381
0.5346
0.6572
0.6572
0.5944
0.5346
0.7900
0.7226
0.5346
0.5944
0.4779
0.4779
0.9293
0.0001

18
0.9293
0.2493
0.5944
0.9293
0.2875
0.7900
0.0056
0.9293
0.7900
0.7900
0.8591
0.9293
0.6572
0.7226
0.9293
0.8591
0.4779
1.0000
0.5346
0.0001

Pr > |T I HO: LSMEAN (i)=LSMEAN (j )
19
i/j
1 0.9293
2 0.2493
3 0.5944
4 0.9293
5 0.2875
6 0.7900
7 0.0056
8 0.9293
9 0.7900
10 0.7900
11 0.8591
12 0.9293
13 0.6572
14 0.7226
15 0.9293
16 0.8591
17 0.4779
18 1.0000

20
0.4779
0.5944
0.9293
0.4779
0.6572
0.7226
0.0307
0.5944
0.7226
0.7226
0.6572
0.5944
0.8591
0.7900
0.5944
0.6572
0.9293
0.5346

21
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

19
20
21

.
0.5346
0.0001

0.5346
.
0.0001

0.0001
0.0001

NOTE: To ensure overall
protection level, only
probabilities associated with
pre-planned comparisons should
be used.
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